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Abstract
The recent resurgence of drug resistant strains of Mycobacterium tuberculosis , the 
causal agent of tuberculosis (TB) has strengthened the need for new anti-TB drugs. 
However, the accompanying experiments are lengthy due to the slow growth rate and 
pathogenic nature of the tubercle bacillus. Consequently a faster growing, non- 
pathogenic Mycobacterium would be ideal as a first screen in drug discovery. This 
project investigated metabolic features of M. smegmatis to establish its utility as a first 
screen in the discovery of metabolic drug targets.
This thesis had two main areas of investigation: Firstly, the elucidation of the 
physiological and metabolic response of M. smegmatis at varying growth rates, under 
carbon-limitation in chemostat experiments. Secondly, the construction of genome 
scale metabolic networks (GSMN) of M. tuberculosis and M. smegmatis, with the 
purpose of consolidating biochemical information and carrying out in silico 
simulations. The accuracy of in silico predictions was assessed by comparison to in 
vitro experimental data.
Results showed that the nature of the carbon source does not impact greatly on the 
macromolecular composition of M. smegmatis cultured at different growth rates. It 
was also shown that M. bovis BCG and M. sniegmatis possess different 
macromolecular compositions when grown under glycerol-limitation, and the 
macromolecular composition of each species responds differently to changes in 
growth rate. The biomass concentration of the two species responded in the same way 
to an increase in dilution rate, and in addition, it was seen that carbon-limited, 
continuously cultured mycobacterial growth cannot be described by Monod kinetics.
The M. smegmatis GSMN predicted the effect of single gene deletions with an 
accuracy of 63%, whereas the GSMN of M. tuberculosis predicted global mutagenesis 
data with an accuracy of 78%. The M. smegmatis GSMN included more pathways 
involved in the metabolism of xenobiotics and it also permitted growth on methanol 
and carbon monoxide.
In conclusion, this thesis contributes to the knowledge of M. smegmatis in the field of 
mycobacterial metabolism. It has implications for the use of GSMNs in drug 
discovery, mycobacterial phylogeny and comparative genomics.
Foreword
Whilst undertaking my PhD I realised it was like a journey, long and meandering with 
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Chapter 1: Introduction
1.1. Mycobacteria
Mycobacteria are a genus of aerobic, acid-fast, non-motile, rod-shaped bacteria. Some 
members are free-living environmental saprophytes, whilst others are successful 
pathogens of humans and animals. As a genus they share a unique and complex ceU 
wall; it is waxy and lipid rich, making it hydrophobic and highly impermeable 
(Brennan and Nikaido, 1995). All mycobacteria stain acid-fast due to their thick cell 
wall which retains the Ziehl-Neelson stain despite treatment with an acidic solution.
Mycobacteria are non-spore forming bacteria of the order Actinomycetales, which 
include amongst others: Corynebacteria, Rhodococcus, Nocardia, and the antibiotic 
producing Streptomyces.
There are over 70 species of mycobacteria and these can be divided into two main 
groups: slow growers and fast growers. M. smegmatis is an example of a fast growing 
Mycobacterium, in that it has a doubling time of 4 hours, as opposed to slow growing 
mycobacteria M. bovis bacille Calmette Guerin (BCG), M. tuberculosis and M. 
paratuberculosis, which have doubling times of approximately 12, 16 and 22 hours 
respectively.
Mycobacteria are responsible for more suffering world wide than the combined total 
of all the other bacterial genera and they can be classified into several major groups 
for the purpose of diagnosis and treatment:
• M. tuberculosis complex which can cause tuberculosis: M. tuberculosis, M. 
bovis, M. africanum, and M. microti.
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• M. leprae which causes leprosy (Hansen’s disease)
• Non-tuberculous mycobacteria (NTM) are all the other mycobacteria which 
have the ability to cause tuberculosis-like pulmonary disease, lymphadenitis, 
wounds infections, or disseminated disease. M. avium is an example of an 
NTM which has the ability to cause opportunistic infection in AIDS (Acquired 
ImmunoDeficiency Syndrome) patients.
1.2. The mycobacterial cell wall
The mycobacterial cell wall is a complex and unique structure consisting of two 
segments: upper and lower (Fig. 1.1). The upper (soluble) segment (consisting of 
three sections: upper, mid and lower) is composed of free lipids, and long and short 
chain fatty acids. In addition to the above components, the upper segment consists of 
lipomannan (LM), lipoarabinomannan (LAM) and various cell wall proteins 
(Brennan, 2003, Ortalo-Magne et al., 1996). The lower (insoluble) segment consists 
of peptidoglycan covalently attached to arabinogalactan, which is in turn attached to 
mycolic acids; the resulting compound is termed the mycolic acid peptidoglycan 
complex (MAPc) (Fig. 1.1 and 1.2)
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Figure 1.1. A schematic representation of the cell wall of the tubercle bacillus. The
upper and lower segments and the proposed location of the various cell wall lipids are shown (Modified 
from Ortalo-Magne et al., 1996).
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It is the thickness, hydrophobicity and complexity of the mycobacterial cell wall 
which give it the following properties:
• Impermeability to aqueous stains and dyes
• Impermeability/resistance to many antibiotics
• Resistance to killing by acidic and alkaline compounds
• Resistance to complement-mediated lysis
• Resistance to intracellular killing by host macrophages
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Figure 1.2. A schematic representation of the mycobacterial cell wall (Modified 
from http://gsbs.utmb.edu/microbook/ch033.htm).
Much of the early structural elucidation of the mycobacterial cell wall began in the 
1960s and 70s. However, since the annotation of the TB genome and the advances in 
analytical techniques, our understanding of the structure and basic genetics and 
biochemistry of the mycobacterial cell wall has increased.
13
1.3. Tuberculosis: Infection and pathogenicity
Tuberculosis (TB) is a chronic (acute) bacterial infection caused by M. tuberculosis. 
In the majority of cases TB localises in the lungs, but may also spread throughout the 
body to affect the brain, kidneys, intestinal tract, bones, spine and lymph nodes (Al- 
Tawfiq, 2007). General symptoms include coughing, chest pain, shortness of breath, 
loss of appetite, weight loss, fatigue, fever and chills. People with lowered immunity 
are most at risk from TB, which is why TB is one of the earliest Human 
Immunodeficiency Virus (HIY)-associated infections in HIV-positive individuals 
(http://www.who .int/mediacentre/factsheets/fs 104/en/index .html).
In 1993 the World Health Organization (WHO) declared TB “a global emergency”, 
and in 1998 the organisation launched the “global stop TB initiative”.
TB statistics from the WHO:
One individual becomes infected with TB every second.
Almost 9 milhon people contracted TB in 2004.
5,000 people die from TB everyday.
Each year, nearly 2 million people die from TB.
Half of all untreated TB cases are fatal.
Each person with active TB disease will infect 10-15 people each year.
Quarter of TB deaths are HIV associated
Global TB incidence is growing at 1% per year due to the rapid increase in 
African cases.
The highest rates per capita are in Africa (29% of all TB cases).
Half of all new cases are in 6 Asian countries; Bangladesh, China, India, 
Indonesia, Pakistan and the Philippines.
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The WHO predicts that between 2000 and 2020, nearly 1 billion people will become 
infected with the TB bacillus and 35 million people will die from the disease.
1.3.1. Tuberculosis: Transmission and infection
TB is transmitted from person to person, usually by the inhalation of infectious 
droplets containing viable tubercle bacilli (M. tuberculosis or any member of the M. 
tuberculosis complex). The viable mycobacteria are then able to enter the lungs and 
multiply (Smith et al., 2004).
It has also been shown that the bacilli are able to enter the body through minor skin 
lesions, forming ‘primary cutaneous tuberculosis’ (Casalini et al., 2003), but this route 
of transmission is less common. Those who handle TB specimens, such as researchers 
and pathologists are at greater risk of contracting this form of TB disease.
If a person does contract the TB, disease can develop in two stages, primary and post­
primary.
1.3.1.1. Primary TB
Primary TB infection typically develops in the lower lobes of the lung after inhalation 
of infectious droplets. During the first few weeks post-infection bacteraemia occurs, 
resulting in disseminated TB infection which can spread to any organ in the body, 
other than the primary site of infection. In the vast majority of patients, primary 
infection is asymptomatic (or minimally symptomatic), and non-contagious (Smith et 
al., 2004).
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After an individual has become infected with M. tuberculosis, macrophages within the 
lungs ingest the bacteria. Once ingested, one of three things may occur: the bacteria 
are destroyed; the progression of the infection is halted (asymptomatic infection); or 
the bacteria multiply and thrive within the macrophage (primary TB) (Smith et al., 
2004).
If the bacteria multiply within the macrophage, primary TB will develop. Symptoms 
include coughing, night sweats, weight loss, and fever. A chest X-ray may show 
shadows in the lung. Alternatively, if the progression of mycobacterial infection is 
halted, the host’s immune system initiates a powerful cell-mediated immune response, 
which results in the formation of a granuloma or tubercle which seals off the 
infection. The tubercle gradually collects calcium deposits which result in the 
formation of a “Ghon focus” (Bendayan et al., 2000). This stage of the disease is 
termed asymptomatic infection, and as long as the immune system remains healthy, 
the latent M. tuberculosis infection will remain sealed off and inactive. During 
asymptomatic infection, the disease does not progress, but the mycobacteria are able 
to persist within the tubercle indefinitely. Conversely, if the immune system becomes 
weakened, the tubercle breaks down, releasing the bacilli; it is at this point that the 
infection could “reactivate” and develop into post-primary TB (Smith et al., 2004). 
For healthy people with asymptomatic TB infection there is a 5-10% risk of 
“reactivation” during their lifetime. However, for those people co-infected with HIV, 
the risk increases to 7-10% per year (Selwyn et al., 1989).
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13.1.2. Post-primary TB
Post-primary TB is often referred to as reactivated TB, and it occurs when the 
persistent tubercle bacilli within granulomatous lesions (sealed off after primary 
infection) reactivate. Once the bacilli break out of latency and start multiplying, they 
destroy lung tissue and bacteraemia occurs causing the bacteria to disseminate 
throughout the body. Fluid or air may collect between the lungs and the lining of the 
lungs, whilst tubercles continue to develop in the lung gradually destroying more lung 
tissue. At this point people may cough up blood/bloody sputum. Those with post­
primary TB are contagious and can spread TB to new naïve hosts. However, it is not 
known why the bacteria break out of latency.
1.4. Mycobacterial genetics
1.4.1. The M. tuberculosis genome
The 4.4mb, GC rich (59-66 %) genome sequence of M. tuberculosis H37Rv was 
completed in 1998 (Cole et al., 1998), and since its completion, investigation into M. 
tuberculosis pathogenesis has gained momentum. The genome is rich in repetitive 
DNA particularly that of IS6770 (Thierry et al., 1990), an insertion sequence of which 
there is sixteen copies; there are also six copies of the more stable IS7057 (van 
Soolingen et al., 1992), plus 32 previously unidentified insertion sequences. Insertion 
sequences specific to the M. tuberculosis complex, play a valuable role as DNA 
targets in the detection of TB in clinical samples. Two prophages have been detected 
in the genome, which have sequence similarity to bacteriophages from Streptomyces 
and saprophytic mycobacteria (Hendrix et al., 1999).
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1.4.2. The M. smegmatis genome
The genome sequence of saprophytic M. smegmatis has now been annotated (TIGR). 
At 6.9mb, M. smegmatis has the largest genome of the sequenced mycobacteria, and 
is 1.5 times larger than that of its pathogenic counterpart. BLAST searches of the 
genome revealed that it contains four ISiüO-like elements (Pagnout et al., 2006).
In silico genome comparisons between the M. tuberculosis and M. smegmatis 
genomes, have elucidated differences and similarities, which may aid in the 
understanding of pathogenesis, and in turn the elucidation of drug targets.
1.5. Mycobacterial metabolism (M. tuberculosis, M. bovis BCG & M. 
smegmatis)
Metabolism is the sum of all the chemical reactions that occur in a cell, and consists 
of two types of processes: catabolism and anabolism.
Catabolism: The process of breaking down large, complex molecules into smaller, 
simpler, molecules with the release of energy and reducing power (electrons) (NB. 
Not all energy generating processes involve the break down of larger molecules). 
Anabolism: The process of synthesising large, complex molecules from smaller, 
simpler molecules, with the consumption of energy and often reducing power.
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1.5.1. Central carbon metabolism
In the same way that power stations convert chemical energy (fossil fuels) into 
electrical energy, living cells also need a versatile energy resource to fuel their 
physiological needs. This resource is ATP (adenosine-triphosphate) and it is generated 
by the oxidation of metabolic fuel molecules. ATP is consumed by many metabolic 
reactions and physiological processes in all forms of life.
The main aim of central metabolism (also termed intermediary or primary) is to 
maintain a steady supply of ATP so that living cells can carry out all their essential 
processes. ATP is generated by the phosphorylation of adenosine diphosphate (ADP) 
by the following two distinct routes:
1. Substrate level phosphorylation occurs in the absence of oxygen. The only 
two glycolytic enzymes (and their respective reactions) that carry out substrate 
level phosphorylation are; Pyruvate kinase: Phosphoenolpyruvate + ADP = 
Pyruvate + ATP; and Phosphoglycerate kinase: 1,3-bisphosphoglycerate + 
ADP = 3-phosphoglycerate + ATP.
2. Oxidative phosphorylation occurs in the presence of oxygen, and is coupled to 
the oxidation of the reduced ‘hydrogen carriers’ NADH and FADH2 via the 
respiratory chain.
Central metabolism consists of the following pathways: glycolysis, the tricarboxylic 
acid (Kreb’s) cycle; the pentose phosphate pathway; fatty acid synthesis; ^-oxidation 
and the respiratory chain.
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I.5.I.I. Glycolysis
In order to conserve energy from the oxidation of glucose, three main catabolic 
pathways are involved; Glycolysis \  the tricarboxylic acid (TCA) cycle and the 
respiratory chain. Glycolysis in mycobacteria, and between mycobacterial species, is 
standard to that of most other organisms: One molecule of glueose is oxidised through 
a series of enzymatic steps, the end product of which is two molecules of pyruvate 
(Fig. 1.3).
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Figure 1.3. Classic glycolysis from E. coli. The enzymes involved are: 1) hexokinase; 2) 
phosphohexose isomerase; 3) phosphofruetokinase-1; 4) aldolase; 5) triosephosphate isomerase; 6) 
glyceraldehyde-3-phosphate; 7) phosphoglycerate kinase; 8) phosphoglycerate mutase; 9) enolase; 10) 
pyruvate kinase. The metabolites involved are: G6P: glucose-6-phosphate; F6P: fructose-6-phosphate; 
F16P: Fructose-1,6-phosphate; DHAP: dihydroxyacetone phosphate; GAP: glyceroaldehyde-3- 
phosphate; BPG: 1,3-bisphosphoglycerate; P3G: 3-phosphoglycerate; P2G: 2-phosphoglycerate; PEP: 
phosphoenolpyruvate; Pyr: pyruvate (Modified from Schwartz and Kanehisa, 2006).
 ^Also known as the Embden-Meyerhof-Pamas pathway
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Even though the genomes of M. tuberculosis and M. bovis share 99.9% identity, there 
are some key in vitro differences between the metabolism between the two species; 
M. bovis has several gaps in carbohydrate metabolism reflecting the following defects 
in its glycerol metabolism:
• The glycerol kinase (glpK) gene of M. bovis AF2122/97 is a pseudogene, thus 
preventing the phosphorylation of glycerol, and in turn its use as a carbon 
source.
• M. bovis lacks pyruvate kinase (pykA) activity, due to a point mutation within 
pykA which affects the binding of the Mg^ "^  cofactor (Gamier et al., 2003). 
Pymvate kinase (pyk) is an important enzyme as it joins glycolysis to the TCA 
cycle. Therefore, when M. bovis is grown on any carbon source which 
proceeds through glycolysis, it will not grow unless pymvate is added to the 
media (Wayne, 1984).
However, the creation of M. bovis BCG via the serial passage of M. bovis for 13 years 
on glycerol-soaked potato shces restored the activity of pykA (Calmette and Guerin, 
1909). This is because any spontaneous mutations within pykA which permits the 
binding of Mg^\ and in turn the metabolism of glycerol, would allow those mutants to 
flourish. It is unsure whether this alteration in metabolism played a role in the 
attenuation of M. bovis BCG (Gamier et al., 2003).
1.5.1.1.1, The utilisation of alternative carbon sources via glycolysis
The glycolytic pathway can process other carbon sources besides glucose. The two 
carbon sources utilised by M. smegmatis in this project are glycerol and succinate. 
Glycerol cannot enter glycolysis as it is, it must first be metabolised to a glycolytic 
intermediate, namely dihydroxy-acetone-phosphate via two reactions. First glycerol
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uptake is coupled to ATP hydrolysis and converted to glycerol-3-phopshate by 
glycerol kinase in the following reaction: Glycerol + ATP = glycerol-3-phosphate + 
ADP. Next glycerol-3-phosphate is then converted to dihydroxy-acetone-phosphate 
by glycerol-3-phosphate dehydrogenase in the following reaction: NAD(P)^ + 
glycerol-3-phosphate = NAD(P)H + dihydroxy-acetone-phosphate. Dihydroxyacetone 
is then able to enter glycolysis and feed through as if it was glucose. N.B. glycerol-3- 
phosphate dehydrogenase of M. tuberculosis H37Rv is NAD dependent, and NADP^ 
dependent in M. smegmatis and M. tuberculosis H37Ra (Ramakrishnan et al., 1972).
I.5.I.2. The tricarboxylic acid cycle
If one glucose molecule was fed into glycolysis, the end product would be two 
molecules of the 3-carbon compound pyruvate. Each molecule of pyruvate is 
converted to acetyl-CoA by pyruvate dehydrogenase (pdh) which in turn is then fed 
into the tricarboxylic acid (TCA) (Kreb’s) cycle in a series of reactions which 
produce: two molecules of CO2 ; three molecules of the reduced electron carrier 
NADH; one molecule of the reduced electron carrier FADH2 ; and one molecule of 
GTP (GTP is energetically similar to ATP, which is readily converted to ATP by 
nucleoside diphosphate kinase). These reduced electron carriers (also called hydrogen 
carriers, or cofactors) are then available to enter the respiratory chain in a series of 
reactions which generate ATP in the presence of oxygen.
The ‘classic’ TCA cycle (Fig. 1.4) is important not just for the production of reduced 
cofactors (electron carriers) and ATP, but also for the production of amino acid 
precursors such as a-ketoglutarate and oxaloacetate.
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Figure 1.4. The classic TCA cycle. The enzymes involved are: 1) citrate synthase; 2) 
aconitase; 3) isocitrate dehydrogenase; 4) a-ketoglutarate dehydrogenase; 5) succinyl-CoA synthetase; 
6) succinate dehydrogenase; 7) fumarase; 8) malate dehydrogenase (Modified from 
http ://ww w . chembio .uoguelph. ca/educmat/chm452/lectureS. htm).
The final step in the TCA cycle catalyses the oxidation of malate to oxaloacetate, via 
malate dehydrogenase. In M. tuberculosis malate dehydrogenase is NAD'^-dependent 
(the MALNAD pathway). Conversely, in fast growing M. smegmatis the same step is 
catalysed by a FAD-dependent malate-vitamin K reductase (the MALFAD pathway). 
Further still, M. phlei, an alternative fast growing Mycobacterium, possess both an 
NAD'^-dependent, and a FAD-dependent malate dehydrogenase (the MALNAD+FAD 
pathway) (Prasada Reddy et al., 1975).
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It has been shown that many organisms operate variant TCA cycles, indicating the 
differences in metabolic roles on the needs of the organism. The classic TCA cycle 
favours the generation of energy as well as biosynthetic precursors. In contrast, those 
organisms which operate a branched version of the TCA cycle, favour the synthesis of 
biosynthetic precursors. The branched version of the TCA cycle lacks a-ketoglutarate 
dehydrogenase {kdh) (converts a-ketoglutarate to succinyl-CoA) and consists of two 
branches, the oxidative branch and the reductive branch. The oxidative branch 
(involving the following enzymes: CIT, ACN, ICD) ends with the synthesis of a- 
ketoglutarate. The reductive branch (involving the following enzymes: CIT, MDH, 
FUM, SDH) leads to succinate production. Organisms which have an incomplete 
TCA cycle include: Haemophilus influenzae (Tatusov et al., 1996); Helicobacter 
pylori (Pitson et al., 1999); Methylococcus capsulatus (Patel et al., 1975); and 
Mannheimia succiniciproducens (Kim et al., 2007b). However, E. coli has the ability 
to operate both complete and incomplete TCA cycles; when grown aerobically it 
operates the classic TCA cycle, and when grown anaerobically it switches to a 
branched TCA cycle lacking kdh (Tian et al., 2005).
Even though M. tuberculosis, M. bovis BCG, and M, smegmatis all possess the kdh 
gene, they all lack in vitro kdh activity (Tian et al., 2005). However, it is not known 
whether they have a branched TCA cycle, or whether their half-cycles are joined via 
an alternative route, thus completing the cycle.
TCA half-cycles can be joined in several ways, for example H. pylori lacks kdh, and 
the oxidative and reductive branches of its TCA pathway are joined by a- 
ketoglutarate:ferredoxin oxidoreductase (2-oxoglutarate synthase) (Pitson et al.,
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1999). M. smegmatis and M. bovis BCG were found to be devoid of a- 
ketoglutarate:ferredoxin oxidoreductase activity (Tian et al., 2005). However, the 
enzyme is labile and oxygen-sensitive (Mai and Adams, 1996), so its presence cannot 
be ruled out. It has also been found that sucA, thought to encode E l - a putative 
component of kdh, instead encodes for a-ketoglutarate decarboxylase {kgd) (Tian et 
al., 2005). This may provide an alternative route from a-ketoglutarate to succinate in 
M. tuberculosis H37Rv, based on conversion of a-ketoglutarate to succinic- 
semialdehyde by a-ketoglutarate decarboxylase, followed by the production of 
succinate by succinic-semialdehyde dehydrogenase. M. tuberculosis has an unusual 
TCA cycle, because 2-ketoglutarate decarboxylase and succinic-semialdehyde 
dehydrogenase substitute for 2-ketoglutarate dehydrogenase and succinyl-CoA 
synthetase (Tian et al., 2005). However, these reactions bypass the production of 
succinyl-CoA which is needed for lysine and methionine synthesis. Therefore 
succinyl-CoA may be produced from succinate via the reverse action of succinyl-CoA 
synthetase.
It has been demonstrated that M. smegmatis is negative for NAD"^-dependent malate 
dehydrogenase activity (Tian et al., 2005) (Table 1.1). However, M. smegmatis has 
been shown to possess AADf ^ -dependent malate dehydrogenase activity, not NAD’*'- 
dependent activity (Seshadri et al., 1972).
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Table 1.1. The activities of nine TCA cycle enzymes from M. bovis BCG, M. 
smegmatis and M. tuberculosis H37Rv (T ian  e t al., 2005).
Enzyme Mtb H37RV M. smegmatis M. bovis BCG E. coli
Vmax, Vmax, Vmax, Vmax,
nmoi/min/mg nmoi/min/mg nmoi/min/mg nmoi/min/mg
P y ru v a te
d e h y d ro g e n a s e
64 33.4 4.4 206
C itra te  s y n th a s e 405 182 99.2 570
A co n itase 195 770 244.4 ND
Isocitra te
d e h y d ro g e n a s e
64 233 22.2 92
a -k e to g lu ta ra te ND ND ND 224
d e h y d ro g e n a s e
S uccinyl-C oA
s y n th e ta s e 7.5 25 20.5 20
S u c c in a te
d e h y d ro g e n a s e
6.4 47.5 11.5 46.1
F u m a ra s e 548 1222 1042 279
M alate
d e h y d ro g e n a s e
1149 ND 35.8 2229
However, the TCA cycle doesn’t just play a role in catabolism (breakdown) it is also 
involved in anabolism. When energy supplies are running low in the low fed state, the 
organism can metabolise its fat stores to produce acetyl-CoA which is able to enter 
the TCA cycle and the glyoxylate shunt (if present) to generate energy.
Most of the understanding on M. tuberculosis’s central metabolism is based on 
sequence homology of M. tuberculosis gene sequences to genes encoding those 
enzymes in other species. Still, sequence homology data must be corroborated with 
enzymatic data before a true metabolic model can be recreated.
I.5.I.3. The Pentose Phosphate Pathway
In the well-fed state cellular ATP levels are high; as a result, glycolysis is inhibited at 
phosphofructokinase (catalyses the conversion of fructose-6-phosphate to fructose- 
1,6-bisphosphate) and glucose is diverted towards glycogen synthesis. Once glycogen
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stores are full, glucose is redirected through the pentose phosphate pathway (PPP), a 
series of oxidative and non-oxidative reactions (Fig. 1.5).
Glucose-
NADPH
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Figure 1.5. The pentose phosphate pathway. The enzymes involved are: C G6PDH, 
glucose 6-phospahte dehydrogenase; 6-PGL, 6-phosphogluconolactonase; 6PGDH 6-phopshogluconate 
dehydrogenase; RPI, ribose 5-phosphate isomerase; RPE ribulose 5-hosphate epimerase; TAL, 
transaldolase; TKT, transketolase (Igoillo-Esteve et al., 2007).
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The first stage of the pathway is the oxidative branch which produces NADPH, a 
hydrogen carrier derived from niacin which is the reducing power for fatty acid 
synthesis and other biosynthetic reactions (unlike NADH which is involved in energy 
production). The second stage of the pathway is the non-oxidative branch and leads to 
the production of fructose-6-phosphate and glyceraldehyde-3-phosphate. Fructose-6- 
phosphate is available to cycle back around the PPP, whereas glyceraldehyde-3- 
phosphate is able to proceed through glycolysis. The PPP also produces ribose-5- 
phosphate, a precursor for purine and pyrimidine synthesis i.e. nucleic acids.
15.1.4. Fatty acid synthesis and degradation
Although fatty acids are structurally very simple, their biological functions are diverse 
and are listed below:
• Component of all cellular lipids
• Provide the cell with an energy storage compound in the form of TAGs
• Key role in the integrity and dynamics of phospholipid membranes
• Control of cellular metabolism and cell physiology, in the form of hormones
and chemical messengers
As mentioned previously, the end product of glycolysis is acetyl-CoA, which can 
either be processed by the TCA cycle, or via fatty acid synthesis pathways to 
synthesise long-chain fatty acids. Fatty acid synthesis is catalysed by the fatty acid 
synthase (FAS) complex which requires malonyl-CoA. A number of FAS systems and 
a large family of FAS-related enzymes have evolved over time, to produce a wide 
range of compounds, each by slight variations in FAS pathways (Schweizer and 
Hofmann, 2004).
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It has been shown that M. smegmatis contains both type I fatty acid synthetase (FAS- 
I) (catalyses de novo synthesis), and type II fatty acid synthetase (FAS-II) (catalyses 
the production of unusually long fatty acids). Type I fatty acid synthetase (FAS-I), is 
an acyl-carrier protein (ACP)-independent, multi-enzyme complex, found in 
eukaryotes and mycolic acid producing prokaryotes; type II fatty acid synthetase 
(FAS-II) is an (ACP)-dependent system found in eukaryotes, and most prokaryotes. 
The FAS-I and FAS-II systems of M. tuberculosis were shown to be similar to those 
of M. smegmatis (Besra et al., 1994, Bloch, 1977, Mehdi et al., 1979). However, a 3*^  ^
system exists in M. tuberculosis which is an extension of FAS-II, and it consists of a 
range of cyclopropane synthases and methyltransferases which catalyse the 
production of cyclopropanated mycolic acids (cyclopropane mycolic acid synthase 
cmaAl-A2, umaAl and proximal cyclopropane synthase pea A) and methoxy- and 
keto- mycolic acids (methyltransferases mmaAl-A4) (Takayama et al., 2005).
The FAS-I system (malonyl-CoA pathway) in mycobacteria enables them to 
synthesise C16-C18 and C24-C26 fatty acids (Bloch, 1977, Bloch and Vance, 1977). 
Acetyl-CoA and malonyl-CoA are the two starting blocks for FAS-I chain elongation, 
which proceeds via a series of cyclic reactions, with each cycle extending the fatty 
acid chain by two carbons. This eventually yields C16- and C18-S-Enz, which are 
converted to the Co A derivative, and used primarily for membrane phospholipid 
biosynthesis. The final cycle of elongation produces C20- and C26-S-Enz products, 
which are released as their CoA derivatives. FAS-I also produces hexacosanoyl-CoA 
(C26), and this fatty acid becomes the short a-chain and methyl carboxyl segment of 
all mycolic acids of M. tuberculosis (Barry et al., 1998, Takayama et al., 2005).
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Eventually FAS-II is required to take over from FAS-I for the synthesis of the very- 
long-chain mero segment of a-, methoxy-, and keto-mycolic acids (It is thought that 
FAS-II takes over from FAS-I at C20). FAS-II chain elongation proceeds via a series 
of cyclic reactions, each cycle extends the chain by two carbons. Fatty acid synthesis 
catalysed via FAS-II includes the following enzymes: p-ketoacyl-ACP synthase 
{kasA, kasW}\ (3-ketoacyl-ACP reductase; p-hydroxyacyl-ACP-dehydratase; 2-trans- 
enoyl ACP reductase (ink A). The product of ink A  can then proceed through the next 
cycle of elongation. P-ketoacyl-ACP reductase catalyses the NADPH (produced by 
the PPP) specific reduction of P-ketoacyl ACP.
Mycobacteria were shown to uptake fatty acids from the culture media and 
incorporate them into triacylglycerols (TAGs) (Daniel et al., 2004), via a series of 
estérification reactions which combine three fatty acids with glycerol-3-phosphate. It 
has been shown that during TB infection. C l6  and C l 8  fatty acids are transported into 
the cell and utilised by FAS-I for the production of mycolic acids (McCarthy, 1971, 
Weir et al., 1972).
Fatty acid degradation (P-oxidation) occurs via a cyclic series of reactions, but can 
only occur from TAGs, once the fatty acids have been detached. Each time the fatty 
acid chain (even number of carbons) enters the cycle, two carbons are lost as acetyl- 
CoA (which enters the TCA cycle) and one molecule of both FADHi and NADH are 
produced. The end product is acetyl-CoA, which is available to enter the TCA cycle.
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1.5.1.4.1. The methylcitrate cycle
The catabolism of odd-chain fatty acids via the p-oxidation cycle yields acctyl-CoA, 
and propionyl-CoA, which arc further metabolised via the TCA cycle (or the 
glyoxylate shunt), and the methylcitrate (MG) cycle (Fig. 1.6), respectively. The MC 
cycle was originally identified in yeast {Candida lipolytica (Tabuchi and Hara, 
1974)), and has since been shown to be present in several bacterial species, including 
E. coli (Textor et al., 1997, London et al., 1999), Salmonella enterica serovar 
typhimurium (Horswill and Escalante-Semerena, 1999), M. tuberculosis (Munoz-Elias 
et al., 2006) and M. smegmatis (Upton and McKinney, 2007).
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Figure 1.6. The methylcitrate cycle in M. tuberculosis. The enzymes involved are: ACN, 
aconitase; MCL, 2-methylisocitrate lyase;.SDH, succinate dehydrogenase; FUM, fumarase; MDH, 
malate dehydrogenase; MQO, malateiquinone oxidoreductase; MCS, methylcitrate synthase; MCD, 
methylcitrate dehydratase (Munoz-Elias et al., 2006).
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The MC cycle is analogous to the TCA cycle, in that the dedicated enzymes 
methylcitrate synthase, methylcitrate dehydratase and methylisocitrate lyase, replace 
those of citrate synthase, aconitase, and isocitrate lyase.
In M. smegmatis and M. tuberculosis, both isoforms of isocitrate lyase (ICLl and 
ICL2) are bifunctional (ICL/MCL), and are able to metabolise both isocitrate, and 
methylisocitrate. In addition to isocitrate lyase, M. smegmatis possesses a dedicated 
MCL. Conversely, M. tuberculosis lacks MCL, but it has been demonstrated that 
ICL/MCL is essential for survival in murine macrophages, highlighting that the MC 
cycle is essential for propionate metabolism in M. tuberculosis (Munoz-Elias et al., 
2006).
1.5.2. Aerobic respiration
Under aerobic conditions the electron carriers NADH and FADH2 carry protons and 
electrons generated by the catabolic pathways (e.g. glycolysis and TCA cycle), to the 
electron transport chain (ETC). The ETC is a series of five complexes embedded in 
biological membranes where ATP is generated by oxidative phosphorylation i.e. 
NADH is oxidised, and in turn ADP is phosphorylated to ATP (Fig. 1.7). The energy 
released from the hydrolysis of ATP can then be used for other physiological and 
biochemical processes.
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Figure 1.7. The electron transport chain. The ec numbers for each enzyme are in boxes 
below each of the complexes. Green boxes are those enzymes which are present in M. tuberculosis 
H37Rv, M. bovis BCG and M. smegmatis. Blue boxes are those enzymes which are present in both M. 
tuberculosis H37Rv, and M. bovis BCG. Yellow boxes are those enzymes which are present in M. 
sm egmatis only. Red boxes are those enzymes which are putative in the above three mycobacteria 
(Modified from Kegg).
The following is a list of each of the five complexes of the ETC and their respective 
reactions:
• Complex I (NADH dehydrogenase): NADH + H'" + ubiquinone = NAD"" + ubiquinol
• Complex II (Fumarate reductase): succinate + acceptor = fumarate + reduced 
acceptor
• Complex III (Ubiquinone cytochrome bc1 complex): QH2 + 2 ferricytochrome-c =
Q + 2 ferrocytochrome-c
• Complex VI (Cytochrome-c oxidase): 4 ferrocytochrome-c + O2 = 4 
ferricytochrome-c + 2 H2O
• Complex V (F1-ATPase): ATP + H2O + = ADP + phosphate + H^ut)
1.5.3. Anaerobic respiration
As mentioned previously, during aerobic oxidation, glucose is metabolised by 
glycolysis to pyruvate and in the process NAD"^ is reduced to NADH. In order to
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generate ATP, NADH is oxidised to NAD^ in the presence of oxygen. Thus, how can 
glycolysis acquire a constant supply of NAD'^ without oxygen as a terminal (final) 
electron acceptor? The answer lies in reactions which convert NADH to NAD"  ^ e.g. 
lactate dehydrogenase.
Anaerobic respiratory chain: Components of several anaerobic phopshorylative 
electron transport chains have been found in the TB genome, including genes for: 
nitrate reductase (narGHIJ): NO3' + NADH = NO2 + H2O + NAD'*'; fumarate 
reductase (frdABCD): succinate + FAD = fumarate + FADH2 ; and possibly nitrite 
reductase (nirBD): NO2' + 3 NADH = 2 OH + N H / + 3 NAD'*’; as well as new 
reductase (narX): acceptor + NO2 = reduced acceptor + NO3 , which results from the 
rearrangement of the narGHIJ operon. Conversely, M. smegmatis does not possess a 
nitrate reductase (Stermann et al., 2004), and was originally thought to be unable to 
reduce nitrate. Recently, a nitrate assimilation pathway was identified, which operates 
in both active and dormant M. smegmatis (Khan et al., 2008). It has also been shown 
that certain species of carbon monoxide oxidising mycobacteria, including M. 
tuberculosis H37Ra and M. vaccae (Park et al., 2003), possess a bifunctional carbon 
monoxide dehydrogenase (CO-DH) with nitric oxide dehydrogenase (NO-DH) 
activity (Hattoii et al., 2005). It has been suggested that the existence of a bifunctional 
CO-DH/NO-DH in pathogenic mycobacteria, may provide a mechanism for 
detoxifying reactive nitrogen species (RNS) during infection.
Truncated-Haemoglobin: Two genes encoding haemoglobin-like proteins which 
may protect against oxidative stress or be involved in oxygen capture have also been 
found in the M. tuberculosis genome. They may provide the tubercle bacillus with a
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mechanism for capturing oxygen while it is persisting in the granuloma. Truncated- 
Haemoglobin O (TrHbO) when expressed in E. coli was found to significantly 
enhance cellular respiration and cell growth (Liu et al., 2004).
1.5.4. Carbon monoxide and methanol dependent growth of mycobacteria
Carbon monoxide (CO) is present at trace amounts in the atmosphere, and its 
oxidation by soil microorganisms plays an important role in the environmental carbon 
monoxide cycle. Carboxydobacteria are bacteria which are able to utilise CO as their 
sole carbon and energy source under aerobic conditions (Park et al., 2003). It has been 
shown that most carboxydobacteria are gram negative, although some gram positive 
and acid fast bacteria of the order Actinomycetales including Streptomyces, Nocardia 
and Mycobacterium have also been described.
Many Carboxydobacteria are able to oxidise CO to CO2 via an inducible oxidase 
coupled to the reduction of O2 . However, in anaerobes, CO oxidation occurs via a 
carbon monoxide dehydrogenase (CO-DH), which inter-converts single carbon units 
and acetyl-CoA. Usually, in order to grow on CO, organisms must possess CO-DH 
and ribulose bisphosphate carboxylase/oxygenase (RuBisCo, an enzyme of the Calvin 
cycle, which catalyses the first step in carbon fixation). CO-DH is present in several 
mycobacterial strains including M. smegmatis, M. tuberculosis, M. phlei and M. 
vaccae (Park et al., 2003), all of which are able to grow on carbon monoxide serving 
as the sole carbon source. Interestingly, RuBisCo activity was detected in extracts 
prepared from all Mycobacterium species grown on CO, except M. tuberculosis. This 
observation is supported by the fact that M. tuberculosis lacks RuBisCo genes, 
indicating that it is utilising an alternative metabolic pathway to fix CO2 . It was
35
originally thought that a reductive TCA cycle was involved, as genes encoding 
fumarate reductase (frdABCD), a-ketoglutarate ferredoxin oxidoreductase (a- 
subunit), and citrate lyase (p chain) (citE) have been found in the genome. However, 
it was noticed that citrate did not affect growth on CO (Park et al., 2003). Recent in 
silico studies showed that growth on CO is likely to be via the fixation of CO to a 
glycolytic intermediate, as the insertion of the RuBisCo pathway into the GSMN of 
M. tuberculosis (iNJ661) did not restore growth on CO in silico (Jamshidi and 
Palsson, 2007). It is likely that M. tuberculosis lost some of the features of its soil- 
dwelling counterparts when it diverged and evolved into an obligate pathogen.
It was demonstrated that all the mycobacteria, except for M. tuberculosis, are able to 
grow on CO and methanol as the sole energy and carbon source, making 
mycobacteria the only taxonomic group known to utilise both substrates as the sole 
source of carbon and energy (Park et al., 2003).
I.5.4.I. Mycobacterial growth on xenobiotics
There are several studies highlighting the ability of fast growing mycobacteria to 
metabolise a broad range of xenobiotics as carbon sources, such as: hydrocarbons 
(Burback and Perry, 1993, Vanderberg et al., 1995); polycyclic aromatic 
hydrocarbons (PAHs) (Derz et al., 2004, Kim et al., 2007a, Kleespies et al., 1996, 
Kweon et al., 2007, Moody et al., 2004, Willumsen et al., 2001); and halogenated 
phenols (Uotila et al., 1992). These mycobacteria appear to play an important role in 
biodégradation and bioremediation of the environment.
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M. smegmatis is able to degrade a small variety of xenobiotics, including acetone, 
propanol, butane, pentane, hexane (Lukins and Foster, 1963), cholesterol (Av-Gay 
and Sobouti, 2000), and secondary amines such as pyrrolidine and piperidine (Poupin 
et al., 1999). Yet, the pathways involved in the degradation of these compounds are 
currently unknown.
1.5.5. Electron Carriers
In aerobic respiration oxygen is the final electron acceptor; however, electrons are not 
transferred directly to oxygen. Instead, when fuel molecules are oxidised, electrons 
are carried by special molecules called ‘electron carriers’ (also known as hydrogen 
carriers), which are either pyridine-based or flavin-based. The reduced forms of these 
electron carriers are then able to transfer their high potential electrons to oxygen via 
the ETC.
Nicotinamide adenine dinucleotide (NAD"*"): NAD"*" is one of the major electron 
carriers in the oxidation of fuel molecules. It contains a reactive nicotinamide ring 
derived from the pyridine-based vitamin, niacin. In the oxidised form, the nitrogen 
atom from the nicotinamide ring carries a positive charge Therefore upon the 
oxidation of a fuel molecule, the nicotinamide ring accepts a proton and two electrons 
(a hydride ion), in the following reaction:
NAD+ + H+ + 2e NADH (2)
The abbreviations for the oxidised and reduced forms are NAD'*' and NADH 
respectively.
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Flavin adenine dinucleotide (FAD): Another major electron carrier is flavin adenine 
dinucleotide (FAD). It contains a reactive isoalloxazine ring derived from the vitamin 
riboflavin. Upon the oxidation of fuel molecules, FAD is similar to NAD'*' in that it is 
able to accept two electrons. However, unlike NAD'*', FAD is able to accept two 
protons. Thus the abbreviations for the oxidised and reduced forms are FAD and 
FADH2 respectively.
Nicotinamide adenosine dinucleotide phosphate (NADP ): NADP^ is almost 
structurally identical to NAD^; however, it has a phosphate group esterified to the 
adenosine moiety of its 2-hydroxyl group. Despite this slight structural difference they 
carry electrons in the same way. Their associated functions are different: NADPH is 
used almost exclusively for reductive biosynthesis (e.g. Pentose phosphate pathway, 
fatty acid synthesis), while, NADH is used primarily for the generation of ATP.
1.5.6. Anaplerosis (anabolism)
As described previously, the TCA cycle oxidises acetyl-CoA (derived from 
carbohydrates, fatty acids and amino acids), to generate reduced cofactors, which are 
required for oxidative phosphorylation. It has also been mentioned that some of the 
TCA cycle intermediates are precursors for certain amino acids. Thus when some 
TCA cycle intermediates are removed for amino acid biosynthesis, they must be 
replaced, otherwise the flux through the TCA cycle will be disrupted and energy 
production will cease.
Anaplerosis is the term used to describe a series of reactions which maintain the flux 
through the TCA cycle by replenishing those intermediates lost to biosynthesis.
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(Anaplerosis literally means ‘topping up’). Aerobic bacteria must contain atleast one 
anaplerotic reaction (when growing on glucose or glycolytic intermediates); to 
maintain a steady supply of reduced cofactors for oxidative phosphorylation. Such 
reactions generate oxaloacetate from PEP via PEP carboxylase (PPG) or from 
pyruvate via pyruvate carboxylase (PC). In E. coli the main anaplerotic enzyme 
during growth on glucose is PEP carboxylase, but this enzyme is missing in M. 
tuberculosis (Cole et al., 1998). However, M. tuberculosis does contain an alternative 
enzyme: pyruvate carboxylase, which is also present in related Corynebacterium 
glutamicum (Peters-Wendisch, 1998).
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Figure 1.8. An outline of anaplerosis. The enzymes involved are: PPDK, pyruvate 
orthophosphate dikinase; PPS, PEP synthase; PK, pyruvate kinase; PC, pyruvate carboxylase; PDH, 
pyruvate dehydrogenase; PPC, PEP carboxylase; PCK, PEP carboxykinase; MEZ, malic enzyme. The 
green boxes highlight the main metabolites involved in anaplerosis. Reactions shown in red are absent 
in M. tuberculosis, but present in M. smegmatis', reactions shown in blue are present in M. tuberculosis, 
but absent in M. sm egm atis (Modified from Dunn, 1998).
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Studies have shown that when the environmental bacterium Methylobacterium 
extorquens was grown on pyruvate, TCA cycle intermediates were replenished via 
PEP synthase (PPS) followed by PEP carboxylase (PPC), or from pyruvate by malic 
enzyme (MEZ) (Van Dien et ah, 2003). M. tuberculosis cannot replenish lost 
intermediates via the same series of reactions. Although malic enzyme (malate 
dehydrogenase (Rvl240)), is present in M. tuberculosis (catalyses the reversible 
conversion of malate to pyruvate: malate + NAD’*' pyruvate + CO2 + NADH), PPS 
and PPC are absent (Munoz-Elias and McKinney, 2006). However, pyruvate 
decarboxylase is present in M. tuberculosis', it catalyses the conversion of pyruvate to 
oxaloacetate. Alternatively pyruvate could be converted to oxaloacetate via pyruvate 
orthophosphate dikinase and PEPCK (both reversible).
The main anaplerotic enzymes are shown in figure 1.8. It is known that most of these 
enzymes are conserved across other bacterial species, yet mycobacterial PEPCK is 
very different to those possessed by other bacteria studied to date. Research has 
shown that M. smegmatis, and M. tuberculosis possess a vertebrate-like GTP- 
dependent PEPCK (pckA) (Mukhopadhyay et al., 2001). As a rule ATP-dependent 
PEPCK is expressed in: protozoa, yeast and bacteria; whereas GTP-dependent 
PEPCK is expressed in: vertebrates, insects, helminths and fungi (Linss et al., 1993).
As mentioned above, the anaplerotic enzyme present in C. glutamicum is pyruvate 
carboxylase (PC). However, a different scenario is thought to exist in M. smegmatis 
regarding pyruvate carboxylase; it has been proposed that pyruvate carboxylase and 
PEPCK favour gluconeogenesis and/or glycerogenesis, rather than anaplerosis 
(Mukhopadhyay et al., 2001, Mukhopadhyay and Purwantini, 2000). Even though the
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pyruvate carboxylase genes of M. smegmatis and M. tuberculosis share significant 
homology, it is not known whether the above scenario can be applied to M. 
tuberculosis.
In summary, it can be seen that oxaloacetate (and malate) can be produced from 
pyruvate and phosphoenolpyruvate via combinations of the anaplerotic reactions 
present: phosphoenolpyruvate (PEP) to oxaloacetate catalyzed by
phosphoenolpyruvate carboxylase (PPC), from pyruvate to oxaloacetate catalyzed by 
pyruvate carboxylase (PC), from oxaloacetate to PEP catalyzed by PEP carboxykinase 
(PEPck), and from malate to Pyruvate catalyzed by malic enzymes (Fig. 1.8).
I.5.6.I. The Glyoxylate shunt
When a cell is in the low energy state, and carbohydrates in the media are absent or in 
low concentration, the cell will utilise its storage lipids/fatty acids (TAGs) as a carbon 
source via the p-oxidation pathway. This results in the production large amounts of 
acetyl-CoA, which is able to do two things:
1. Enter the TCA cycle
2. Feed into the glyoxylate shunt
Therefore by feeding acetyl-CoA (C2 compound) into the glyoxylate shunt, the 
organism is able to conserve those two carbons by avoiding the CO2 producing 
section of the TCA cycle. On the other hand, if the glyoxylate shunt was absent, the 
flux would flow through the lower half of the TCA cycle, and in the process two CO2  
molecules would be lost, thus rendering the cycle ineffective.
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The glyoxylate shunt is a pathway which produces two TCA cycle intermediates 
(succinate and malate) from one intermediate (isocitrate) plus a compound outside the 
cycle (acetyl-CoA). The glyoxylate shunt consists of two enzymes: Isocitrate lyase 
{id) and malate synthase {mas) (Fig. 1.9).
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Figure 1.9. The glyoxylate shunt. The enzymes involved are: isocitrate lyase and malate 
synthase (Modified from http://www.chembio.uoguelph.ca/educmat/chm452/lecture9.htm).
Isocitrate lyase is the first enzyme in the shunt and it produces glyoxylate and 
succinate from isocitrate. M. smegmatis, M. tuberculosis and M. bovis each possess 
two isoforms of isocitrate lyase (ICLI and ICL2); however, the genes which encode 
these enzymes have varying arrangements in different species of mycobacteria: In M. 
tuberculosis H37Rv, ICL2 is encoded by two overlapping genes aceAa and ace Ah, 
they share a single base pair at the 3' end of aceAa and the 5' end of aceAb; while in
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M. tuberculosis CDC1551 aceA encodes a single product. In M. bovis and M. bovis 
BCG Pasteur, a single base insertion leads to a single gene product (Cole et al., 1998, 
Marri et al., 2006).
Malate synthase is the second enzyme of the shunt; it catalyses the conversion of 
glyoxylate and acetyl-CoA to produce malate. The net reactions avoid the two CO2  
producing reactions of the TCA cycle. If the glyoxylate shunt was missing, anabolism 
would be pointless because the two carbons of acetyl-CoA would enter the TCA 
cycle, but would be lost as carbon dioxide by the time the cycle reaches succinyl- 
CoA, making the cycle ineffective as a mode of anabolism.
1.5.6.11. Regulation of the glyoxylate shunt
In bacteria with a functional glyoxylate pathway, isocitrate is the branch point 
between the oxidative TCA cycle (which leads to a net release of two CO2 from 
acetyl-CoA) and the biosynthetic glyoxylate pathway (which converts two acetyl- 
CoAs to malate).
The flow of isocitrate into either the TCA cycle or the glyoxylate shunt is controlled 
by the regulation of isocitrate dehydrogenase (icdh). icdh is inhibited when there is a 
large supply of NADH, which prevails in the high-energy state. A protein kinase 
(isocitrate dehydrogenase kinase phosphatase) phosphorylates icdh, converting it to an 
inactive form. When icdh is inhibited the flux through this section of the TCA cycle is 
inhibited. This diverts the isocitrate into the glyoxylate shunt to avoid release of CO2  
and generate TCA intermediates. On the other hand the presence of glycolytic and 
TCA intermediates, or indicators of energy shortage (ADP, NADP^) cause
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déphosphorylation and activation of icdh, thus reverting the flux through the TCA 
cycle once more.
The glyoxylate shunt is suppressed by glucose and the Arc system under anaerobic 
conditions (the arc system represses aerobic function under anaerobic conditions) in 
E. coli (luchi and Lin, 1988). In E. coli the isocitrate lyase gene (aceA), the malate 
synthase gene (aceB), and the isocitrate dehydrogenase kinase phosphatase gene 
{aceK), are organised together in the ace operon. Isocitrate dehydrogenase is activated 
(dephosphorylated) and deactivated (phosphorylated) by aceK. Isocitrate 
dehydrogenase functions at a branch point, thus by altering the activity of isocitrate 
dehydrogenase, the flux of isocitrate entering the glyoxylate cycle can be regulated 
(Chung et al., 1988, Honer Zu Bentrup et al., 1999). The isocitrate lyase repressor 
protein iclR (positively regulated by fadR, a fatty acid degradation/synthesis 
regulator), regulates the expression of the ace operon. As a result, the expression of 
the ace operon is limited to growth on acetate and fatty acids as the sole carbon 
source. Conversely, the expression of the glyoxylate shunt enzymes is suppressed if 
another preferred substrate is present e.g. glucose or pyruvate.
I.5.6.I.2. The role of the glyoxylate shunt in pathogenesis
The isocitrate lyase gene (id) was one of the first genes shown to have a role in 
persistent M. tuberculosis infection, when it’s disruption resulted in attenuated 
virulence and persistence (McKinney et al., 2000). During persistent TB infection, 
the organism adopts a slow growth rate, where it is thought to metabolise fatty acids 
within the macrophage (Russell, 2003). In support, it has been shown that M. 
tuberculosis isolated from chronically infected human lung tissue, preferentially
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utilises fatty acids over glucose as a carbon source (Bloch and Segal, 1956). It has 
also been demonstrated, that when M. avium was grown on palmitate, isocitrate lyase 
activity was over 12 times that when grown on glucose (Honer Zu Bentrup et al., 
1999).
The glyoxylate shunt has also been shown to be important in the pathogenesis of other 
organisms. For example, Rhodococcus fascians is a plant pathogen which triggers 
leafy gall formation via the secretion of signal molecules that interfere with the 
hormone balance of the host. A mutant was identified which had a mutation in its vicA 
gene rendering it avirulent. vicA was shown to have 6 6 % homology to mas (malate 
synthase) from M. tuberculosis. Malate synthase functions in the second step of the 
glyoxylate shunt (Vereecke et al., 2002). It has also been shown that when Candida 
albicans is phagocytosed, both enzymes of the glyoxylate shunt are upregulated 
(Lorenz and Fink, 2001). Both Candida and M. tuberculosis mutants lacking isocitrate 
lyase are less virulent in mice than the wild type organism (McKinney et al., 2000, 
Vereecke et al., 2002). This data in conjunction with previous evidence that isocitrate 
lyase is upregulated and required for virulence of M. tuberculosis (Lorenz and Fink, 
2002), demonstrates the significance of the glyoxylate shunt in virulence. To complete 
the story, Transposon Site Hybridisation (TraSH) mutagenesis was used to identify 
genes required for mycobacterial growth, and found that pckA (the gene which codes 
for phosphoenolpyruvate (PEPCK)), and id  (the gene which codes for isocitrate 
lyase), and enzymes involved in fatty acid degradation were essential for growth in 
vivo (Sassetti and Rubin, 2003).
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These observations suggest that an important survival mechanism for intracellular 
pathogens is the acquisition of nutrients from their host. Within the macrophage, 
growth depends on the activity of the glyoxylate shunt, which allows growth in an 
environment where fatty acids are the most likely carbon source (Russell, 2003).
1.5.7. The Phosphoenolpyruvate-glyoxylate cycle
As mentioned previously, for each turn of the TCA cycle, the two carbon compound 
acetyl-CoA is gained. Subsequently these two carbons are lost in the form of CO2, 
rendering the cycle ineffective under conditions of carbon deprivation. However, a 
novel cycle has been described in E. coli, where two molecules of PEP are 
metabolised via acetyl-CoA, citrate, glyoxylate, and oxaloacetate, to regenerate one 
molecule of PEP whilst losing one molecule of carbon in the form of CO2 (Fischer 
and Sauer, 2003) (Fig. 1.10).
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Figure 1.10. The Phosphoenolpyruvate-glyoxylate cycle in E. coli.
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The key reactions in this cycle are the enzymes of the glyoxylate shunt plus PEPCK. 
Together, their functions in this anabolic and catabolic cycle are separate to their 
recognised functions as enzymes of anaplerosis and gluconeogenesis respectively.
In a slow growing batch of “hungry” E. coli during conditions of carbon limitation, 
simultaneous operation of the PEP-glyoxylate cycle and the TCA cycle was seen 
(Fischer and Sauer, 2003). They found than when E. coli was shifted from a fast to 
slow growth rate, isocitrate dehydrogenase (idh) and PEP-carboxylase (pepc) were 
down regulated and PEPCK, isocitrate lyase, and malate synthase were upregulated, 
and as a result oxaloacetate is produced exclusively via the glyoxylate shunt. 
However, no evidence of the PEP-carboxylase cycle during fast growing chemostat 
cultures was observed.
More oxaloacetate is generated than is necessary for biosynthesis, therefore PEPCK is 
essential to convert the excess oxaloacetate to PEP, as it cannot be oxidised directly 
by the TCA without additional acetyl-CoA.
The absence of PEP-carboxylase in M. tuberculosis (Cole et al., 1998), and 
preliminary evidence that several key glycolytic enzymes are non-essential for in vitro 
growth (triosephosphate isomerase, glyceraldehyde-3-phophate dehydrogenase 
phosphoglycerate kinase) (Sassetti and Rubin, 2003), suggests that carbohydrates may 
be used for biosynthetic (anabolic) rather than catabolic processes in TB. If this theory 
is correct then pyruvate and PEP could be generated by TCA intermediates rather than 
glycolysis. The essentiality of id  and PEPCK in vitro could be down to the PEP- 
glyoxylate cycle (Fischer and Sauer, 2003). Other than the TCA cycle, the pep-
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glyoxylate cycle is the only energy yielding cycle capable of complete oxidation of 
carbohydrates to CO2 . During growth on fatty acids, the acetyl-CoA would be 
oxidised to CO2 whilst generating PEP and pyruvate for biosynthetic pathways. Under 
these conditions the TCA would operate in a bifurcated mode, as succinyl-CoA would 
be generated from succinate (Tian et al., 2005).
1.5.8. Gluconeogenesis
When carbohydrates in the media are close to exhaustion during starvation, 
intracellular fatty acids and amino acids are mobilised as carbon sources by the cell 
via gluconeogenesis. Alternatively gluconeogenesis is utilised when the organism is 
grown on a non-carbohydrate carbon source such as amino acids or fatty acids.
The TCA cycle intermediate OAA (oxaloacetate), is the starting point for 
gluconeogenesis (Fig. 1.11). First it must be decarboxylated and simultaneously 
phosphorylated by PEPCK (phosphoenolpyruvate carboxykinase), along with the 
simultaneous hydrolysis of GTP, to produce PEP (phosphoenolpyruvate). The 
remaining steps are the same as glycolysis in reverse, with one exception, fructose- 
1 ,6 -bisphosphatase which converts fructose-1 ,6 -bisphosphate to fructose-6 -phosphate. 
The purpose of this reaction is to overcome the large negative AG of 
phosphofructokinase ipfk).
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Figure 1.11. Classic gluconeogenic pathway. The enzymes involved are: 1) 
phosphoenolypyruvate-carboxykinase; 2) enolase; 3) phosphoglycerate mutase; 4) phosphoglycerate 
kinase; 5) glyceraldehyde 3-phosphate dehydrogenase; 6) aldolase; 7) fructose-1, 6-bisphosphatase; 8) 
phosphoglucose isomerase; 9) glucokinase/hexokinase. The metabolites involved are: G6-P: glucose-6- 
phosphate; FI,6-BP: fructose-1,6-bisphosphate; PEP: phosphoenolpyruvate; OAA: oxaloacetate 
(Modified from Velayudhan and Kelly, 2002).
The glyoxylate shunt and gluconeogenic pathways are both required in situations 
where the organism is utilising fatty acids; fatty acids are broken down to acetyl-CoA, 
which is used to fuel the glyoxylate shunt, which then generates TCA cycle 
intermediates which proceed through gluconeogenesis, which leads to the synthesis of 
glucose and other related sugars. These sugars are then available for assembly into 
various wall carbohydrates and complex mycobacterial lipids.
It is important to remember that gluconeogenesis is only possible from fatty acid 
breakdown in the presence of a functioning glyoxylate shunt. Without the shunt.
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gluconeogenesis would be futile, as both carbons from acetyl-CoA (entering the TCA 
cycle) would be lost as CO2 .
1.6. Chapter 1 conclusions
In summary, mycobacteria possess characteristic cell walls, hydrophobic, and rich in 
complex lipids. It has been shown, that although M. smegmatis and M. tuberculosis 
possess common cell wall components, the components specific to M. tuberculosis are 
virulence-associated. Yet, the similarities show that the two have obviously originated 
from a common ancestor. However, even though the two posses different lipid 
components, they may have a similar/identical macromolecular composition (Lipids, 
protein, carbohydrates, nucleic acids). If this is the case, fluxes towards the 
macromolecules may be similar, enabling the discovery of essential genes, which 
could be translated from M. smegmatis to M. tuberculosis.
It is known that there are numerous genetic factors involved in the pathogenesis of M. 
tuberculosis, including transcription factors, metabolic genes, and genes of unknown 
function. Although some M. tuberculosis virulence factors have homologues in M. 
smegmatis, these are thought to be housekeeping genes. Therefore, while M. 
smegmatis lacks genetic virulence factors, it does share some of the genetic features 
associated with oxygen depletion, thus enabling M. smegmatis to be used to explore 
and model certain aspects of persistence.
It has been shown that there are a few slight differences between the metabolic 
pathways and the reaction cofactors required between the three mycobacterial species. 
Yet even though the differences are subtle, it is these differences which have allowed
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the tubercle bacillus to survive intracellularly within macrophages and have 
contributed to its success as a pathogen. The experimental chapters will cover the 
reconstruction of genome scale models and their potential uses in mycobacterial 
research. Therefore, by carrying out Flux Balance Analysis (Chapter 3) on the 
metabolic models of M. tuberculosis and M. smegmatis, differences and similarities 
between the two will be highlighted. If the two have similar metabolic capabilities, 
then the M. smegmatis model may be suitable for identifying essential reactions, 
provided they can be translated into M. tuberculosis.
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1.7. Project aims and objectives
The aim of this project was/is to compare the metabolism and metabolic capabilities 
of M. smegmatis vs. the tubercle bacillus (M. bovis BCG). Could M. smegmatis be 
considered as a faster growing, non-pathogenic metabolic model of the tubercle 
bacillus?
The following specific experimental objectives are to be addressed:
1. Continuously culture M. smegmatis in a chemostat at different growth rates.
M. smegmatis will be continuously cultured under carbon-limitation (succinate or 
glycerol), at four growth rates in a chemostat. This will provide a large population of 
homogenous steady-state cells for subsequent biochemical biomass analysis.
• Will the succinate grown cells have the same biomass composition as glycerol 
grown cells?
• Will macromolecular compartments from succinate and glycerol grown cells 
respond in the same way to an increase in dilution rate?
• Will the biomass (dry weight) of succinate and glycerol grown cells respond in 
the same way to an increase in dilution rate?
• How different are the substrate uptake rates?
The glycerol-limited M. smegmatis biomass composition will be compared to that of 
glycerol-limited M. bovis BCG cells.
• Will the two species grown under glycerol-limitation have similar 
macromolecular biomass compositions?
• Will the macromolecular compartments from each species grown under 
glycerol-limitation respond in the same way to an increase in dilution rate?
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• Will the biomass (dry weight) of each species grown under glycerol-limitation 
respond in the same way to an increase in dilution rate?
• Will the two species have similar glycerol uptake rates?
The macromolecular biomass data will be combined with previously published M. 
smegmatis biomass data, to generate an estimated/hypothetical biomass composition 
which will form the biomass formula in the M. smegmatis GSMN (See 3).
2. Construct a genome scale metabolic network of M. tuberculosis
The construction of a GSMN will enable observation into the global effects of in 
silica gene deletions. The resulting data will be compared to previously published 
mutagenesis data from M. tuberculosis (Sassetti and Rubin 2003).
• Will the in silica deletions replicate the published data?
• Prediction of uptake rates?
The GSMN of M. tuberculosis will provide a basis from which to generate a GSMN 
of M. smegmatis.
3. Construct a genome scale metabolic network of M. smegmatis
The construction of a M. smegmatis GSMN will serve to increase the understanding 
of the metabohc system via exploratory in silica simulations. Will predicted (in silica) 
substrate uptake rates replicate in vitro measured substrate uptake rates?
M. smegmatis can utilise carbon monoxide and methanol, and a range of xenobiotic 
compounds. Can the model replicate these metabolic features?
Evaluating the information produced by the GSMN will reveal the reliability of the 
simulations.
To date there is no global mutagenesis data for M. smegmatis (as there is with M. 
tuberculosis (Sassetti and Rubin, 2003)), however, there is knockout data for a limited
53
number of metabolic genes. The model will undergo in silico gene deletions, the 
results of which will be compared against a small list of in vitro, metabohc gene 
deletions.
• How accurately will the model predict gene essentiality? Will it correctly 
predict previously identified front-line drug targets? Are those targets essential 
to M. smegmatisl
The M. smegmatis GSMN will be compared to the GMSN of M. tuberculosis.
• Do they possess identical pathways? If not, where are the differences? Do the 
differences reflect their natural environments?
M. smegmatis can be used to investigate metabolism of mycobacteria. Do the 
simulations reveal/predict any reactions or metabolic pathways that are active at 
different growth rates?
The answers to the above questions, will lead to an insight into the metabolic 
capabilities of the system, and in turn lead to the design of hypothesis driven 
experiments. The results to such in vitro experiments will go towards validating the 
model, which will in turn increase the predictive power of the model. Any differences 
in the metabolism between the two species could be used for possible future in vitro 
investigation into the evolution of the two species.
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Chapter 2: Elucidating the macromolecular composition of 
continuously cultured mycobacteria at varying growth rates 
within a chemostat (M. smegmatis vs. M. bovis BCG).
2.1. Introduction
The chemostat has been an invaluable tool for the study of microbial physiology since 
its development in the 1950’s. The growth rate of the microorganism under 
investigation can be manipulated by precisely controlling the environment within the 
chemostat vessel. Continuous culture involves pumping media into the vessel at the 
same rate that waste is pumped out the vessel. After several volume changes the 
metabolism within the culture reaches a phase called “steady-state”, at which point, 
all the physiological properties of the system are invariant, and the concentration of 
intracellular metabolites can be assumed to be constant (i.e. the sum of metabohc 
fluxes that produce each internal metabolite is equal to the sum of the fluxes which 
consume it). The chemostat is therefore essential for the production of large, 
homogenous populations of steady-state cells, which are grown within constant 
defined environmental conditions.
Chemostat culture enables observations to be made on how growth conditions impact 
on the physiology and biochemistry of the culture under investigation (cause-and- 
effect relationships). For example, how dilution rate impacts on the intracellular 
fluxes, substrate uptake rates, and macromolecular biomass composition. Studies on 
various microorganisms e.g. Cellulomonas sp. (Summers and Srinivasan, 1979), S. 
coelicolor A3(2) (Shahab et al., 1996), E. coli (Wang et al., 2006), Acineîobacter 
calcoaceticus (Abbott et al., 1974), have shown that the biomass composition varies
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in response to changes in the growth conditions. Steady-state cells allow for a more 
realistic estimation of metabolic fluxes, as all the metabolite pools are assumed to be 
invariant, and the resulting data doesn’t require the complex kinetic mathematics 
which are required for the data from batch cultures. In summary, the chemostat allows 
the investigation into cause-and-effect relationships on the bacteria under 
investigation.
It is easy to see how chemostats provide a suitable system for studying the metabolic 
and physiological response of a pathogen to specific conditions, by altering the 
conditions within the vessel to mimic those found within the host.
2.2. Chemostat theory
The theory of the chemostat was independently developed by Monod (1950) and 
Novick & Szilard (1950). The theory emphasises the importance of the relationship 
between specific growth rate (jj) and substrate concentration (s). The basis of this 
theory is that the specific growth rate of an organism, relative to its theoretical 
maximum growth rate (fimax), is governed by the concentration of a limiting external 
substrate (Novick and Szilard, 1950).
The specific growth rate of an organism is the rate of increase in culture biomass (X) 
per unit biomass already present, per unit time (r).
jL/= (dx/dt) • (1/X) (1)
A continuous culture is generally preceded by a short time as a batch culture, where 
growth follows the usual growth profile (lag, log, stationary and death phase). 
However, the continuous addition of fresh sterile medium to the culture vessel at a
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fixed rate, without the removal of waste, would mean that the culture volume and 
biomass would increase at the same rate, indefinitely. This type of system is termed 
fed batch culture, and an advantage of this process is that the population of cells 
within the vessel are growing at a fixed and constant rate. However, due to the 
dynamic conditions within the vessel (i.e. pH changes, build up of waste), this type of 
system is transient, and will never reach a steady-state.
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Figure 2.1. Diagram of a chemostat. An O2 probe measures the dissolved O2 in the culture. 
Sterile air enters through a port in the top plate. Media flow rate is controlled by a pump in relation to 
the working volume of the vessel to determine the dilution rate and in turn the specific growth rate of 
the culture. The sample port extends to the bottom of the culture, to ensure that all the contents of the 
vessel can be harvested at steady-state. The pH is measured by a pH probe and is maintained at a 
constant pH by the addition of acid and/or alkali. Waste media flow rate is controlled by a pump which 
ensures that birth rate is equal to death rate. Exhaust gas is measured by a gas analyser (Diagram 
adapted from www.chemsoc.org).
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The continuous culture system used to date (Fig. 2.1) was adapted from Monod’s 
preliminary research. The experiment (outlined above), was altered in such a way that 
during continuous culture, the influx of sterile medium was balanced by the efflux of 
waste medium; this allowed growth to occur at equilibrium, because the rate of cell 
division in the culture (the “growth rate”) was equal to the rate at which the culture is 
diluted (the “dilution rate”). The flow rate of fresh media into the continuous culture 
system is related to the volume of culture within the vessel, and is defined by the 
dilution rate:
D = F / V  (2)
D = dilution rate (1/h)
F  = flow rate (ml/h)
V  = culture volume (ml)
The main advantage of continuous culture is that the dilution rate controls the rate of 
microbial growth via the rate of supply of the growth-limiting nutrient to the culture. 
As long as the dilution rate is lower than the maximum growth rate (//max) of the 
species under investigation, the cell density will increase to a point at which the cell 
division rate exactly balances the cell washout rate. When the biomass concentration 
and exhaust gas remain constant over time, the culture is said to be at steady-state 
(Kubitschek, 1970).
It has been stated that under steady-state conditions, the dilution rate is numerically 
equal to growth rate. The critical dilution rate (Dc), is the dilution rate which is equal 
to the maximum specific growth rate (//m ax). Subsequently, if the dilution rate exceeds 
Dc, the cells are removed faster than they are produced, and disappearance of the
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entire population eventually occurs. It is at this point, that the culture is said to have 
suffered “wash-out” (Fig. 2.2).
a
co
E
mocoo
Dilution rate (1/h)
Washout
Figure 2.2. Steady-state relationship in the chemostat. The dilution rate is determined 
from the flow rate and culture volume. Note at high dilution rates, growth cannot balance dilution and 
the population washes out.
As mentioned previously, the most commonly used continuous culture device is the 
chemostat, designed to maintain a continuous culture of microorganisms in liquid 
medium at a constant density and at a constant growth rate. Fresh culture medium is 
added at a constant rate, F, and a fraction of the culture continuously washes out at 
the same rate F. Thus the volume V, of the culture remains constant, and the specific 
dilution rate, F/V, is also the specific rate of washout that every organism is subject 
to. The generation time of the chemostat td is defined as:
td = ln2/D (3)
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td = doubling time of the organism under investigation (h)
D  = dilution rate (1/h)
Ln2 = natural logarithm of 2
Therefore the maximum specific dilution rate is calculated from the washout. The 
maximum specific growth rate (pmax) for M. smegmatis was calculated as 0.17h'^ 
(from a doubling time of 4h from batch culture (data not shown)).
2.2.1. The Advantages of using continuous cultures
Chemostat grown cells are not subjected to the same growth perturbations that occur 
during batch culture, such as changing pH, build of waste and depletion of nutrients. 
Therefore, an advantage of chemostat experiments is that the physiological conditions 
reached are much more reproducible than those of batch cultures, which is important 
when it comes to reproducing and comparing data from independent experiments. 
Also steady-state chemostat cultures, allow for more realistic estimation of metabolic 
fluxes, as the system is assumed to be at steady-state, which is a pre-requisite for 
MFA, and the resulting data doesn’t require the complex mathematical kinetics which 
are required for the data from batch cultures.
2.3. “Maintenance energy” and Yxatp
Cell growth and in turn cell division are two of the most fundamental features of 
living cells. Both processes require vast amounts of energy, and are often the sole 
criterion used to gauge whether microorganisms are alive. However, judgements 
regarding whether a cell is alive, cannot be based solely on whether growth is evident 
or not. It must be remembered that living cells are expending energy, even if cells are
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not seen to be growing or dividing. This energy expenditure is termed the 
maintenance energy, and is the energy needed to maintain the life functions of a static 
cell e.g. regulation of osmotic potential, sensors, rebuilding structural proteins etc 
(Tempest and Neijssel, 1984).
Conversely, the growth yield of an organism is proportional to the amount of ATP 
produced by its catabolic processes (Bauchop and Elsden, 1960). This parameter is 
termed Y xatp (also known as Y atp) and is defined as the biomass (g) produced per 
mole of ATP consumed, which upon average is 10.5g, and is independent of organism 
and environment (Bauchop and Elsden, 1960, Senez, 1962). However, the value of 
Yxatp can vary between 5 - 30 g, and increases as the dilution rate increases (Giraud 
et al., 1991, Hitchener et al., 1979, Russell, 1991, Stouthamer and Bettenhaussen, 
1976, Verdoni et al., 1992).
TaTP =  YxATP • H +  niA TP (4 )
patp = rate of ATP consumption (mol ATP / g biomass / h)
Yxatp = yield of biomass on ATP (mol ATP / g biomass)
niATP = specific maintenance requirements of ATP (mol ATP / g biomass / h) (a
constant)
p = dilution rate (1 /h)
2.4. The use of the chemostat in M. tuberculosis research
As mentioned above, chemostats allow investigations into the physiological and 
biochemical effects of altering the growth conditions (i.e. growth rate, carbon source, 
presence of anti-mycobacterial drugs), on the bacterial population within the 
chemostat. Thus during chemostat culture, cells can be (in theory) continuously
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cultured indefinitely, to obtain a large amount of steady-state cellular material from 
which to obtain the necessary proteomic, genomic and metabolomic data. By carrying 
out metabolomic analysis, a snap shot of the internal metabolic workings of a 
mycobacterial cell can be recreated.
By controlling the environmental conditions within the chemostat, the impact of 
different growth rates on mycobacterial metabolism can be studied, which will aid in 
the elucidation of the metabolic differences between active and persistent TB, and 
between slow and fast growing mycobacteria.
It has been mentioned previously that infection with M. tuberculosis occurs in two 
phases: an acute (active) phase of the disease in which the bacilli are assumed to be 
growing at or near the maximum growth rate; and a persistent (slow growing) phase 
of the disease in which the individual is asymptomatic for TB infection. Consequently 
growth rate appears to be a critical factor in the physiology and pathogenesis of M. 
tuberculosis. The chemostat has enormous potential in the field of TB research, and 
has been used to culture the tubercle bacillus for a number of years (Bacon et al., 
2007, Bacon et al., 2004, Beste et al., 2005, Golby et al., 2007, James et al., 2000, 
Williams et al., 2005).
Chemostat culture provides an ideal in vitro method of studying mycobacterial 
metabolism. M. tuberculosis grows much slower than most other microbes that have 
been studied within a chemostat; with a doubling time that does not exceed one 
division every 14 hours (James et al., 2000), compared to for instance Saccharomyces
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cerevisiae which has a doubling time of 6.93 hours (Boer et al., 2005), consequently 
experiments are lengthy.
Previous in vitro culture models for the tubercle bacillus have mostly relied on batch 
culture (Mehta et al., 1996, Sun and Zhang, 1999, Winder et al., 1970, Winder and 
Rooney, 1970), which, as mentioned previously, subjects the bacteria to ill defined 
and constant changing vessel conditions. The resulting population of mycobacterial 
cells are heterogeneous, and bear little resemblance to cells in the host environment.
Continuous culture was shown to have a role in TB research when it was 
demonstrated that chemostat-grown M. tuberculosis produced disseminated infection 
in aerosol-infected guinea pigs similar to that caused by plate-grown cells (Bacon et 
al., 2004, James et al., 2000, Williams et al., 2005). In addition it was also shown that 
chemostat-grown cells were more invasive for mouse macrophages than batch-grown 
or plate-grown cells (James et al., 2000). In summary, these results highlight the 
importance of chemostats as a tool for continuously culturing pathogenic 
mycobacteria in a defined physiological state, whilst maintaining their pathogenicity.
2.4.1. Macromolecular and chemical composition of mycobacteria
Very limited data is available for the chemical and macromolecular composition of 
mycobacteria. Most analyses were performed in the 60s and 70s on batch cultures of 
various species of mycobacteria (i.e. M. tuberculosis H37Ra and H37Rv, M. phlei, 
etc). The datasets from such batch cultures are diverse, as the mycobacteria under 
investigation are frequently cultured on different media; the assays often measure 
different macromolecules; and the assays are carried out on different cellular
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compartments e.g. the cell wall, the entire cell, the basal layer. Therefore, from this 
data it is difficult to estimate the complete and true composition of the mycobacterial 
cell, as the data is scant and incomplete.
As mentioned previously, the major limitation of batch culture is that the 
environmental conditions are constantly changing as a result of bacterial metabolism, 
excretion of metabolic products and depletion of nutrients. This in turn has an 
unpredictable impact on the physiology and growth rate of the organism under 
investigation. Therefore can the macromolecular biomass composition of a batch 
culture be a true representation of their internal physiology? The conditions within 
batch cultures are not defined or controlled; they provide no information about the 
effects of changing certain parameters (i.e. growth rate) on the macromolecular 
content and in turn, the steady-state internal metabolic fluxes. However, as mentioned 
previously, continuous culture provides the investigator with an opportunity to study 
the effects of altering certain parameters on the cellular physiology and metabolism 
via approaches such as metabolic flux analysis, and flux balance analysis (See 
Chapter 3). In order to perform metabolic flux analysis, controlled and defined 
conditions are needed which lead to a steady-state, the resulting macromolecular 
analyses are used to determine intra and extracellular fluxes.
2.5. Chapter 2: Experimental aims
The aim of the research presented in this chapter was to study the metabolic effects of 
varying the carbon source and growth rate on the macromolecular biomass 
composition from continuously cultured wild type M. smegmatis cells.
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M. smegmatis will be cultured with two different carbon sources (glycerol-limited and 
succinate-limited), at four different growth rates, in order to perform biochemical and 
metabolic analyses of the microorganism:
• The macromolecular biomass composition and in turn metabolic flux 
distributions will be determined, and it will be seen if and how the biomass 
composition of M. smegmatis changes/differs with changes in carbon source 
and growth rate.
• The macromolecular biomass composition from M. smegmatis will be 
compared to that of M. bovis BCG in order to elucidate whether the biomass 
composition of saprophytic mycobacteria is comparable to that of the tubercle 
bacillus. If the two are comparable, then M. smegmatis could be used as a 
faster growing metabolic model of the tubercle bacillus.
Studying cells grown at different growth rates should enable the identification of 
metabolic differences between slow and fast growth rates, and between slow and fast 
growing mycobacteria.
2.6. Materials and methods
Strain of M. smegmatis
All experiments were conducted with M. smegmatis MC^155 (obtained from the 
American Type Culture Collection (ATCC)). Small aliquots of seed stocks were 
maintained in 10% glycerol at -80°C.
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Cultivation in liquid medium
All liquid culture experiments (flasks and bioreactor cultures) were conducted in 
Roisin’s minimal medium (carbon limited) for mycobacteria. The medium 
composition was (g/1): CaCl2 , 0.074; MgCb, 0.102; KH2PO4 , 1.0; Na2HP0 4 , 2.5; 
NH4 CI, 5.9; K2SO4 , 2.0; and trace elements (mg/1); ZnCh, 0.08; FECI3 .6 H2 O, 0.4; 
CUCI2 .2 H2O, 0.02; MnCl2 .4 H2 0 , 0.02; Na2B4O7 .1 0 H2 O, 0 .0 2 ; (NH4) 6M0 7 O2 4 .4 H2 O, 
0.50, and
The medium was supplemented with either glycerol (5 ml/1) or succinate (1181 mg/1). 
Tween 80 (2 ml/1) and Antifoam (0.5 ml/1). The pH was adjusted to 6 . 6  and was 
autoclaved at 121°C for 30 minutes, or filtered through a sterile 0.2 pm filter 
(Sartorius Ltd, Epsom, UK), and stored at room temperature.
Two types of containers were used for liquid cultures: Screw capped “universal” 
bottle (25 ml capacity), and conical flasks with a 500ml capacity. Sponges were used 
to seal the conical flasks. Inoculated flasks were kept within a rotary shaker-incubator 
at 37°C. Growth was monitored by measuring the ODeoo in a spectrophotometer.
Cultivation on solid medium
Nutrient broth #2 agar containing 0.5% glycerol was used to grow cultures from the 
frozen stocks. The same medium was used for viable counts in chemostat samples, 
and to test culture purity.
66
Continuous culture system
M. smegmatis was grown under carbon-limitation in either a Biolab Fermentation 
system (Braun, Melsungen, Germany), or an Adaptive Biosystems bioreactor system 
(Adaptive Biosystems Ltd, Luton, UK). Each system possessed a 2 1 (total volume) 
vessel fitted with a sealed titanium top plate. Culture conditions were continuously 
controlled by sensor probes inserted into the culture vessel through sealed ports in the 
top plate. Cultures were stirred using an impeller set to 500 rpm. Continuous culture 
was maintained by controlling nutrient addition from the media reservoir (Roisin’s 
minimal media) using a Gilson MinipulsS peristaltic pump, whilst waste was removed 
via a dip-tube attached to a Gilson Minipuls2 peristaltic pump, to ensure that the 
working volume was maintained at 1.51. The system was monitored daily to ensure no 
blockages were hindering media delivery. The temperature within the Biolab system 
was measured using a B. Braun temperature probe, and maintained at 37°C by an 
external heating jacket surrounding the vessel; the temperature within the Adaptive 
Biosystem was measured using a Biolab temperature probe and maintained at 3TC  by 
an internal heating rod. Culture pH was monitored using a FermProbe pH electrode 
(Broadley Technologies Ltd., Bedford, UK) and maintained at 6 . 6  by the automatic 
addition of either IM NaCl or IM HCl. The dissolved oxygen concentration was 
measured using a polarographic oxygen electrode (Ingold, Mettler Toledo, UK), and 
was monitored so that the culture was at 1 0 0 % oxygen saturation by ensuring 
adequate stirring, and air flow rate. Air was pumped into the vessel though a sterile 
filter (Sartorius, Ltd, Epsom, UK), and the flow rate was controlled externally. 
Exhaust gas was passed through a cooling condenser (to avoid water vapour entering 
the gas analyser), before it entered the gas analyser where the composition was 
measured.
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Vessel inoculation and continuous culture of M. smegmatis 
Inoculum cultures were grown in 150ml of Roisin’s media (glycerol-limited or 
succinate-limited) in glass conical flasks until late exponential phase. Prior to 
inoculation, the culture purity was determined by spread plates. The M. smegmatis 
inoculum was transferred into the vessel through the inoculation port in the top plate 
of the vessel. After inoculation the culture was grown in batch mode until the optical 
density (OD) had reached >1.0 at 600nm, at which time the media and waste vessels 
were connected. Continuous culture was then initiated at one of four dilution rates 
(Table 2.1), and maintained aerobically at pH 6 . 6  and 37°C, under carbon limitation, 
until the culture had reached steady-state (usually 4 volume changes). Samples were 
taken aseptically throughout fermentation and collected on ice via the waste port, to 
ensure minimal disturbance of the culture within the vessel. Once the culture within 
the vessel has reached steady-state, the contents of the vessel were harvested.
Table 2.1. Dilution rates employed in this study.
Growth rate (1/h) ml/h Time taken to reach steady-state (h) Doubling time (h)
0 .0 7 5 112 .5 6 0 .0 0  (2 .50  d ay s) 9 .2
0 .0 5 75 .0 9 0 .00  (3 .75  d ay s) 13.9
0 .0 2 5 37 .5 180 .00  (7 .50  d ay s) 2 7 .7
0.01 14.4 4 6 8 .7 5  (19 .53  d ay s) 69 .3
Culture analysis
To monitor the growth and purity of the culture, samples (40ml) were collected daily, 
aseptically throughout fermentation, into a sterile 100ml Duran (on ice) connected to 
the culture vessel via a branch off the waste port.
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The optical density of culture samples (3 x 1 ml) were measured at 600 nm (ODeoo) 
using a Pharmacia Biotech Ultraspec 200 UV-Visible spectrophotometer against a 
water reference.
Dry cell weight (DCW) was determined (3 x 10ml) (or 5ml if the culture reached an 
ODôoo of 2.0) by the method of Lynch and Bushell (Lynch and Bushell, 1995) (See 
appendix for method).
The Miles-Misra (Miles et al., 1938) enumeration method was used for estimating 
viable counts. The resulting dilutions were plated onto nutrient agar 2, and were 
enumerated after 4 days incubation at 37°C. The purity was also monitored daily by 
streak plates and/or gram staining. The purity of the cultures was obvious after 2 days 
incubation at 37°C. Acid fastness was determined by the Ziehl-Neelson staining 
method (BDH, Lutterworth, UK) according to the manufacturer’s protocol.
Samples were spun down in a chilled centrifuge at 30,000 rpm. The supernatant was 
removed, for supernatant analysis, and the pellet was washed with phosphate buffered 
saline (PBS) then spun at 30,000 rpm. This procedure was repeated 3 times, and the 
pellet was then freeze dried for later macromolecular analysis (DNA, protein, lipid, 
carbohydrate, RNA). The supernatant was kept at -20°C for later analysis.
2.6.2. Measuring substrate uptake/consumption
Glycerol and succinate were measured by commercial enzymatic assay kits (Roche).
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2.6.1. Macromolecular biomass analysis
Total protein, total carbohydrate, total lipid and total RNA and DNA were measured 
according to the procedures outlined in the appendix.
2.7. Results and discussion
M. smegmatis was continuously cultured under carbon limitation (glycerol and 
succinate), at four separate dilution rates (Table 2.1). Once the culture had reached 
steady-state at each of the 8  conditions (+ replicates), the contents of the vessel were 
harvested and the biomass was analysed for five macromolecular components (lipid, 
protein, carbohydrates, RNA and RNA), and its composition was determined.
The experiments discussed in this chapter were aimed at answering the following 
questions:
• Will the biomass concentration (dry cell weight) of M. smegmatis 
continuously cultured under carbon-limitation (glycerol or succinate), respond 
differently to an increase in dilution rate? How will it vary between carbon 
sources?
o Does M. smegmatis reach a similar biomass concentration (dry cell 
weight) to M. bovis BCG? Do they each respond in a similar manner to 
an increase in dilution rate?
• Will the macromolecular biomass composition of M. smegmatis continuously 
cultured under carbon-limitation (glycerol or succinate), respond differently to 
an increase in dilution rate? How will it vary between carbon sources?
o Does M. smegmatis have a similar macromolecular biomass 
composition to M. bovis BCG? Does the macromolecular composition
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of both species respond in a similar manner to an increase in dilution 
rate?
• Can M. smegmatis replace M. bovis as a faster metabolic model of the tubercle 
bacillus?
2.7.1. Dilution rates and the in vivo growth rate of the Tubercle bacillus
As mentioned previously, there were four dilution/growth rates employed in this 
study: 0.01; 0.025; 0.05; 0.075 h'  ^ (See table 2.1, pg 6 8 ). The in vivo doubling time of 
the Tubercle bacillus has been determined experimentally, by plating lung 
homogenates from chronically infected (acute-phase growth) mice (Munoz-Elias, 
2005), and was found to be approximately 24.6 h. This value is equivalent to a growth 
rate of 0.028 h '\  which is the middle point of the interval 0.03 h'  ^ and 0.025 h"\ Thus, 
when M. smegmatis is grown at 0.025 h'  ^ (or M. bovis BCG at 0.03 h'  ^ (Beste et al, 
2005)), this is equivalent to the doubling time of of the tubercle bacillus during acute- 
phase growth.
2.7.2. Biomass under carbon-limitation
The biomass concentration and optical density (not shown) did not vary significantly 
between glycerol-limited or succinate-limited cultures of M. smegmatis, at each 
dilution rate. However, there were observable differences between each dilution rate. 
It can be seen (Fig. 2.3) that as the dilution rate is increased, the biomass 
concentration decreases, following a trend of exponential decay towards theoretical 
wash-out (//max) in carbon-limited cultures of M. smegmatis and M. bovis BCG.
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The error bars show that the standard deviation of the biomass concentration 
decreases as the growth rate increases. This was expected, as the waxy, hydrophobic 
nature of mycobacterial cells predisposes them to bacterial adhesion, resulting in large 
amounts of cellular aggregation, or “clumping” (Borrego et al., 2000, Jarlier and 
Nikaido, 1994). Consequently, at lower dilution rates, the increased biomass 
concentration will result in larger amounts of “clumps”, and also higher degrees of 
biofilm formation (Recht et al., 2001, Zambrano and Kolter, 2005) (Detergents, such 
as Tween 80 are added to the liquid medium to alleviate the phenomenon). Therefore, 
the cultures from higher dilution rates are more dispersed, and in turn more 
homogenous than the cultures from low dilution rates, resulting in similar replicates.
It has been shown that typical bacterial growth can be described by Monod growth 
kinetics (Fig. 2.2). However, mycobacteria are more complex, as their growth (Fig.
2.3), cannot be described by classical Monod kinetics. Yet, this is not the first 
example of a culture not following typical Monod kinetics. Chemostat cultures of 
certain thermophilic bacteria have been shown to possess a similar growth profile to 
that reported here for mycobacteria, in that the biomass concentration also decreased 
as the dilution rate increased (Stoner et al., 1998).
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Figure 2.3. Effect of dilution rate on the biomass concentration during carbon- 
limited growth of M. smegmatis and M. bovis BCG. (o )  succinate-limitation (M  
smegmatis)', ( • )  glycerol limitation (M. smegmatis)', (T )  glycerol-limited (M. bovis BCG (Beste et al, 
2005)). (n = 3x3, error bars represent standard deviation of the mean).
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2.7.3. Substrate uptake/consumption
Chemostat experiments revealed that specific succinate uptake (qS) increased 
exponentially as the growth rate increased, whereas specific glycerol uptake (qS) 
increased linearly (Fig. 2.4). This result complements the previous observation (Fig.
2.3), that an increase in dilution rate was accompanied by a decrease in biomass 
concentration.
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Figure 2.4. Effect of dilution rate on the rate of substrate consumption during 
carbon-limited growth of M. smegmatis and M. bovis BCG. (•) qS succinate (M
sm egm atis); (O) qS glycerol (M. sm egm atis). (n = 3, error bars represent standard deviation o f  the 
mean).
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The specific substrate uptake rate (qS);
qS = rS / X
qS = Specific substrate uptake rate (mmol/g biomass/h) 
rS = Substrate uptake rate (constant) (mmol/h)
X = Biomass (g/l)
(5)
When the previous two results (Fig. 2.3 and 2.4), were combined it was seen that they 
complimented each other: as the population decreased, the specific substrate uptake 
increased (qS) (Fig. 2.5). This is because the substrate uptake (rS) of the culture 
remains constant, regardless of biomass. The same effect was observed in glycerol- 
limited cultures of M. bovis BCG (Beste et al., 2005).
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Figure 2.5. Effect of dilution rate on the biomass concentration and substrate 
uptake during carbon-limited growth of M. smegmatis and M. bovis BCG. (o)
succinate-limitation (M. smegmatis)-, ( • )  glycerol limitation (M. smegmatis)-, ( T )  glycerol-limited (M. 
bovis  BCG (Beste et al., 2005)).
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2.7.4. Gas consumption and production (qOi and qCOz)
An increase in oxygen uptake was seen as the dilution rate increased, in succinate and 
glycerol limited cells (Fig. 2.6).
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Figure 2.6. Effect of dilution rate on gas production and consumption during 
carbon-limited growth of M. smegmatis. (•) qCOz succinate; (o) qOz succinate; (▼) qCOi 
glycerol; (A) q 0 2  glycerol, (n = 3, each point represents the mean).
However, it was seen that succinate limited cells showed an oxygen uptake rate twice 
that of glycerol limited cells. There is some conflicting data regarding different 
substrates and their associated oxygen uptake rates in mycobacteria. It has been 
claimed previously, that succinate and its homologues cause a small increase in
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oxygen uptake in M. tuberculosis and M. avium (Edson, 1951). This is in agreement 
with observations from other microorganisms; succinate-limited cultures of E. coli 
had a larger oxygen uptake rate (qOi) than glycerol-limited cultures (Hempfling and 
Mainzer, 1975). Similarly, batch cultures of E. coli cultured with succinate as carbon 
source showed higher q0 2  than those with glycerol (Andersen and von Meyenburg, 
1980). This is logical, because glycerol transport is passive, whereas because 
succinate/succinic acid is a dicarboxylic acid, it requires active transport, thus causing 
an observable increase in oxygen uptake rate (Succinate uptake is an active process; 
in E. coli K12 succinate uptake is accompanied by two protons (Gutowski and 
Rosenberg, 1975), whereas in Corynebacterium glutamicum succinate uptake is 
facilitated by a Na'^-coupled mechanism (Ebbighausen et al., 1991). Yet the 
mechanism of succinate uptake is not known in M. smegmatis). Conversely, it has 
been reported that glycerol (and fatty acids) proved to be the greatest stimulant of 
oxygen uptake and in turn respiration in mycobacteria (Hunter, 1953, Nakamura, 
1938). However, no relevant data regarding the qOi of mycobacteria has been 
reported recently.
Therefore, even though the evidence for differences in uptake rates between the two 
substrates is conflicting, there is general agreement that mycobacteria cannot derive 
energy from nutrients in the absence of oxygen.
Results from chemostat cultures (Fig. 2.6) show that the carbon dioxide production 
rate follows a linear increase with dilution rate. This is expected, as it is an indicator 
of increased rate of respiration.
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2.7.5. Macromolecular biomass (cell) composition under carbon-limitation
The macromolecular content of microbial biomass has been shown to change with 
changes in growth conditions e.g. M. bovis BCG (Beste et al., 2005), S. coelicolor 
(Olukoshi and Packter, 1994). Consequently the steady-state biomass composition 
was analysed for five macromolecules (protein, lipids, carbohydrates, DNA and 
RNA), following protocols described in the appendix, and the biomass composition as 
determined for each of the 8  conditions studied.
When M. smegmatis grows under carbon limitation, its metabolic response to an 
increase in dilution rate is different for each of the macromolecular biomass 
components. Those are summarised (Fig. 2.7 and 2.8), and discussed below.
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Figure 2.7. The effects of dilution rate and glycerol-limitation on the 
macromolecular biomass components of M. smegmatis and M bovis BCG. (a) Total 
protein, Total Carbohydrate and Total Lipid; (b) Fructoysl Carbohydrates, Total DNA and Total RNA. 
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smegmatis)', (Blue bars) 0.075 h  ^ (M. smegmatis)', (Yellow bars) 0.01 h^ (M. bovis BCG); (Magenta 
bars) 0.03 h"' (M. bovis  BCG (Beste et al., 2005)). (n = 3, error bars represent standard deviation of the 
mean).
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2.7.5.I. Total Protein
Results show that there is very little difference between the mean protein content of 
succinate and glycerol-grown cells. Results from carbon-limited cultures show that 
glycerol-grown cells have upon average 1 .8 % less protein than succinate-limited cells 
at each growth rate. To see if the differences in protein values between the two carbon 
sources were statistically significant, the Student’s T-test was performed on the 
protein data from both carbon sources for each of the four dilution rates. 
Unfortunately, the resulting P values revealed that the differences between the two 
carbon sources were not statistically significant for any of the dilution rates (P = 
0.213, P = 0.611, P = 0.870 and P = 0.474 at 0.01, 0.025, 0.05 and 0.075 h"' 
respectively).
However, despite the statistical findings, succinate-limited cells may have a higher 
mean protein content due to a larger number of dicarboxylic-acid transporters in the 
succinate grown cells. This theory is supported by evidence that in Bacillus subtillis 
active transport of succinate, fumarate and malate was inducible by these dicarboxylic 
acids, via the C4-dicarboxylic acid transport (dct) system (Ghei and Kay, 1973). 
Moreover, it has been shown that expression of the genes involved in dct are 
positively regulated in response to exogenous C^dicarboxylates in Rhizobium 
leguminosarum and Rhizobium meliloti (fording et al., 1992, Reid and Poole, 1998). 
However, it is not known if the increase in transporters would account for almost 2% 
of the total protein in a cell. An alternate theory for an increase in protein content in 
succinate grown cells is that it may be more energy demanding to produce protein 
from glycerol, than from succinate.
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Results show that the mean protein content of glycerol-limited cells increases by an 
average of 5.2% for each increase in dilution rate and the mean protein content of 
succinate-limited cells increases by an average of 8.7% for each increase in dilution 
rate. This is because succinate is more oxidised than glycerol, therefore less energy 
can be gained from it as a carbon source, and may require a larger activity of enzymes 
from central metabolism to supply the energy demands. However, ANOVA analysis 
was performed on the results from each carbon source to see if the differences 
between growth rates were statistically significant; it was revealed that the observed 
differences were only statistically significant for the glycerol-limited cells with a P 
value of 0.02, as opposed to succinate-limited cells with a P value of 0.08.
The mean total protein content of the M. smegmatis biomass is correlated with 
dilution rate i.e. as the growth rate increased, the protein content increased. This was 
also reported in Saccharomyces cerevisiae (Nissen et al., 1997) and Acinetobacter 
calcoaceticus (Abbott et al., 1974). The increase in protein content may enable the 
organism to cope with the extra metabolic burden placed on its metabolism at the 
higher dilution rates.
2.7.5.2. Carbohydrate (Total and Fructosyl)
2.7.5.2.I. Fructosyl Carbohydrates
The results suggest that there is a small difference in the mean fructosyl content 
between the succinate and glycerol grown cells. However, closer investigation 
revealed that the fructosyl carbohydrate portion of glycerol-limited M. smegmatis 
biomass had upon average 7.95% more fructosyl carbohydrates than succinate-limited 
cells at each dilution rate. Student’s T-test analysis revealed that the differences
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between the two carbon sources were only statistically significant at the lowest 
dilution rate (P = 0.050, P = 0.571, P = 0.876 and P = 0.587 at 0.01, 0.025, 0.05 and 
0.075 h'  ^respectively).
Analysis of the results showed that the mean fructosyl carbohydrate content of 
glycerol-limited cells increased by an average of approximately 15% for each increase 
in dilution rate. However, a larger increase was seen in succinate-limited cells, the 
fructosyl carbohydrate content increased by an average of approximately 63% for 
each increase in growth rate.
2.7.S.2.2. Total Carbohydrate
In the carbohydrate portion of M. smegmatis biomass, the glycerol-limited cells have 
upon average a 5.4% higher mean carbohydrate conten than succinate-limited cells at 
each dilution rate. However, P values from the Student’s T-test showed that the 
differences between the two carbon sources were only statistically significant at the 
two lowest dilution rates (P = 0.003, P = 0.028, P = 0.311 and P = 0.330 at 0.01, 
0.025, 0.05 and 0.075 h'  ^respectively).
It has been claimed previously, that succinate causes a small increase in oxygen 
uptake, and in turn respiration in M. tuberculosis and M. avium (Edson, 1951). 
Therefore by stimulating respiration, succinate may be increasing carbohydrate 
catabolism in M. smegmatis (the increased rate of glycolysis with the accompanying 
production of reduced cofactors available for oxidative phosphorylation), which in 
turn will cause a slight decrease in storage carbohydrates compared to those cells 
grown with glycerol. Alternatively, it may be more energy demanding to produce
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carbohydrates from succinate via gluconeogenesis, than from glycerol, a glycolytic 
intermediate. This would result in less carbohydrate production via the gluconeogenic 
substrate succinate.
Results show that the total carbohydrate content of glycerol-limited cells decreased by 
an average of 7.5% for each increase in dilution rate. However, a slightly lower 
decrease was seen in succinate-limited cells, the carbohydrate content decreased by 
5.1% for each increase in growth rate. Conversely, ANOVA analysis revealed that 
the differences were not statistically significant for glycerol or succinate grown cells, 
with P values of 0.14 and 0.17 repectively.
Chemostat experiments show that the total carbohydrate content of the M. smegmatis 
biomass decreases with increasing growth rate. There is a higher metabolic burden 
placed on the organisms at higher dilution rates, and as a consequence, the cells 
produce less storage carbohydrates. This is in agreement with previous chemostat 
studies, in that storage carbohydrates accumulate in carbon-limited cultures at low 
dilution rates and low glycolytic flux in M. bovis BCG (Beste et al., 2005), S. 
cerevisiae (Frick and Wittmann, 2005, Larsson et al., 1997, Nissen et al., 1997), and 
Cellulmonas (Summers and Srinivasan, 1979). However, it was reported that if the 
glycolytic flux is increased then the storage carbohydrate content of the cells 
diminishes (Larsson et al., 1997). Therefore the increased glycolytic flux at higher 
growth rates decreases the flux towards the synthesis of storage carbohydrates.
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2.7.S.3. Lipids
There is a clear difference in the mean lipid content between the succinate and 
glycerol grown cells. Across all four dilution rates, the mean hpid content of glycerol- 
grown cells is upon average 16% more than that from succinate-grown cells at each 
dilution rate. Surprisingly, Student’s T-test analysis showed that the differences 
between the two carbon sources were only statistically significant at the highest 
dilution rate (P = 0.307, P = 0.194, P = 0.013 and P = 0.035 at 0.01, 0.025, 0.05 and 
0.075 h'  ^respectively).
Chemostat experiments reveal (Fig. 2.7 and 2.8) that the lipid content of M. 
smegmatis appears to remain constant as the growth rate increases, under glycerol- 
and succinate-grown cells respectively. However, there appears to be two anomalous 
results with respect to the mean; one at 0.05h"  ^ (succinate-limited growth. Fig. 2.8), 
and O.Olh'  ^ (glycerol-limited growth. Fig. 2.7). The same effect was highlighted by 
Borodina et al (2005), when discussing the results observed in cultures of S. 
coelicolor (Olukoshi and Packter, 1994), and also for Cellulomonas sp. cultivated in 
continuous culture under glucose limitation (Summers and Srinivasan, 1979), and S. 
cerevisiae continuously cultured under glucose limitation (Frick and Wittmann, 2005, 
Nissen et al., 1997). Upon initial investigation, it is expected that the macromolecular 
profiles of the mycobacteria would be similar. However, the macromolecular profiles 
of M. bovis are representative of a tubercle bacillus, and may reflect the 
macromolecular profile needed for survival within the host granuloma. Conversely, it 
could be because M. smegmatis is an environmental Mycobacterium, and may not be 
under the same nutritional restrictions as the tubercle bacillus i.e. the lipid-rich 
content of the granuloma vs. a lipid deficient soil environment. The lipid content of
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M. smegmatis cells is lower than that of M. bovis BCG cells (Beste et ah, 2005). 
However, it has been noticed previously that cell lipids are maximum in slow growing 
M. tuberculosis, and minimum in fast growing M. smegmatis (Prasada Reddy and 
Venkitasubramanian, 1975).
The results show that the lipid content of M. smegmatis was higher in the glycerol 
grown cells than in the succinate grown cells. This may be in part because glycerol is 
the backbone of triacylglycerols (TAG), therefore in glycerol grown cells, glycerol is 
already available for TAG synthesis, whereas in succinate grown cells, the 
mycobacteria have to synthesize glycerol via glycerogenesis (TCA, gluconeogenesis 
from pyruvate to glyceraldehydeS-phosphate, or glycerate-3-phosphate towards 
glycerol). Alternatively, glycerol promotes an excess of energy that needs to be stored 
as lipids. Conversely, ANOVA analysis showed that the differences between dilution 
rates for each carbon source were only statistically significant for succinate grown 
cells with P values of 0.04 as opposed to glycerol cells with a P value of 0.76.
2.7.5.4. Nucleic Acids
It can be seen (Fig. 2.7 and 2.8) that increasing the growth rate for carbon-limited 
cultures of M. smegmatis, had an effect on the mean RNA and DNA content of the 
cells:
2.7.5.4.I. RNA
It can be seen from chemostat experiments that as the dilution rate increased, the 
RNA content decreased, in carbon-limited cultures of M. smegmatis. The converse 
was observed in glycerol-limited cultures of M. bovis BCG (Beste et al., 2005), where 
the RNA content increased as the dilution rate increased.
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There is a significant difference in the mean RNA content between succinate-limited 
and glycerol-limited cells. Across all four dilution rates, glycerol-grown cells present 
on average 72% less RNA than succinate-grown cells. In contrast, the Student’s T-test 
revealed that the differences in RNA content between the two carbon sources were 
not statistically significant at any of the dilution rates (P = 0.217, P = 0.351, P = 0.060 
and P = 0.151 at 0.01, 0.025, 0.05 and 0.075 h'  ^respectively).
In the glycerol-grown cells, the mean RNA content decreased by an average of 9.8% 
for each increase in dilution rate, and almost exact decrease was observed in 
succinate-limited cells with an average decrease of 9.5% for each increase in dilution 
rate. This observation was partially supported by ANOVA analysis, as it revealed that 
the differences seen at each growth rate were only statistically significant for glycerol- 
limited cells, with a P value of 0.05, whereas the succinate-limited cells had a P value 
of 0.019.
It can be seen that under carbon-limitation, the RNA content decreases with an 
increase in dilution rate. This may be due to RNA being degraded via the endogenous 
metabolism of M. smegmatis, to supply the building blocks for the synthesis of DNA 
or other macromolecules (Reutgen and Iwainsky, 1972). Endogenous metabolism is 
defined as ''the total metabolic reactions that occur within an organism when it is 
held in the absence of compounds which may serve as specific exogenous substrates” 
(Dawes and Ribbons, 1964). Specific intracellular macromolecules are degraded 
during endogenous metabolism; in particular RNA, whereas DNA and lipid are 
generally not degraded (Jacobson and Gillespie, 1968). Arthrobacter crystallopoietes
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is able to survive with 85% RNA degradation, as a result of endogenous metabolism 
(Boylen and Ensign, 1970).
However, as RNA content is a reflection on the metabolic state of the cell, there is no 
evidence in the existence of any microorganisms which have a negative correlation 
between growth-rate (dilution rate), and RNA content. This result may require further 
investigation (See RNA-DNA ratio, RNA-protein ratio).
2.7.S.4.2. DNA
It appears that the mean DNA content remains almost constant as the growth rate 
increased in carbon-limited cultures of M. smegmatis. The same effect was seen in 
cultures of S. coelicolor A3(2) (Shahab et al., 1996), and Selenomonas ruminantium 
(Russell, 1986). However, in glycerol-limited cultures of M. bovis BCG, the DNA 
content decreased (Beste et al., 2005).
There is a small difference in the mean DNA content between the succinate and 
glycerol grown cells. Results revealed that glycerol-limited cells have upon average 
4% less RNA than succinate-limited cells. In support. Student’s T-test analysis 
showed that the differences in DNA content between the two carbon sources had 
mixed statistical significance, but were on average statistically significant across all 
dilution rates (P = 0.009 P = 0.021, P = 0.054 and P = 0.012 at 0.01, 0.025, 0.05 and 
0.075 h'  ^respectively).
In the glycerol-limited cells, the mean DNA content increased by an average of 7.5% 
for each increase in dilution rate. However, the opposite was seen in succinate-limited
cells; the DNA concentration decreased by an average 3.4% for each increase in 
dilution rate. Conversely, ANOVA analysis revealed that the observed differences in 
DNA content between dilution rates were only significant for succinate grown cells 
with a P value of 0.03, whereas glycerol grown cells had a P value of 0.06.
It was also seen that the mean DNA content of succinate grown cells is almost a third 
more than glycerol grown cells. A reason for this increase in DNA content in 
succinate grown cells is that previous studies on other microorganisms show that the 
carbon source has an effect on pyrimidine synthesis. Levels of enzymes involved in 
pyrimidine synthesis in Pseudomonas stutzeri, had the lowest activity in glucose, than 
succinate grown cells (West, 1997). The converse was seen in cultures of 
Pseudomonas mendocina, glucose lessened regulation compared to succinate 
(Santiago and West, 2003).
A second reason for the increase in DNA content in succinate grown cells was 
reported for cultures of E. coli. In cultures fed with glucose, E. coli cells possessed 
more DNA than cells fed with succinate. The carbon and nitrogen source supplied to 
the cells, determined whether or not set regions of the DNA would undergo more than 
one round of replication (Webb and Rokosh, 1971).
An alternative reason for succinate grown cells to contain more DNA than glycerol 
grown cells, is that the early stages of purine synthesis are inhibited by purines (ADP, 
AMP, GDP, GMP). The later half of the pathway is under reciprocal control by ATP 
and GTP (ATP levels control GMP synthesis, whereas GTP levels control AMP 
synthesis). A balance (approximate) between ATP and GTP is required to complete
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synthesis. Thus, if glycerol grown cells have a higher ATP content, this may in turn 
be inhibiting DNA synthesis.
2.7.5.4.3. RNA-DNA and RNA-Protein ratios
The growth rate dependent changes in the RNA, DNA and protein content of a cell 
can be described by the RNA-DNA and RNA-protein ratios (Table 2.2).
Table 2.2. RNA-DNA and RNA-Proteln ratios at each dilution rate
Ratios Dilution rate (1/h)0.01 0.025 0.05 0.075
RNA-Proteln 0.26 0.24 0.18 0.16
RNA-DNA 4.89 4.00 3.94 3.04
The RNA-protein ratio is proportional to the number of ribosomes (rRNA) per 
amount of protein, and is thus a measure of ribosome concentration. The belief is that 
ribosomes function at a constant maximum efficiency; thereby by increasing the 
ribosome concentration, the cell can cope with increases in growth rate (Cox, 2004). 
However, the results presented here for M. smegmatis (Table 2.2), show that the 
RNA-protein ratio be decreases with growth rate; this is because the RNA 
concentration decreases and the protein concentration increases with dilution rate. 
This suggests that cells at higher growth rates require fewer rRNA molecules to 
synthesise the same amount of protein per unit time than at lower dilution rates, a 
unique result which has not been demonstrated previously. In other words, indicating 
that the libosomal efficiency increases with an increase in dilution rate. Conversely, 
results from chemostat cultures of M. bovis BCG showed an increase in RNA-protein 
ratio (Beste et al, 2005).
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The RNA-DNA ratio reflects the level of metabolic activity of the cell, and is known 
to correlate with growth rate and metabolic activity (Kerkhof and Ward, 1993). The 
results presented here from M. smegmatis shown that the RNA-DNA ratio decreases 
with dilution rate, and to date this result is unique.
Experimental error associated with the insensitivity of RNA and DNA assays could 
provide a reason for these unique RNA-DNA and RNA-Protein ratios (Table 2.2). 
The method employed to measure RNA in this project, was the orcinol method; one 
disadvantage to the orcinol method, is that it is non-specific for libose sugars, and as a 
result is subject to interference by glucose, sucrose, deoxypentoses and cell wall 
pentoses. However, the DNA assay is without such complications, as diphenylamine 
does not react with ribose derivatives, making it possible to assay DNA in the 
presence of contaminating RNA (Burton, 1956). Therefore, the RNA assay is likely to 
have led to incorrect RNA determination, and in turn, errors in the RNA-DNA and 
RNA-protein ratios. RNA seems the most likely source of error, as it is the common 
denominator between the two ratios.
Alternatively the experimental error may lie in sample preparation; it is possible that 
the sample may have suffered some mRNA degradation, in which case only the stable 
RNA (tRNA and rRNA) would have been assayed. This seems logical, because if the 
“degraded” mRNA is proportional to the amount of protein (i.e. increases with growth 
rate), then when combined with the tRNA and rRNA pool, the total RNA content 
would increase with growth rate.
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2.8. Chapter 2 conclusions
It was seen that there were slight variations in biomass concentration/dry cell weight 
between succinate-hmited and glycerol-limited cultures of M. smegmatis. However, 
the two different types of carbon-limited cultures responded identically to an increase 
in growth rate. When compared to M. bovis BCG, both types of mycobacteria are seen 
to follow the same growth profile, yet their growth cannot be described by typical 
Monod growth kinetics, indicating that mycobacteria may possibly have different 
energy costs, and in turn, different internal physiology and metabolism, to other 
bacteria previously studied in chemostat. The differences in in vitro macromolecular 
biomass composition are shown below (Table 2.3).
Table 2.3. The different macromolecular contents of M. smegmatis and M. bovis 
BCG at five dilution rates
Biomass
component
M. smegmatis
0 . 0 1  h ' 
Gly Sue
0.025 h ' 
Gly Sue
0.05 h ' 
Gly Sue
0.075 h'^  
Gly Sue
M . bovis 
BCG
0.01
h"*
Gly
0.03
h"*
Gly
Total Protein 
Total 
Carbohydrate 
Total Lipid 
Total DNA 
Total RNA
0.36 0.33
0.31 0.27
0.11 0.11 
0.02 0.04
0.10 0.09
0.37 0.38
0.27 0.27
0.17 0.12
0.02 0.03
0.09 0.09
0.38 0.39
0.26 0.25
0.15 0.18
0.02 0.03
0.07 0.08
0.42 0.44
0.25 0.23
0.16
0.02
0.07
0.12
0.04
0.07
0.23
0.29
0.23
0.03
0.01
0.21
0.22
0.47
0.02
0.03
Gly, glycero ; Sue, succinate.
Subsequently, continuous culture experiments have highlighted that the biomass 
composition responds in the same way to an increase in dilution rate, in succinate- 
limited and glycerol-limited M. smegmatis cells. Nonetheless, there are slight 
variations in biomass composition between the two types of carbon limitation at each 
grow rate. These are mostly likely to be due to the differences in biochemistry and 
energetic costs associated with each carbon source. Conversely, when the biomass
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composition of M. smegmatis was compared to that of M. bovis BCG (Beste et ah, 
2005), it was seen that there were significant differences between the two species in 
the content of each macromolecular biomass component. Specifically, there were 
opposing trends between the macromolecular responses to increases in growth rate 
between the two species. These differences probably reflect the metabolic capabilities 
of each of the different types of mycobacteria: M. smegmatis is a fast growing 
Mycobacterium, so will consequently have different metabolic capabilities compared 
to the slow growing M. bovis BCG. The only macromolecular compartment which 
follows the same profile between the two species (i.e. decreases as growth rate 
decreases) is the carbohydrate pool. This is universally recognised as a reflection of 
the glycolytic flux: the carbohydrate pool is bigger at a low glycolytic flux, and 
smaller at a high glycolytic flux. Conversely, as M. smegmatis is a fast growing 
mycobacteria, its protein content should be positively correlated to growth rate, as the 
increased protein content at high growth rates would allow M. smegmatis to cope with 
the increased metabolic burden. Therefore because the two species have different 
biomass compositions and in turn different physiological and metabolic responses to 
different environmental conditions, it is likely that they will present different internal 
metabolic fluxes reflecting these differences.
In summary, the results demonstrate that M. smegmatis is not a suitable model for 
tubercle metabolism, and should be solely used as a model of fast growing 
mycobacterial metabohsm. However, this study may offer useful insights to the 
metabolic differences between environmental and pathogenic mycobacteria. As 
mentioned previously, M. smegmatis is predominantly an environmental 
Mycobacterium, whereas the tubercle bacilli are predominantly pathogenic. The
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phylogenetic tree of the 16S rRNA DNA sequence of 80 species of the genus showed 
two very distinct clades; slow growers and fast growers. The slow growing clade 
(which was predominantly pathogenic) branched from the fast growing clade 
(predominantly non-pathogenic) (Gey van Pittius et al., 2006); therefore, it is likely 
that the ancestor of M. smegmatis and M. tuberculosis, was a fast growing, 
environmental (non-pathogenic) Mycobacterium. Thus any metabolic variations 
between the two types of mycobacteria, and how they respond to different 
physiological conditions, would be differences which have been gained/lost since the 
tubercle bacilli diverged from the mycobacterial ancestor, evolving into a pathogenic 
strain. The altered metabolic responses of the tubercle bacillus to varying 
physiological conditions may indicate how the metabolism of the pathogens has 
changed during evolution, and may offer insights into their survival 
mechanisms/strategies.
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Chapter 3: Constructing an in silico genome scale metabolic 
network model of M, smegmatis metabolism
3.1. Introduction
Access to an annotated genome sequence provides the basis from which to begin 
constructing an in silico metabolic network of a micro-organism. These networks can 
either be genome scale (that is, containing all metabolic reactions present in the 
sequence) or smaller scale networks (for example, representing central carbon 
metabolism). Both types of models have specific uses, and each employs different 
algorithms to calculate a solution; Genome scale metabolic models require flux 
balance analysis (FBA) to calculate a solution, and are utilised when examining the 
metabolic system from a performance perspective. They can also be utilised in 
predicting the phenotypes of knock-out strains in silico. Conversely, smaller scale 
models are utilised by metabolic engineers, as their aim is to optimise and improve 
the production of a specific metabolite (e.g. antibiotics, amino acids, organic acids, 
etc), either by the removal or addition of reactions. Recently, the focus has been 
diverted from central metabolic models, to genome scale models.
It is already known, that M. smegmatis serves as a good model for studying 
mycobacterial dormancy, as it shares some dormancy-related features with its 
pathogenic counterpart, such as its ability to survive gradual oxygen depletion until 
anaerobiosis is achieved (Dick et al., 1998), despite the fact that mycobacteria are 
obligate aerobes. In addition, 12 out of 19 virulence associated genes in M. 
tuberculosis have homologues in M. smegmatis (Reyrat and Kahn, 2001). In
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particular, homologues of the two-component system devRJdevS», and a-crystallin 
(hspX) are present in the M. smegmatis genome, implying that the molecular 
mechanisms involved in dormancy are conserved between the species (Mayuri et ah, 
2002). This also implies that a dormancy mechanism was present in the mycobacterial 
ancestor, before these two species diverged. A feature of M. tuberculosis anaerobiosis 
is its ability to reduce nitrate (i.e. to use nitrate as a terminal electron acceptor). 
Conversely, M. smegmatis does not possess a nitrate reductase (Stermann et ah,
2004), and was originally thought to be unable to reduce nitrate. Yet recently, a nitrate 
assimilation pathway was identified, which operates in both active and dormant M. 
smegmatis (Khan et ah, 2008). As a result, the above features emphasize why M. 
smegmatis may serve as a fast growing model of dormancy. Can M. smegmatis be 
accepted as a fast growing “metabolic” model of the pathogen? This would only be 
possible if the two organisms have similar metabolism/metabolic profiles/metabolic 
responses to external stimuli.
As mentioned previously, TB still remains one of the deadliest and most prevalent 
diseases in the world today. Thus, due to the attached containment issues and slow 
growth of the tubercle bacillus, it would be beneficial to the mycobacterial scientific 
community, for mycobacterial biology, and in particular TB research, to be able to 
study metabolic and physiologic phenomena on fast growing, non-pathogenic 
mycobacteria. This would avoid containment requirements and lengthy experiment 
duration associated with M. tuberculosis, provided that the results could be transposed 
to pathogenic species.
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3.2. Flux-based and pathway analysis methods
Flux based analysis methods are based on the principle of mass conservation for each 
metabolite in a given metabolic system. In contrast, pathway analysis methods are 
non-flux based, and describe the topology/structure of the metabolic system. The 
following three methods are well established methods employed in current scientific 
research:
• Metabolic Flux Analysis (MFA): MFA characterises the flux distribution 
based on experimental data (e.g. consumption and production rates, growth 
rate etc), estimating internal fluxes based on a combination of mathematical 
analysis and external metabohte measurements (substrate, 0 2 , CO2 , 
micronutrients). Recently, in order to achieve more accurate estimation of 
internal fluxes, and the interaction between pathways in a given metabolic 
network, isotope labelling techniques have been employed (Blank et al,
2005).
• Flux Balance Analysis (FBA): This technique examines the metabolic 
network from a performance perspective, using linear programming to 
calculate a solution to the optimisation problem (the objective function), 
under changing environmental and genetic conditions. More details about 
FBA are given in section 7.2.1.
• Pathway analysis: Focussed around two techniques, namely extreme 
pathways, and elementary mode analysis. These methods are used to perform 
topological analysis on the metabolic network; they are able to define the 
structure, and overall metabolic capabilities of the organism, by decomposing 
the network into smaller sub-networks, whilst allowing the system to function 
at steady-state.
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3.2.1. Flux Balance Analysis
Flux balance analysis (FBA) (Stephanopoulos, 1998) is a method which relies on the 
principle of mass conservation. During steady-state, it is assumed that the metabolic 
system is in equilibrium; thus by knowing the structure of the metabolic network, it is 
possible to perform mass balance analysis over the entire cell. This analysis is 
performed under steady-state conditions and requires the knowledge of the 
stoichiometric coefficients of all the reactions involved in a given metabolic network, 
their thermodynamic constraints, and the reaction reversibility. This method is 
applicable to annotated genomes, as the reaction stoichiometries have been elucidated 
for each reaction. FBA calculates the flux through every pathway in the network, thus 
yielding information on the: biochemical capabilities/limits of the cell; maximum 
possible yields of a product; and the identities of the pathways being utilised.
FBA is based around the understanding that biochemical reaction networks are 
subject to certain physicochemical constraints (e.g. stoichiometric, thermodynamic 
and reaction reversibility), that limit or ‘constrain’ the possible behaviour of the 
system (Palsson, 2000). By applying these constraints, a closed ‘soltition space’ is 
defined, within which the set of all possible steady-state solutions must lie. The 
“optimal” solution is found in the solution space using linear optimisation. It should 
be noted that FBA is different to MFA, where experimentally measured data is used 
to reduce the undetermined nature of a metabolic system. This enables the calculation 
of all the unknown steady-state fluxes without the need for optimisation principles 
(Stephanopoulos, 1998).
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In order to perform basic FBA, a stoichiometric matrix N  is constructed from all the 
metabolites m (rows), and all the reactions g (columns) present in the metabolic 
network. The values within the matrix (of dimension m x q) equate to the 
stoichiometry of the metabolites involved in each of their respective reactions. 
Substrates have a negative value (as they are consumed), and products have positive 
values (as they are produced). The resulting matrix contains all the information 
needed to model the cell’s metabolism at steady-state. The steady-state assumption 
states that "for each metabolite the sum of the fluxes producing that metabolite is 
equal to the sum of the fluxes consuming that metabolite” (i.e. at steady-state there is 
no change in the metabolite pool over time). The data from continuous culture is more 
suited to flux analysis than those from batch culture, as it is at steady-state, whereas 
batch culture is not. The reaction stoichiometries can be thought of as a system of 
linear equations (convex analysis) that can be solved to find the flux of each reaction 
in the network^. However, these systems are underdetermined and some fluxes need 
to be measured in order to decrease the number of degrees of freedom, and to solve 
the system. These measurable fluxes are usually the substrates of the cell (e.g. 
glycerol, 0% ), extracellular products (e.g. CO2) or biomass components.
Once a working network has been produced, it can be used for several purposes: to 
investigate and maximise the flux of metabolites to a product of choice; to establish 
the sensitivity of the whole network or particular product fluxes to certain 
perturbations; to determine the theoretical conditions for maximal product flux, 
among others. Yet there are complications with this, as some enzymes are regulated 
as to prevent over-production of the end product of a pathway. FBA can be used to
 ^For a detailed description of the mathematics behind FBA, see Beste et al, 2007, in the appendix.
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identify branching points or nodes; these are tightly controlled points in the network. 
Each network has many nodes, but only a few are critical in directing the flux to a 
particular product, and it is these principal nodes which must be studied for their 
rigidity or flexibility towards metabolic perturbations (Simpson et al., 1999). 
Identification of these nodes is important as it determines which approaches are likely 
to be successful in enhancing the yield of product.
3.2.2. Genome scale metabolic network models
Genome scale metabolic network (GSMN) models involve the entire repertoire of 
reactions encoded for by a particular genome. The annotation of each open reading 
frame (ORE) is assigned by BLAST and FAST A homology searches with genes of 
known function (Altschul et al., 1997). As the number of annotated genomes 
increases, a large proportion of the genes from a newly sequenced organism can be 
identified using this method. Unfortunately, a large number of ORFs cannot be 
identified using this particular homology technique, consequently some pathways will 
have gaps. For instance, during the construction of the E. coli K-12 GSMN, 70 gaps 
were identified which were subsequently filled by identifying new functional 
assignments based on sequence homology searches, using a bioinformatic technique 
called Hidden Markov Models (HMMs are complex algorithms involved in speech 
recognition) (Reed et al., 2003, Green and Karp, 2004). Consequently, filling in the 
gaps in genome annotation, completes metabolic reconstruction.
By reconstructing the metabolism of a microorganism in silico, including the 
stoichiometry of the encoded enzymatic reactions and their directionality, constraint- 
based computer simulation methods can be employed to analyse, interpret, and predict
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cellular phenotype from the genotype under defined environmental conditions. The 
resulting simulations provide a basis from which to study the metabolism of a desired 
microorganism which can in turn lead to experimental design and possible drug target 
discovery^.
Previously, in silico gene deletions have been performed on genome scale models of 
H. influenzae (Schilling and Palsson, 2000), Helicohacter pylori 26695 (Schilling et 
al., 2002), and Streptomyces coelicolor A3(2) (Borodina et al., 2005). The GSMN of
H. influenzae enabled predictions to be made, regarding which genes were essential 
for growth on fructose. As a result the model enabled them to determine which 
biomass components could/could not be made when a particular knockout mutant of
H. influenzae was grown on a particular minimal media (Schilling and Palsson, 2000). 
This approach was also applied to the S. coelicolor A3(2) GSMN; a "core" set of 
essential reactions was identified by observing the impact of each reaction-knockout 
on the growth of the in silico strain on 62 carbon sources and two nitrogen sources 
(Borodina et al., 2005).
Genome scale metabolic networks are suited to “systems biology” approaches, as they 
can involve integrative analysis of all/some of the heterogeneous ‘omic’ datasets from 
the microbial cell, including genomic, proteomic and fluxomic data (Becker and 
Palsson, 2005, Covert et al., 2004, Forster et al., 2003, Palsson, 2002, Reed et al., 
2003, Schilling et al., 2002).
 ^For examples and applications of current microbial GSMNs, see Beste et al, 2007, in the appendix.
101
Metabolic networks constructed solely from genomic information, must be validated 
using biochemical, physiological and growth characteristics of the organism. 
Subsequently, the information gained from these metabolic models (constructed 
solely from genomic databases) can be used to generate new independent 
experimental data/information, which can in turn corroborate and/or aid in genome 
annotation.
3.2.2.I. Mycobacterial metabolic models
The first published mycobacterial metabolic model was focussed on a smaller 
network of reactions involved in mycolic acid synthesis in M. tuberculosis (Raman et 
al., 2005). FBA was used to identify and confirm six novel drug targets originally 
identified through TraSH experiments"^ (Sassetti et al., 2001). However, the network 
did not involve mycobacterial metabolism as a whole; the model was focussed on the 
fatty acid and mycolic acid synthesis pathways and included just 28 enzymes. 
Subsequently, two GSMNs of M. tuberculosis metabolism were published in short 
succession in 2007 (Beste et al., 2007, Jamshidi and Palsson, 2007); the first GSMN 
closely predicts gene essentiality when compared to TraSH data, with a prediction 
accuracy of 78%; the second GSMN has a lower prediction accuracy of 55%, 
emphasizing the fact that these models are not universal, as prediction accuracy is 
dependent on prior knowledge and understanding of the organism, and the literature 
used to supplement the model.
For a detailed explanation on TraSH, see Beste et al, 2007, in the appendix.
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3.2.2.2. The aims of a GSMN
Once a metabolic network has been reconstructed, the experimenter should specify 
the aims of the model. Wiechert (2002) has described a list of aims, which are ordered 
by the increasing demand for precision and quality required in a model:
1. Structural understanding’. This is structuring knowledge in mathematical 
terms, and can be used as a method used to organize diffuse and scattered 
knowledge. Even if the resulting model is not used for simulation studies, it 
can help focus the attention to essential parts of the system.
2. Exploratory simulation: The most common application of metabolic models is 
the exploration of the possible behaviour of the system. Simulation scenarios 
on rather crude/automatic models can help to achieve a rough understanding 
of the system behaviour and to reject false hypotheses. They aid in furthering 
the understanding of the behaviour of the system.
3. Interpretation and evaluation of measured data: The reproduction of 
experimental data by mathematical models is a well established tool in 
scientific disciplines.
4. Systems analysis: When applied to a particular model, mathematical models 
can help to generate a better understanding of the systems structure and its 
qualitative behaviour. A highly precise model is required to obtain meaningful 
results.
5. Prediction and design: This particular step requires a validated model, and 
from this future experiments can be predicted. This particular stage is used by 
metabolic engineers, and aims to the rational design of processes for 
engineering metabolic pathways. However, predictive power may only be true
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for a select few parameters, such as media composition, substrate uptake or 
growth rate.
6 . Optimisation: Once a predictive model has been produced, the goal in 
metabolic engineering is the computation of an optimal metabolic design, with 
or without targeted mutagenesis (Wiechert, 2002).
3.2.3. Genome Scale Flux Balance Analysis: Limitations
There are disadvantages and limitations associated with FBA. One of the 
disadvantages is that measurable parameters are not always enough to elucidate 
unique flux distributions. In addition, FBA does not account for regulatory effects; it 
can lead to false predictions in systems where regulatory effects have a large impact 
on the behaviour of the organism. This makes metabolic pathway analysis on genome 
scale models a very difficult and sometimes inaccurate task.
3.2.4. Chapter 3: Experimental Aims
A model of central metabolism is ideal for calculating the metabolic fluxes within 
central carbon metabolism. However, if the behaviour of the system on a global scale 
is to be understood, or the effect of in silico gene deletions on global metabolism / cell 
growth / viability is to be investigated, a genome scale metabohc network (GSMN) is 
essential. Thus, the first aim of the research presented in this chapter was to build a 
GSMN of M. smegmatis, and compare it to the GSMN of M. tuberculosis. Are there 
any differences between the metabolic pathways of the two organisms? It is known 
that M. smegmatis is able to grow on methanol and carbon monoxide. Will the model 
replicate this metabolic feature, and how closely will the predictions be to the 
published experimental data?
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Once a model has been produced, it will be used to generate predictions (uptake rates 
etc), which will in turn, be compared to the experimental data from chemostat cultures 
of M. smegmatis grown under carbon-limitation, at four growth rates (data presented 
in chapter 2). Will the in silico predictions, mimic those of the experimental data? The 
results will indicate if the model needs more data, or increased refining.
It has already been stated, that M. smegmatis serves a good, fast growing model of 
mycobacterial dormancy. The question to be asked is: Can M. smegmatis be accepted 
as a fast growing “metabolic” model of the pathogen? This will only be possible if the 
two organisms have similar metabolism/metabolic profiles/metabolic responses to 
stimuh etc. It has already been shown in chapter 2, that the macromolecular content of 
the two mycobacteria responds differently to changes in growth rate.
The final aim was to compare the accuracy of the model vs. in vitro deletion data. 
How closely will the in silico deletions predict the results from in vitro single gene 
knock-outs? There is no global mutagenesis data for M. smegmatis. Instead, a list of 
46 single metabolic gene deletions was compiled which is used for in silico vs. in 
vitro comparison.
3.3. Methods
3.3.1. Construction of the Genome Scale Metabolic Network of M. smegmatis 
The genome of M. smegmatis MC^155 has been sequenced and annotated and the 
entire list of metabolic reactions present in its genome are available in the Kegg and 
BioCyc databases. Currently, the M. smegmatis genome is the largest of the 
sequenced mycobacteria, at 6.9mb vs. the 4.4mb M. tuberculosis genome, and
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although the two mycobacteria are distant from an evolutionary point of view (Gey 
van Pittius et al., 2006), they share a portion of genome synteny^. Thus the GSMN of 
the pathogenic Mycobacterium M. tuberculosis H37Rv (Beste et al., 2007) provided 
the basis from which to construct the genome scale metabolic network (GSMN) of M. 
smegmatis. The method used to assign the respective M. smegmatis gene numbers to 
the genes present in the M. tuberculosis H37Rv model was identical to the curation 
method employed when generating the M. tuberculosis model (see Appendix, Beste et 
al, 2007). All the M. tuberculosis reactions present in M. smegmatis were assigned 
their corresponding gene (MSMEG) number. The KEGG and “Mycobacterium 
smegmatis MC2” (part of BioCyc) databases were used to incorporate additional M. 
smegmatis specific reactions that did not have homologues in M. tuberculosis. 
Conversely, there are a significant number of reactions which are present in the M. 
smegmatis genome, but not the M. tuberculosis genome. These missing reactions 
seem to reflect the metabolic adaptation of M. smegmatis, in that they are reactions for 
the metabolism of xenobiotic/environmental compounds.
As in the M. tuberculosis model, in situations where a reaction was essential to 
produce a viable in silico model but there appeared to be a pathway gap; the reaction 
was included in the model without genomic evidence but based on biochemical 
knowledge. A small proportion of the model was manually inserted into the model 
based on scientific literature. For instance, M. smegmatis possesses a different malate 
oxidase system (designated MALFAD pathway) in which malate oxidation is 
exclusively carried out by the FAD-dependent malate-vitamin K reductase whereas 
NAD'^-dependent malate dehydrogenase is present only in slow growing M.
 ^Genome synteny is the ‘'preserved o rd er o f  gen es on chrom osom es o f  re la ted  species, as a resu lt o f  
descen t fro m  a com m on ancestor".
106
tuberculosis (Imai and Murata, 1989, Prasada Reddy et al., 1975, Seshadri et al., 
1972). Another example is the lack of genomic evidence regarding L-lactate 
dehydrogenase; although enzymatic activity has been reported in M. smegmatis 
(Chacon et al., 2002).
The mycobacterial cell envelope is complex, and contains a diverse array of 
carbohydrate and lipid components, which are important for growth (and pathogenesis 
in the tubercle bacillus); as a result, their synthesis pathways are important drug 
targets in the virulent strains. Therefore, because the cell wall composition of 
saprophytic and virulent mycobacteria is different, some of the biomass components 
had to be removed from the M. smegmatis model during curation. Macromolecules 
present in both M. tuberculosis and M. smegmatis, such as the mycolic acids, had to 
be modified to match the mycolic acid profile of M. smegmatis; M. tuberculosis 
contains a, keto, and methoxy meromycolates, whereas M. smegmatis contains a  (ai, 
«2 , a ’) and epoxy meromycolates. Macromolecules present in M. smegmatis were 
added to the model, and conversely, those not present were removed (Table 3.1).
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Table 3.1. Lipids/cell wall components from M. tuberculosis vs. M. smegmatis
Component M. tuberculosis H37Rv M. smegmatis Mo 155
Mycolic Acids Y es (a, m ethoxy, keto) Y es (a , epoxy)
T reh a lo se  d im ycolate Y es Y es(Cord Factor)
Sulfolipids/sulfatides Y es No
Di, Tri an d  P o lyacy ltreha loses Y es No
L ipo-o ligosaccacharides Y es Y es
P henolic glycolipids Y es No(A, B, G M ycosides)
Pyruvated  glycolipids No Y es
Phosphatidylinositiol m a n n o sid es Y es Y es
Phthiocerol d im ycocerosa te Y es No
L ipoarab inom annan Y es (ManLAM) Y es (PI-LAM/PI-GAM)
L ipom annan Y es Y es
Polyphthienoyl T reh a lo se Y es No
Polyphleoyl T reh a lo se No Y es(Phleic acids)
G lycopeptidolipids (M ycoside C) No Y es
P olyglu tam ate (PL-GLX) Y es No
G am a-glutam ylinked F420S Y es Y es
Mycothiol Y es Y es
P hospholip ids (PE, CL, P G P , PI) Y es Y es
3.3.I.I. Biosyntbetic pathways
The final GSMN of M. smegmatis consists of 1287 unique reactions, reactions (see 
appendix) which make up the following sets of pathways (Table 3.2).
Table 3.2. The biosyntbetic pathways present in the GSMN of M. smegmatis
Biosynthetic pathway Description
1. Central carbon metabolism
•  G lycolysis
•  P e n to se  p h o sp h a te  pathw ay
• T he TOA cycle an d  th e  
glyoxylate shun t
•  A naplerotic reactions________
E nzym es with m issing activity in M. smegmatis 
w ere rem oved  from th e  netw ork e.g . a -k e to g iu ta ra te  
d eh y d ro g e n a se  (Tian e t al., 2005).
2. Respiratory pathways
All com p lex es in th e  m ycobacterial resp ira tory  
chain w ere  re ta ined  from th e  M. tuberculosis GSM N 
(B este e t al., 2007).________________________________
3. Fatty acid metabolism
• (3-oxidation of fatty ac id s
•  C atabolism  of odd and  even  
num bered  chain  fatty ac ids
•  C atabolism  of un sa tu ra ted  fatty 
ac ids
Fatty ac id s  provide the  b ack b o n e  to th e  en tire a rray  
of m ycobacterial lipids, explaining w hy fatty acid 
m etabolism  is believed to  b e  a  crucial fac to r in 
m ycobacterial survival an d  a lso  in I B  p a th o g e n e s is  
(M unoz-Elias an d  McKinney, 2006).
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Amino acid metabolism
Am ino acid  d e g ra d a tio n  (for all 
20  am ino  ac ids)
Am ino acid  sy n th e s is  (for all 20  
am ino  ac ids)
A m ino ac id  sy n th e s is  a n d  d e g ra d a tio n  p a th w a y s  
w e re  a d d e d  acco rd ing  to  th e  re a c tio n s  p re s e n t in 
th e  g e n o m e . D epend ing  on th e  am in o  acid , th e re  
a re  a  vary ing  am o u n t of sy n th e s is  a n d  d e g ra d a tio n  
p a th w a y s , an d  different o rg a n ism s  h a v e  d ifferent 
p a th w a y s . F or ex am p le , th e re  a re  fou r arg in ine  
sy n th e s is  p a th w a y s  listed in M etaC yc; p a th w a y  I is 
p re s e n t  in M. tuberculosis] p a th w a y  II is p re s e n t in 
M. tu bercu losis  a n d  M. sm eg m a tis]  p a th w a y  III is 
p re s e n t  in Shigella  d ysen te r ia e  a n d  Yersinia p es tis ]  
an d  p a th w a y  IV Is p re s e n t in H om o s a p ie n s  an d  M. 
sm eg m a tis ._________________________________________
5. Nucleotide metabolism
• P u rin e  an d  pyrim idine 
nu cleo tid e  sy n th e s is
• D e novo b io sy n th es is  of 
pyrim idine ribonucleo tides
• D e novo b io sy n th es is  of 
pyrim idine
deo x y rib o n u c leo tid es
• S a lv a g e  p a th w a y s  of p u rine  
an d  pyrim idine n u c leo tid es
6. Biomolecules/Cofactor 
metabolism
• M olybdenum  (Mo) a n d  co b a lt 
(Co) m etabo lism  
T h iam ine  b io sy n th es is  
M olybdopterin b io sy n th es is  
F 420  b io sy n th es is  
M ycothiol b io sy n th es is  
F erric iron tra n sp o rt (both 
citra te  an d  s id e ro p h o re -  
m ed ia ted )
S id e ro p h o re  b io sy n th es is  
(exochelin  an d  m ycobactin )
Iron p lay s an  im portan t role in m y co b ac teria l 
m e tab o lism , an d  in turn bac te ria l surv ival 
(R odriguez , 2006). H igh-affinity s id e ro p h o re s  
m e d ia te  th e  c a p tu re  of ex trace llu la r iron, w hich is 
e s se n tia l for th e  grow th an d  survival of p a th o g e n ic  
an d  n o n -p a th o g e n ic  b a c te ria . H igh-affinity ferric iron 
c a p tu re  is of particu lar im p o rtan ce  to  p a th o g e n ic  
b ac te ria , a s  th e y  a re  in com petition  with h o s t 
transfe rrin  an d  lactoferrin , tw o p ro te in s  w hich a re  
ab le  to  b ind ferric iron with high affinity (R a tled g e  
an d  D over, 2000).
7. Miscellaneous pathways
T h e s e  a re  p a th w a y s  involved in th e  m e tab o lism  of 
vario u s env ironm en ta l c o m p o u n d s . T h e  e n z y m e s  of 
w hich a re  e n c o d e d  for by  th e  M. sm e g m a tis  
g e n o m e  e .g . ca te ch o l an d  ta u rin e  d e g ra d a tio n .
8. Transport reactions
C o fac to r tran sp o rt 
F atty  Acid tra n sp o rt 
Am ino Acid tra n sp o rt 
N ucleo tide tra n sp o rt 
S u g a r  tran sp o rt 
F re e  diffusion (of low 
m o lecu lar w eight co m p o u n d s)
Fatty  ac id  tra n sp o rt is inc luded , a s  th e re  is 
e v id en c e  th a t M. sm e g m a tis  is ab le  to  hy d ro ly se  
T w een  80 an d  utilise th e  fre e  o le ic  ac id  a s  a  ca rb o n  
so u rc e  (Tom ioka, 1983). T h u s  it is a s s u m e d  th a t M. 
sm e g m a tis  is ab le  to  u p ta k e  fatty  a c id s  by  th e  s a m e  
m e ch a n ism  th a t h a s  b e e n  p ro p o se d  to  b e  u s e d  by  
M. tu bercu losis  to c o n s u m e  h o st-d e riv e d  lipids in 
vivo  (M unoz-E lias a n d  M cKinney, 2 0 06).
9. Macromolecular biomass 
synthesis
P rotein  sy n th e s is  
C a rb o h y d ra te  sy n th e s is  
Lipid sy n th e s is  
DNA/RNA sy n th e s is  
Lipid sy n th e s is_____________
A s m en tio n ed  prev iously , th e  m y co b ac te ria l cell 
wall is a  com plex  s tru c tu re , con ta in ing  a  d iv e rse  
a rray  of com plex  lipids a n d  c a rb o h y d ra te s . M ost a r e  
e s se n tia l for grow th, a n d  a re  im portan t d rug  ta rg e ts  
in M. tu berculosis.
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3.3.I.2. Mycobacterial cellular components
There are many cellular components which are common to both M. tuberculosis and 
M. smegmatis (Table 3.3). The elucidated biosynthetic pathways for these common 
components have been retained from the M. tuberculosis GSMN (Beste et al., 2007), 
either in their entirety, or the initial stages of the pathway, as in mycolic acid 
synthesis.
Table 3.3. The biosynthetic pathways for the cellular components shared 
between M. tuberculosis and M. smegmatis.
Biosynthetic pathway Pathway reference
A ra b in o g a lac tan -p ep tid o g ly can  co m p lex  ( f r i c k ^  al  ^ 2001)
Mycolic ac id s  (initial s ta g e s )  {M. tuberculosis). ^ n ^ g n d
T re h a lo se  m o n o m y co la te  (TMM), tre h a lo s e  (O rta lo -M agne e t al., 1996 , W oodruff e t al., 
d im yco la te  (TDM) 2004)
P hosphatidy linosito l m a n n o s id e s  (PIM S) (M orita e t al., 2004)
L ipom annan  (LM) (K aur e t al., 2006)
L ip o a rab in o m an n an  (initial s ta g e s )  (LAM) l^ u ^ l^ a i* ^  ?0(?6)
S id ero p h o re : m ycobactin  (Q uadri e t al., 1998)
P n fp p tn r-F 4 Pn (Chol e t al., 2002 , G u erra -L o p e z  e t al.,
u o ta c to r .  2 0 0 7 , Purw antin i an d  D an ie ls , 1998)
. .  , (B ornem ann  e t al., 1997 , N ew ton e t al.,
2 0 0 6 , R aw at e t al., 2007)
K eggC atab o lic  p a th w a y s: A dditional p oxidation 
p a th w ay s .
C a tab o lic  p a th w a y s: O dd a n d  ev e n  n u m b e re d  
fatty  ac id  ca tab o lism .
R esp ira to ry  p a th w a y s: NADH d e h y d ro g e n a s e s , (Boshoff an d  Barry, 2 0 0 5 , K u sa k a  e t al.,
cy to ch ro m es 1964 , M a tso so  e t al., 2005)
R esp ira to ry  p a th w ay s: N itrate a s  an  a lte rn a tiv e  o n n c \
e lec tron  a c c e p to r  ______________________________ (S o h a sk ey , 2005)____________________________
The biosynthetic pathways for many of the M. smegmatis specific components have 
yet to be elucidated (Table 3.4). The pathways for these components have been 
derived from direct observation of the chemical structure, by separating the 
macromolecule into its smaller metabolic constituents. For example, 
glycopeptidolipids (GPL) are formed from the following metabolites: dTDP-
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rhamnose, GDP-fucose, docosanoyl-CoA, alanine, alanylalanine, phenylalanine and 
crotonyl-CoA; thus the formulae for GPL synthesis was composed of the relative 
amounts of each of the metabolites.
Table 3.4. Biosynthetic pathways that have been derived by direct observation of 
biochemical structure.
Molecule Molecule reference
P hleic  ac id s
M ycolic ac id  sy n th e s is  
( a 1 , a 2 , a ’ a n d  epoxy)
P yuvy lated  glycolipid (PGL) 
L ip o a rab in o m an n an  (PI-GAM)
G lycopeptidolipid (GPL)
T re h a lo s e -b a s e d  o lig o sa c c h a rid e s  
S id ero p h o re : exochelin
(A sse lin eau  a n d  A sse lin e a u , 1978 , A sse lin e a u  an d  
M ontrozier, 1976 , A urelle e t al., 1987)
(Liu a n d  Nikaido, 1999 , W ong  a n d  G ray, 1 979 , Y uan 
e t al., 1998)
(K am isango  e t al., 1985 , Khoo e t al., 1995b , S a a d a t  
a n d  Ballou, 1983)
(G u era rd e l e t al., 2 0 0 2 , Khoo e t al., 1 995a)
(Khoo e t al., 1995b , Ripoll e t al., 2007 , M iyam oto e t 
al., 2 0 0 6 , P a tte rso n  e t al., 2 000 , B illm an -Jaco b e  e t al., 
1999 , E ckste in  e t al., 1998)
(O h ta  e t al., 2002)
(S h a rm a n  et al., 1 995 , Yu e t al., 1998)
3.3.2. M. smegmatis biomass composition
The macromolecular biomass composition of M. smegmatis (in terms of the 
percentages of RNA, DNA, protein, total carbohydrate (+ fructose), and lipid), was 
measured from carbon-limited chemostat cultures of M. smegmatis.
3.3.3. Constructing macromolecular synthesis reactions
As mentioned previously for metabolic flux analysis, a stoichiometric matrix N  is 
generated from all the metabolites m (rows), all the reactions q (columns). In addition, 
vector r  represents the net specific reaction rates (mmol/(gDW h)) and vector c 
represents the metabolite concentrations (mmol/gDW). Biomass synthesis is also 
incorporated in the GSMN; therefore the stoichiometric matrix includes a
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‘biosynthesis’ column which quantifies the cumulative efflux of metabolites into 
biomass (mmol metabolite/gDW).
When defining the biomass, five components were measured: carbohydrates (total 
carbohydrate and fructose), protein, lipid and nucleic acids (RNA and DNA) (The 
individual lipids were not measured, their proportions were estimated from research 
articles).
The composition of each average macromolecular component (mmol/g 
macromolecule) was calculated and is detailed below.
3.3.3.I. Protein composition
The composition of the average protein produced by M. smegmatis was estimated 
using data from the Horizontal gene transfer database (HGT-DB)^ (Garcia-Vailve et 
al., 2003). The amino acid content of the average protein produced by M. smegmatis 
was calculated using the mean amino acid content (%) of the average protein 
produced by M. tuberculosis and S. coelicolor.
The average protein produced by M. smegmatis was estimated to contain 316.18 
amino acids (calculated from the total number of codons divided by the total CDS in 
M. smegmatis). From this value, the amino acid content per gram of protein could be 
calculated and expressed as mmol (of each amino acid)/g of macromolecule as it is 
shown in Table 3.5. The values for each amino acid in mmol/g macromolecule are the 
vales entered into the final protein equation. It should be emphasised that this average
 ^Horizontal gene transfer database: http://www.fut.es/~debb/HGT/
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protein does not take into account the relative abundance of all the different proteins, 
which is currently not known.
Table 3.5. Composition of average protein from M. smegmatis
Mw
Amino
acid
(aa)
% of 
each aa 
in
average
protein
(316.18
aas)
mois of 
each aa 
(# aas in 
average 
protein 
316.18 aa)
Total 
weight (g) 
of each aa 
in average 
protein 
(316.18 
aas)
mmol 
(of each aa 
in average 
protein)
mmol/g
Protein
89 Ala 13 .45 42 .59 3 7 9 0 .5 8 4 2 5 9 0 .7 4 1.08
174 Arg 8 .10 2 5 .65 4 4 6 3 .0 0 2 5 6 4 9 .4 4 0 .65
132 A sn 1.95 6.17 8 1 5 .0 8 6 1 7 4 .8 7 0 .16
133 A sp 5.95 18 .84 2 5 0 5 .8 9 1 8 8 4 1 .2 6 0 .48
121 C ys 0.90 2 .85 3 4 4 .8 4 2 8 4 9 .9 4 0 .0 7
146 Gin 2 .85 9 .02 1 317 .62 9 0 2 4 .8 0 0 .23
147 Glu 5 .25 16.62 2 4 4 3 .8 2 1 6 6 2 4 .6 4 0 .42
75 Gly 9.35 29.61 2 2 2 0 .5 8 2 9 6 0 7 .6 9 0 .75
155 His 2 .35 7 .44 1 153 .43 7441.51 0 .19
131 lie 3 .55 11 .24 147 2 .6 3 1 1 2 4 1 .4 2 0 .2 8
131 Leu 10.00 31 .67 4 1 4 8 .2 4 3 1 6 6 5 .9 8 0 .80
146 Lys 2 .05 6.49 9 4 7 .7 6 6 4 9 1 .5 3 0 .16
149 M et 1.75 5 .54 8 2 5 .6 9 5 5 4 1 .5 5 0 .1 4
165 P h e 2 .75 8.71 143 6 .8 4 8 7 0 8 .1 4 0 .22
115 P ro 6.00 19.00 2 1 8 4 .9 5 18 9 9 9 .5 9 0 .4 8
105 S e r 5 .25 16.62 1 745 .59 1 6 6 2 4 .6 4 0 .42
119 T hr 6 .00 19 .00 2 2 6 0 .9 5 1 8 9 9 9 .5 9 0 .48
20 4 T rp 1.50 4 .75 9 6 8 .9 8 4 7 4 9 .9 0 0 .12
181 Tyr 2 .05 6.49 11 7 4 .9 7 6 4 9 1 .5 3 0 .1 6
117 Val 8 .80 2 7 .87 3 2 6 0 .3 3 2 7 8 6 6 .0 6 0 .70
Total 100.00 316.18 39481.77 316184.82 8.00
3.3.3.2. Lipid composition
Estimation of lipid composition is complex due to the high complexity and diversity 
of lipids found in mycobacteria. The synthesis equations for each lipid component 
were added to the metabolic network. Synthesis equations were elcudiated from 
calculating the momeric composition of each lipid component (Table 3 .6-3 .12).
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The data available in the literature for the lipid synthesis pathways and the 
composition of the lipid fraction is not complete. Thus, the resulting composition is an 
approximation, as the percentage of each component in the biomass of M. smegmatis 
is not certain. Synthesis pathways which have not been elucidated were added as 
hypothetical. The composition of the estimated M. smegmatis lipid-fraction is 
summarised below (Table 3.14).
Table 3.14. The estimated lipid composition of M. smegmatis (g/g biomass)
Lipid component % Normalised% Reference
Total ph o sp h o lip id s 4 7 .80 43.61 (E tienne  e t al., 2002)
Phosphatidylethanolamine * 12.40 11.31 (S a re e n  a n d  Khuller, 1990)
Phosphatidylinositol mannosides * 36.85 33.62 (S a re e n  a n d  Khuller, 1990)
Cardiolipin* 50.48 46.05 (S a re e n  a n d  Khuller, 1990)
Tri acyl glycerol (TAG) 13.90 12.68 (E tienne  e t al., 2002)
G lycopeptidolip id  (GPL) 18 .30 16 .69 (E tienne  e t al., 2002)
P yruvy la ted  glycolipid (PGL) 1.00 0.91 E stim ated
P h leic  Acid 5 .00 4 .5 6 (G oren , 1972)
L ipom annan  (LM) 0.80 0 .80 % of LAM from  TB m odel
P hosphatidy linosito l- 2 .50 2 .50 (H a m a su r e t al., 1999)
g ly c e ro a rab in o m an n a n
(PI-GAM /  PI-LAM)
T re h a lo se  m o n o m y co la te  (TMM) 11.20 10 .22 (E tienne  e t al., 2002)
T re h a lo se  d im yco la te  (TDM) 8.80 8 .03 (E tienne  e t al., 2002)
Total 109 .30 100 .00
^Individual ph o sp h o lip id s , a s  a  p e rc e n t of total p h o spho lip id s .
The average lipid content measured from glycerol-limited M. smegmatis cells grown 
at four growth rates was 16.68%. This is in agreement with previous findings of 18.13 
± 5.57% (Etienne et al., 2005) and 14.1% (Verma et al., 1999). It was also shown that 
out of all the mycobacteria studied at the time, cell lipids were highest in M. 
tuberculosis, and lowest in fast growing M. smegmatis (Prasada Reddy and 
Venkitasubramanian, 1975).
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• Mycolic Acids: Cell wall linked mycolic acids represent approximately 80% 
of total mycolic acids (Lacave et ak, 1987). It has been reported that mycolic 
acids account for 153mg per g of dry cell wall (Verma et al., 1999).
• Pyruvylated glycolipid (PGL): There was no data available for the content of 
PGL in cells, so it was set as an arbitrary 1%.
• Lipomannan LM and phosphatidylinositol-glyceroarabinomannan (PI- 
GAM): The PI-GAM content of M. smegmatis was assumed to be equal to the 
LAM content of M. tuberculosis, which was reported to be 25mg/g (Hamasur 
et al., 1999). The ratio of LAM to LM in M. tuberculosis is 2:1 (Beste et al., 
2007); so the LM content of M. smegmatis was estimated at 8 mg/g.
3.3.3.3. Carbohydrate composition
The carbohydrate content was calculated from cultures of M. smegmatis. From the 
experimental data, carbohydrates make up nearly a third of the dry weight of the M. 
smegmatis cell. As the MAPc content of M. smegmatis cells is unknown, the MAPc 
and glucan content was calculated using the ratio of MAPc to glucan from M. 
tuberculosis GSMN (2.125:1) (Beste et al., 2007).
3.3.3.4. RNA composition
RNA composition forM. smegmatis (Table 3.15) was calculated for a GC content of 
67.4%. The total RNA composition takes into account the 3 types of RNA, tRNA, 
mRNA and rRNA.
118
Q. a. a  Q.
H O O  >
2 2 2 2
■D "0 "0 "U
CO CO CO CO
ro 4 o CO
ro N ■'si —*■
b ro Kd Kd
ro o ro
CO CO
G) CO CO G)
CO k i k i CO
o o o o
o o o o
CO CO
O) cn —» G)
b k j b b
cn ■vi cn o
CD CD cn 00
CO
8ro oCO
b bro b b4 ro
CO CO cn
; 8 o o
b b ro jo
œ CD cn cn
O) 00 00 O) 
b ) CO ^  CD O) 00 G) 00 
CD -vj -vj CO
iiii
P  cn cn P
P  P  r* r* P0  4  0  0  4  cn CD CO CO CD G) 00 O O 00
slCD >
ÎI
>  CD 
1!
D  O
I(Q3T
So3"
cr
%Q
0-3fi} o
(A O<D U)
= a
is
>§•
S o
D)O
Ii
p
> a
ll
IÎ
il
I
î-ko\
i
I
I
1
2
s
2 ,
c§
Î-
I
I
Io
§
(%
i
UO
I— k
e
0
0
1ICL
8 "
o
n
0
1
s,
3
4
W
W
w
In
I
I
g
H c O Q >
2 - 2 2 2
"0 "0 13 D
CO CO CO COro ro cn 44 CO CO 's i
Li. ro to io
00 o ro ro
, p o o p
b b bo cn CO CO cno CO -sJ 's j CO
p o o o
b ro b roo CD 4 CO COo 4 ro 4
o o o p
b ro ro bo o 00 CO 's io ro cn 4 00
ro CO ro
p cn CO
b ro bcn ■vj cn o
00 CD ro
cn 00 roo
N
p ro p
o bcn g bcncn CD o o
G) 00 _L 's i
p ■vj CO 4
b k i
00 k jcn
's i
b
CDro cn 00
to ro 4 ro
00 cnro CO CO o
CO 's j ro o
N ro ro cn
k j b b roro 00 ro ro
CD 4 ro CD
I 008 CO's icn
's j
§
p 4 00
cn b 4o cn 00
ro o o o o
b b k i b bro at) cn -sJ 4cn o CO
s#Q >
Î!
iiîi-h ^
ill
ill
I?|i
n
3 S
i 'g
> 30
+ + >
O- O 330 0) 3
f i n3 3" (A
If I
ill
II
|i
ilCQ
I
î-^cn
g
!
I
I
g
§
2 ,
Ia
I
3.3.3.6. Small molecules and mycothiol content
The composition of the pool of small molecules and the percentage they constitute in 
the biomass, was retained from the GSMN of M. tuberculosis (Beste et al., 2007). The 
mycothiol content of M. smegmatis was calculated as 0.009g/g DW (Newton et al, 
1996).
3.3.3.7. Biomass composition
The biomass composition of M. smegmatis cells changes with the carbon source, and 
the average biomass composition for succinate-limited and glycerol-limited cells, 
highlights these differences (Table 3.17).
Table 3.17. Biomass composition for succinate-limited and glycerol-limited M. 
smegmatis cells (g/g biomass)
Biomass components Glycerol Succinate
PRO TEIN 0 .394 0 .4 2 9
RNA 0 .085 0.071
DNA 0.023 0 .0 3 7
SM ALLM OLECULES 0.030 0 .0 3 0
PE 0 .006 0 .0 0 5
TAGbio 0 .016 0 .0 1 2
PIM S 0.022 0 .0 1 6
CL 0 .0 2 8 0.021
PI-GAM 0 .025 0 .0 2 5
LM 0 .008 0 .0 0 8
M APC 0 .200 0 .1 7 5
PHLEIC ACIDS 0 .006 0 .0 0 4
G PL 0.021 0 .0 1 6
PG L 0.001 0.001
MYCOTHIOL 0 .009 0 .0 0 9
GLUCAN 0 .0 9 4 0 .0 8 2
TREHA LOSEDIM YCOLATE 0 .010 0 .0 0 8
TR EH A LO SEM O NO M Y CO LA TE 0 .013 0 .0 1 0
ATP* 47 47
* retained from the GSMN of S. coelicolor (Borodina et al, 2005).
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3.3.4. Flux Balance Analysis
Computer simulation protocols used in this work are available on the SBMS Systems 
Biology server ( h ttp : //sy sb io .sb s .su r r e y .a c .u k /) (Beste et al., 2 0 0 7 ) .
Metabolite transport and biomass synthesis were modelled as in the M. tuberculosis 
GSMN^. The optimal solution to the flux balance model was calculated using linear 
programming (LP) (See Appendix, Beste et al, 2007), where the cellular objective 
function Z was set to “biomass”. The result of LP optimisation was the maximal 
theoretical growth rate.
3.3.4.I. M. smegmatis in vitro growth requirements
The M. tuberculosis GSMN contains two biomass formulae (objective functions), for 
the purpose of gene essentiality predictions {in vitro /  in vivo vs. in silico), as it is 
known that many biomass components from M. tuberculosis are essential for 
virulence, but not for in vitro growth. Unlike the facultative intracellular pathogen M. 
tuberculosis, M. smegmatis is killed by macrophages; thus it can be suggested that it 
does not have cellular components which would be essential for pathogenicity but not 
for in vitro growth. Therefore, one approximate biomass composition for M. 
smegmatis was assembled from published data and chemostat data presented in this 
thesis (Table 3.17), reflecting the estimated macromolecular composition of M. 
smegmatis grown in vitro but could be used for in vivo growth also.
 ^For modelling details, see Beste et al, 2007, in the appendix.
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3.3.4.2. Modelling of in silico cofactor requirements
The model includes a “replenishing flux”  ^to stimulate de novo synthesis of cofactors 
(Beste et ah, 2007).
3.3.4.3. Model calibration.
Quantitative model predictions were compared to chemostat data by constraining the 
in silico growth rate to the chemostat dilution rate, and in turn, and computing the 
minimal uptake rate for each carbon source (glycerol and succinate) for each dilution 
rate.
The stoichiometry of the electron transport chain and energetic parameters (ATP yield 
coefficient, Yxatp; maintenance energy coefficient (ATP dissipation flux), mATP: and 
the P /0  ratio) were retained from the M. tuberculosis GSMN^ (Beste et al., 2007).
3 3.4.4. Gene essentiality: in silico vs. in vitro deletion data.
The predictive power of the M. tuberculosis GSMN was evaluated by comparing the 
phenotype of in silico deletions against in vitro and in vivo TraSH data for M. 
tuberculosis (Beste et al., 2007, Sassetti et al., 2003, Sassetti and Rubin, 2003). 
Currently, there is no such data for M. smegmatis; so the validation strategy was to 
compare the results from in silico gene deletions against a list of 30 single in vitro 
metabolic gene deletions. As the hst of in vitro gene deletions is small, comparison 
with the list of in silico gene deletions was performed manually^®.
For details o f the “replenishment flux”, see Beste et al, 2007, in the appendix.
 ^For modelling details, see Beste et al, 2007, in the appendix.
For a detailed description of the process o f in silico  gene deletion using LP, see Beste et al, 2007, in 
the appendix.
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3.3.4.S. Modelling of aerobic growth on xenobiotics
It has been mentioned previously that one of the basic aims of a GSMN is to aid in the 
understanding of the structure of the metabolic system, by focussing our attention on 
essential or uncharacteristic parts of the system. Following this, when the GSMN of 
M. smegmatis was compared to that of M. tuberculosis it was seen that there are 
numerous reactions present in the M. smegmatis genome involved in the metabolism 
of xenobiotics, which are not present in the M. tuberculosis genome.
As mentioned previously, M. smegmatis is known to metabolise acetone and 
propanol; even though there have been no genes identified in the genome which 
encode enzymes involved in the metabolism of these substrates or their metabolites 
(i.e. acetol, etc). The three corresponding reactions (as described in MetaCyc for other 
microorganisms) were added to account for this experimental evidence (Lukins and 
Foster, 1963).
M. smegmatis has also been shown to be able to oxidise butane, pentane, hexane, 
(Lukins and Foster, 1963), cholesterol (Av-Gay and Sobouti, 2000), and secondary 
amines: pyrrohdine and piperidine (Poupin et al., 1999). However, pathways which 
encompass the metabolism of these substrates have not been elucidated in any 
bacterial strains, so the pathways cannot be added to the model, even though they are 
known to exist.
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3.3.4.6. Modelling of aerobic growth on carbon monoxide and methanol in silico 
In order to simulate aerobic growth on carbon monoxide (CO) in silico (i.e. carbon 
monoxide as both a carbon and energy source), the CO and oxygen gates were 
opened.
It has been shown experimentally, that M. smegmatis is able to grow on methanol, this 
has been partially supported by genomic evidence, as enzyme 1.1.99.8 (an alcohol 
dehydrogenase) (MSMEG_3726), converts methanol to formaldehyde in the 
following reaction:
methanol + oxidized cytochrome c = formaldehyde + reduced cytochrome c
However, original inspection of the GSMN revealed that no flux was able to proceed 
through this reaction because formaldehyde was a sink. Experimental evidence 
indicates that there should be a non-annotated reaction which bridges the “pathway 
hole”, connecting formaldehyde to the rest of the metabolic network. Thus, when 
mining the M. smegmatis genome via BioCyc, it was seen that M. smegmatis 
possessed 4 out of the 6  reactions in the formaldehyde oxidation cycle. Subsequently, 
the two missing reactions were added to the model to complete the pathway. This is 
an example of how experimental data implied that these reactions (or similar) are 
present in the genome but were not detected or annotated.
3.4. Results
3.4.1. Construction of the genome-scale metabolic network of M. smegmatis.
The M. tuberculosis and M. smegmatis genomes are just two of the many microbial 
genomes which have been sequenced and annotated to date, and from these genome 
annotations, a GSMN of M. smegmatis was constructed; consisting of 1287 unique
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stoichiometric reactions (317 of those are transport reactions), 830 metabolites and 
involving 1140 genes. The information contained in the GSMN includes all the 
reaction formulae, each with its corresponding: EC number, MSMEG number (unique 
gene identifiers for M. smegmatis), enzyme name, FBA parameters, gene-protein 
associations and references. The resulting GSMN is presented in an excel file, which 
can be read by computer simulation protocols and is presented in the appendix.
The GSMN of M. smegmatis was constructed as described in the methods, and out of 
1287 unique reactions present in the final model, 773 (64%) were directly transferred 
from the M. tuberculosis model following the KEGG gene orthology mapping. This 
preliminary model has been further supplemented by data from KEGG and BioCyc 
databases. The fact that there is minimal amount of research articles with which to aid 
in model validation makes this is a model of invaluable theoretical importance.
During the construction of the GSMN, 151 isolated reactions were identified from 
unusual pathways. These particular pathways were incomplete, as they had only one 
or two reactions. Therefore, these reactions were not included in the model, but have 
been listed in a separate excel spreadsheet. Thus if experimental evidence confirms 
the presence of these reactions, they can easily be added to future versions of the 
model.
The majority of central biosynthetic pathways were retained from the M. tuberculosis 
GSMN as they homologues in M. smegmatis', the mycobacterial-specific lipids and 
carbohydrates and their corresponding synthesis pathways had to be altered to reflect 
those present in M. smegmatis (Table 3.2, 3.3 and 3.4).
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3.41.1. GSMN model calibration: Estimation of energetic parameters
It has been mentioned previously that the quantitative results obtained from FBA on a 
GSMN depend on the following three energetic parameters'^:
1. P/O ratio: The amount of ATP produced per oxygen atom consumed, which 
gives a measure of the efficiency of oxidative phosphorylation. Values of 0.5- 
3 have been reported for a wide range of organisms e.g. Xanthomonas 
campestris (Jarman and Pace, 1984).
2. mATP: ATP cost (mol/g/h) for non-growth associated maintenance i.e. energy 
dissipation. This parameter accounts for all ATP not consumed by biomass 
formation.
3. YxATP: ATP costs for growth-associated maintenance, and represents the 
amount of cells produced per mole ATP consumed. Yxatp is made up of three 
components:
• ATP costs for the synthesis of biomass building blocks (amino acids, 
nucleotides, etc.). This parameter is accounted for via stoichiometric 
reactions.
• ATP costs for the polymerization of monomers into macromolecules 
(amino acids into proteins, nucleotides into DNA, etc.).
• ATP costs associated with growth are included in the biomass equation 
i.e. the energy required for biomass formation (DNA replication etc.).
The average value of Yxatp is approximately 10.5 g/mol (Bauchop and Elsden, 1960), 
and differs depending on the organism, carbon source and the P /0  ratio (Table 3.18) 
(Hernandez and Johnson, 1967).
The three energetic parameters are also discussed in Beste et al, 2007 in the appendix.
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Table 3.18. Yxatp values of Pseudomonas flourescens grown on 3 carbon sources 
calculated from yields on oxygen and from assumed P/O ratios of 1, 2 and 3.
Carbon source Y xATP*
P/O = 1 P/O = 2 P/O = 3
A cetic ac id 7.3 4.2 2.7
M alic acid 12.6 7.3 4.9
G lu co se 10.2 6.3 4.3
^Expressed in grams o f cells produced per mole o f ATP formed.
There are many factors affecting the energetic parameters, including: the 
macromolecular content of the biomass, in particular the protein content has a 
considerable effect on the ATP requirement for biomass formation (Yxatp) (Verduyn, 
1991). Other factors contributing to Yxatp include active transport of the carbon 
source; P/O ratio, which depends on the carbon source, for example succinate has a 
P/O ratio of: 1.5 in mitochondria, 1.2 in Micrococcus denitrificans, and 1 in 
Pseudomonas AMI; maintenance and environmental factors, such as 0%, 00%, 
temperature, pH; energy content of the growth substrate; metabolites, weak acids can 
act as proton conductors. Thus combinations of energetic parameters elucidated under 
a specific experimental situation (i.e. organism, carbon source, and environmental 
conditions), will differ depending on the particular circumstance i.e. the energetic 
parameters will be different between M. smegmatis and M. bovis BCG grown on 
glycerol, and also between succinate and glycerol grown M. smegmatis.
The ATP required for biomass formation can be calculated by summing the: ATP 
requirements for precursor metabolites, polymerisation of macromolecules, and the 
model based ATP requirement to meet the particular biomass yield of the culture 
(biomass gDW/g carbon source) (Verduyn, 1991). However, as there was no data 
regarding the energetic parameters from mycobacteria, subsequent FBA simulations
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(minimization of substrate (glycerol or succinate) consumption at fixed growth rates) 
were performed using the following data obtained from related bacteria: P/O ratio to 1 
(glycerol), or 1.5 (succinate); the non-growth associated maintenance (mATp) to 1.0 
mmol/g DW/h (Stouthamer, 1979); and the ATP required for biomass formation 
(Yxatp) to 47 ATP (Borodina et al., 2005).
Gene essentiality predictions, substrate uptake rates, and other qualitative and 
quantitative findings, were not affected when the values of the energetic parameters 
(Yxatp, niATP and P/O ratio) were varied. However, the growth rate changed 
significantly when the values of the energetic parameters were varied: mATP was 
varied between 1 - 1 0  mmol/g DW/h; Yxatp was varied between 15 -  60 mmol ATP/g 
DW; and the P/O ratio was varied between 1 - 3  (Table. 3.19).
Table 3.19. Growth rate as a function of Yxatpj hiatp and P/O ratio
Y xATP
(m m ol
Growth rate (p.)
mATP (m m ol/g DW /h)
10
DW)
1
P /O  ra tio  
2 3 1
P /O  ra tio  
2 3 1
P /O  ra tio  
2 3
15 0 .0 1 4 7 0 .0 1 6 2 0 .0162 0 .0 1 1 4 0 .0 1 4 9 0 .0 1 6 2 0 .0 0 7 0 .0 1 2 6 0 .0 1 4 7
30 0 .0 1 4 5 0 .0 1 6 2 0 .0162 0 .0 1 1 3 0 .0 1 4 8 0 .0 1 6 2 0 .0 0 7 0 .0 1 2 5 0 .0 1 4 6
45 0 .0 1 4 3 0 .0 1 6 2 0 .0162 0.0111 0 .0 1 4 7 0.0161 0 .0 0 7 0 .0 1 2 4 0 .0 1 4 5
60 0.0141 0 .0 1 6 2 0 .0 1 6 2 0 .0 1 1 0 0 .0 1 4 6 0.0161 0 .0 0 7 0 .0 1 2 3 0 .0 1 4 4
The process involved fixing the glycerol uptake rate, and changing each of the three 
energetic parameters in turn, solving the system, and recording the resulting growth 
rate (Table 3.19). When the mAxp value was fixed, it can be seen that increasing the 
P/O ratio from 1 to 3, resulted in an increase in growth rate (Table 3.19). This was 
expected because as the P/O ratio increases, the efficiency of the respiratory chain 
increases, resulting in a higher rate of ATP synthesis. However, when the P/O ratio
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and niATP are kept constant, an increase in Yxatp caused no significant change in 
growth rate, or qualitative and quantitative findings (Table 3.19). It was also seen that 
when Yxatp and the P/O ratio are fixed, an increase in iuatp from 1- 10 ,  results in a 
decrease in growth rate (Table 3.19), this is because the increase in ATP dissipation 
means that there is less ATP available for growth-associated ATP demands.
3.4.1.2 GSMN model calibration: predicted vs. experimental substrate uptake 
rates
Experimental data obtained for growth of M. smegmatis in glycerol-limited and 
succinate-limited continuous culture at four growth rates were compared with the 
quantitative predictions of the GSMN.
The In silica simulations demonstrate that the predicted and experimental glycerol 
uptake rates are virtually identical at the two lowest growth rates (Fig. 3.1). 
Conversely, at the two highest growth rates the experimental glycerol consumption 
rates were approximately three times higher than the experimental values. At higher 
growth rates the model uses glycerol more efficiently than the M. smegmatis 
experimental data.
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Figure 3.1. Comparison of predicted and measured glycerol uptake rates as a 
function of dilution rate. Crosses and thick line indicate experimentally measured glycerol 
uptake rates for four growth rates set by four different dilution rates in the chemostat model. Solid  
circles and solid hne represent predictions o f the model if  glycerol were the only carbon source. 
Hollow circles and dotted line show predictions o f the model when additional oleic acid (hydrolysis 
product o f Tween 80) transport in the range o f 0 to 0.04 mmol/g dry weight (DW) per hour was 
allowed. Solid triangles and dashed lines represent measured glycerol uptake flux.
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Figure 3.2. Comparison of predicted and measured succinate uptake rates as a 
function of dilution rate. Crosses and thick line indicate experimentally measured succinate 
uptake rates for four growth rates set by four different dilution rates in the chemostat model. Triangles 
and solid line represent predictions o f the model if  succinate were the only carbon source. Circles and 
dotted line show predictions of the model when additional oleic acid (hydrolysis product of Tween 80) 
transport in the range of 0 to 0.04 mmol/g dry weight (DW) per hour was allowed. Solid triangles and 
dashed lines represent measured glycerol uptake flux.
131
It was seen that the predictions for succinate consumption rates across all 4 growth 
rates, were significantly higher than those found experimentally (Fig. 3.2). M. 
smegmatis experimental data uses succinate more efficiently than the model. A 
similar result was observed in the M. tuberculosis GSMN, the glycerol consumption 
rates were higher than the experimentally measured values, yet the predicted uptake 
rates were still within the 95% confidence limits (glycerol-limited cultures of M. bovis 
BCG).
A possible explanation of the discrepancy between the predicted and experimental 
data (as with M. bovis BCG), is that the M. smegmatis cells consumed carbon from an 
additional source. Although there is only one main carbon source (glycerol or 
succinate) in Roisin’s minimal medium, Tween-80 is also present. Tween-80 is a non­
ionic surfactant, added to culture media to reduce cell clumping and to obtain a 
homogenous cell suspension. Like the tubercle bacillus, M. smegmatis is known to be 
able to hydrolyse Tween-80, and can also utilise this compound as a sole carbon 
source (Akao et al., 1981, Saito et al., 1983). The FBA simulation was repeated with 
minimization of substrate (succinate or glycerol) uptake flux and oleic acid transport 
flux constrained in the range of 0.00 - 0.04 mmol/g DW/h. The resulting plot (Figures 
3.1 and 3.2) demonstrates that the predicted uptake rate (succinate 4- oleic acid or 
glycerol + oleic acid), has little effect on the substrate uptake rate. Therefore as the M. 
smegmatis model has not been validated experimentally, there could be several 
reasons for these errors: one (or all) of the global energetic parameters (P/O ratio, 
niATP, Yxatp) are incorrect or; some pathways or reactions are missing or; that the 
model needs more experimental data to corroborate the model, such as biomass 
composition, the existence of isoenzymes, or the existence of alternative
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reactions/pathways to a particular metabolite. There is data available for the biomass 
composition of M. smegmatis (as it has been combined in this thesis), but no data are 
available regarding the complete biomass composition i.e. proportions, nature and 
identity of all the different biomass components.
3.4.I.3. Comparison of flux distributions
Simulations were performed by constraining the minimal substrate uptake flux for 
each carbon source, at each of the four growth rates. The resulting flux distributions 
from the simulations were compared.
3.4.13.1. Flux distributions under in silico succinate-limitation
Under in silico succinate-limitation, it was noticed that the fluxes through each 
particular reaction, either increased or decreased in steady increments as the carbon 
source, uptake rate and growth rate increased. As an example, the flux through 
trehalose phosphate phosphatase showed the following values when the rates of 
substrate consumption were increased (Fig. 3.3). This distribution was expected since 
an increase in growth rate is accompanied by an increase in substrate uptake rate, 
resulting in an increase in flux through the system.
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Figure 3.3. Flux through trehalose phosphate phosphatase at four growth rates 
in silico under succinate-limitation.
This was the scenario for the majority of reactions except the following 10: purine- 
nucleoside phosphorylase, ribonucleoside hydrolase, ribokinase, 2-deoxyribose 5- 
phosphate aldolase, acetaldehyde dehydrogenase, citrate synthase, aconitase, 
isocitrate lyase, and malate synthase. The flux distribution for these 10 reactions 
showed an increase in flux between 0.01-0.025h'\ followed by a decrease in flux 
between 0.025-0.075h'^ (Fig. 3.4). As these enzymes are consecutive, this flux 
distribution could be explained by taking into account the energetic cost of following 
this series of reactions: ribokinase, 2-deoxyribose 5-phosphate aldolase consumes 
ATP during this enzymatic conversion. Thus in order to conserve ATP, there is less 
flux through these reactions.
134
0.35
0.30 -
0.25 -
0.20
0.15 -
0.10
0.05 -
0.00
0.00 0.02 0.04 0.06
G row th  ra te  (1/h)
0.08
Figure 3.4. Flux through isocitrate lyase at four growth rates in silico under 
succinate-limitation.
Isocitrate lyase and malate synthase stood out as being of importance, as it is 
hypothesized during in vitro growth on succinate there would be no flux / minimal 
flux through the glyoxylate shunt due to feedback inhibition on isocitrate lyase. 
Currently the network does not accommodate product feedback inhibition, so the flux 
is able to proceed through these reactions. As a consequence, the network could be 
adapted to account for product feedback inhibition on isocitrate lyase, by blocking the 
flux through isocitrate lyase when the cells are grown on succinate; however, there is 
no experimental data to confirm this theory. It is also possible that feedback inhibition 
would only occur when succinate is in excess, and not during succinate-limitation. 
Therefore this situation is purely speculation until it can be investigated 
experimentally.
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3.4.I.3.2. Flux distributions under in silico glycerol-limitation
Under in silico glycerol-limitation, the trend followed that of succinate-limitation; the 
fluxes through each particular reaction, either increased or decreased in steady 
increments as the carbon source uptake rate and growth rate increased (Fig. 3.3). 
However, there were 10 reactions which did not follow this trend: glycerate kinase, 2- 
hydroxy-3-oxopropionate reductase, phosphate acetyltransferase, acylphosphatase, 
glyoxylate carboligase, pymvate kinase, isocitrate lyase, malate synthase, threonine 
aldolase, acetaldehyde dehydrogenase.
There was a flux through pyruvate kinase, and both enzymes of the glyoxylate shunt 
at the lowest growth rate (0 .0 Ih'^), but there was no flux through these reactions at the 
higher growth rates (Fig. 3.5).
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Figure 3.5. Flux through pyruvate kinase, isocitrate lyase, and malate synthase at 
each growth rate under glycerol-limitation. Pyruvate kinase (Black bar), isocitrate lyase 
(Red bar), and malate synthase (Green bar).
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This is in agreement with previous experimental evidence. It has been shown that 
isocitrate lyase is more active in M. bovis BCG during low growth rates (Beste et al., 
2007), an effect that was replicated in silico by the M. tuberculosis model. However, 
there is no experimental evidence to show that pyruvate kinase is essential to M. 
tuberculosis in vivo, although there is experimental evidence to show that optimal 
growth of M. tuberculosis in glucose medium required the pykA  gene (Sassetti et ah, 
2003). Pyruvate kinase generates ATP by substrate level phosphorylation, thus the 
flux through this enzyme at the lower growth rates may be to maintain ATP levels in 
spite of a lower substrate uptake rate; the reduced glycolytic flux and in turn reduced 
rate of cofactor production, indicates a lower energy state in the cell.
An alternative flux distribution was observed, as it was also seen that there was zero 
flux through the following four reactions at the lowest growth rate: 
phosphotransacetylase, acetylphosphatase, acetaldehyde dehydrogenase, threonine 
aldolase (Fig. 3.6).
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Figure 3.6. Flux through phosphotransacetylase, acetylphosphatase, threonine 
aldolase and acetaldehyde dehydrogenase at each growth rate under glycerol- 
limitation. Phosphotransacetylase (Black bars), acetylphosphatase (Red bars), threonine aldolase 
(Green bars), and acetaldehyde dehydrogenase (Blue bars).
These four enzymes: phosphotransacetylase, acetylphosphatase, threonine aldolase, 
and acetaldehyde dehydrogenase are consecutive, and appear to cycle threonine 
during the three higher growth rates, generating cobalamin and NADH via 
acetaldehyde dehydrogenase; thus more NADH is generated at the higher growth 
rates than the lowest growth rate. On the other hand, even though there is a lower 
amount of NADH available for oxidative phosphorylation during the lowest growth 
rate, the ATP deficit is compensated for by the substrate level phosphorylation 
provided by the flux through pyruvate kinase.
The enzyme phosphotransacetylase {pta) is involved in acetate metabolism, it 
catalyses the conversion of acetyl-CoA to acetyl phosphate, and although it is not 
essential in M. tuberculosis, it may play a role in in vivo growth on host fatty acids, as
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pta mutants of salmonella, have reduced virulence in mice (Kim et ah, 2006). If M. 
tuberculosis is growing near, or at its maximum growth rate during active infection, 
then this enzyme would be advantageous (but not essential) for growth on acetate or 
fatty acids, but not during low growth rates or dormancy. Its essentiality is not known 
in M. smegmatis.
3.4.I.4. Validation of the model: in silico vs. in vitro deletion phenotypes
The next step in model validation was to check the accuracy of the predictions 
generated by the M. smegmatis GSMN. The list of essential and non-essential genes 
predicted by the model, were compared with the phenotype of known individual gene 
knock-out mutants in M. smegmatis^^ (Table 3.20).
Table 3.20. A list of enzymes and their corresponding genes in M. smegmatis each 
followed with their respective gene essentiality in vitro, and in silico, and the 
result of the essentiality comparison. The following list o f genes has been knocked out in 
vitro  and in silico , and the gene essentiality from each type of experiment was compared; the result for 
each comparison has been designated FP, FN, TP or TN.
Enzyme GENE(s) Essential in vivo
Essential 
in silico
TN TP 
FN FP Reference
adhC (alcohol 
dehydrogenase C)
(2 isoenzymes) 
adhC (alcohol 
dehydrogenase C) 
adhC (alcohol 
dehydrogenase C)
air A (alanine racemase)
ask (aspartokinase)
asnB (asparagine 
synthetase)
cydAB (cytochrome bd 
oxidase)____________
MSMEG_1037;
MSMEG_2317
MSMEG_1037
MSMEG_2317
MSMEGJ575
MSMEG_6257
MSMEG_2594;
MSMEG_4269
MSMEG 3232
NO NO TN
NO NO TN
NO NO TN
NO YES FP
YES YES TP
NO
NO 
(YES if both 
KO)
TN
NO NO TN
(Galamba et al., 
2001)
(Galamba et al., 
2001)
(Galamba et al., 
2001)
(Chacon et al., 
2002)
(Cirillo et al., 1994, 
Paveika and 
Jacobs, 1996)
(Ren and Liu, 
2006)
(Kana et al., 2001)
1 2 For a detailed description of in silico knockouts, determining in silico gene essentiality and gene
essentiality assignments, see Beste et al, 2007 in the appendix.
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cysH (APS/PAP 
reductase)
ddl (d-alanine:d-alanine 
ligase)
embABC (arabinosyl 
transferase)
embA (arabinosyl
transferase)
embB (arabinosyl
transferase)
embC (arabinosyl
transferase)
fas1 (P subunit of fatty
acid synthetase)
F0F1-ATPase 
(FO complex = 
(AtpB)(AtpF)(AtpE))
(F1 complex =
(AtpA)(AtpD)(AtpG)
(AtpH)(AtpC))
fbpA (mycolyltransferase) 
(antigen 85-A) 
gif (UDP-
galactopyranose mutase) 
hisD (histidinol 
dehydrogenase) (If all 3 
copies knocked out, its 
essential)
impA (inositol
monophosphate
phosphatase)
Icl1 and icl2 (isocitrate 
lyase)
Icl1 (isocitrate lyase)
icl2 (isocitrate lyase)
mcl (methylisocitrate 
lyase)
inhA (enoyl-[acyl-carrier- 
protein] reductase)
kasA (B-keto-acyl-ACP 
synthase) 
katG (catalase- 
peroxidase)
LunS (fadD33 of MTb)
Lun9 (gramicidin 
synthetase subunit B) 
(mbtE of MTb)
manA (phosphomannose 
isomerase)
MAT (Methionine 
adenosyl transferase) 
mshA
(Mycothiol glycosyl
transferase)
mshB (Mycothiol
deacetylase)
mshC (Mycothiol ligase)
MSMEG 4528 YES YES TP
MSMEG_2395 NO YES FP
MSMEG 6387;
MSMEG 6389; YES 
MSMEG 6388
YES TN
MSMEG_6387 NO NO TN
MSMEG_6389 NO NO TN
MSMEG_6388 NO NO TN
MSMEG_4757 YES YES TP
MSMEG 4938 
MSMEG 4942 
MSMEG 4935 
MSMEG 4936 
MSMEG 4941 
MSMEG 4939 
MSMEG_4937
YES
NO
(lowered
GR)
FN
MSMEG_6398 NO YES FP
MSMEG_6404 YES YES TP
MSMEG 2012;
MSMEG 3205; YES 
MSMEG 5656
NO FN
MSMEG_3210 NO NO TN
MSMEG 3706 
MSMEG_0911 NO YES FP
MSMEG_3706 NO NO TN
MSMEG_0911 NO NO TN
MSMEG_6646 NO NO TN
MSMEG_3151 YES YES TP
MSMEG_4327 YES YES TP
MSMEG_6384 NO NO TN
MSMEG_2131 NO NO TN
MSMEG_4511 NO NO TN
MSMEG_1836 YES YES TP
MSMEG_3055 NO YES FP
MSMEG_0933 NO YES FP
MSMEG_5129 NO YES FP
MSMEG 4189 NO YES FP
(Williams et al., 
2002)
(Belanger et al., 
2000, Feng et al., 
2002, Peteroy et 
al., 2000)
(Zhang et al., 2003)
(Zhang et al., 2003) 
(Zhang et al., 2003)
(Zhang et al., 2003)
(Zimhony et al., 
2004)
(Iran and Cook, 
2005)
(Nguyen et al., 
2005)
(Pan et al., 2001)
(Hinshelwood and 
Stoker, 1992)
(Parish et al., 1997, 
McMurry et al., 
1999, Vilcheze et 
al., 2000)
(Upton and 
McKinney, 2007) 
(Upton and 
McKinney, 2007) 
(Upton and 
McKinney, 2007) 
(Upton and 
McKinney, 2007) 
(McMurry et al., 
1999, Vilcheze et 
al., 2000).
(Bhatt et al., 2005)
(Milano et al.,
2001)
(LaMarca et al., 
2004)
(LaMarca et al., 
2004)
(Guerin et al.,
2005, Patterson et 
al., 2003)
(Berger and 
Knodel, 2003) 
(Newton et al., 
2003, Rawat et al., 
2007)
(Rawat et al., 2007) 
(Rawat et al., 2007)
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mshD (Mycothiol 
synthase) MSMEG_6830 NO YES FP (Rawat et al., 2007)
namH (N-acetylmuramIc MSMEG_0928 NO YES FP (Raymond et al..acid hydroxylase) 2005)
ndh (nadh 
dehydrogenase) MSMEG_3621 YES NO FN (Miesel et al., 1998)
otsA (glycosyl- MSMEG_6043 NO YES FP (Woodruff et al..transferase) 2004)
(Tuckman et al..
pgi (glucose-6-phosphate MSMEG_5541 YES NO FN 1997, Boshoff andisomerase) Mizrahi, 2000, Guo 
et al., 2000))
pgsA (CDP-
diacylglycerol-glycerol-3- MSMEG_2692 YES YES TP (Jackson et al..phosphate 3- 2000)
phosphatidy-ltransferase)
pimA (Guerin et al..MSMEG_2935 YES YES TP 2005, Patterson et(mannosyltransferase) al., 2003)
pks13 (Polyketide MSMEG_6392 YES YES TP (Portevin et al..synthase) 2004)
pncA and pzaA (Boshoff and
(pyrazinamidase / MSMEG_6506 NO NO TN Mizrahi, 2000, Guo
nicotinamidase) et al., 2000)
pyrF (orotidine 
monophosphate MSMEG_3048 YES YES TP (Pashiey et al., 2003)decarboxylase)
rmID (dTDP-rhamnose) MSMEG_5233; YES YES TP (Ma et al., 2002)
treS (Trehalose MSMEG_6515 NO YES FP (Woodruff et al..synthase) 2004)
whmD (whiB2 homolgue) MSMEG_1831 YES YES TP (Gomez and Bishai, 2000)
It was seen that 14% of the model predictions were false negative (FN) genes (non- 
essential in silico, essential in vitro). Yet, upon closer inspection, it was noticed that 
some of these “FN” genes may be isoenzymes, and may be under gene regulation (a 
feature not supported by the GSMN). For example, hisD (histidinol dehydrogenase) 
appears to have three isoenzymes, and in turn is predicted as FN by the GSMN. In 
contrast, the literature states it has one hisD (Hinshelwood and Stoker, 1992). Thus, 
either two of the isoenzymes are pseudogenes, or they’re under gene regulation. Also 
asnB (asparagine synthetase) is not essential in vitro, but has two isoenzymes both of 
which are deemed as essential in silico, but if they are knocked out individually, they 
are not essential. Therefore, either one of the enzymes is a pseudogene, or each 
isoenzyme may be specific for each chiral form of asparagine.
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Some of the differences between in silico and in vitro predictions may suggest the 
existence of alternative pathways, or presence of undiscovered isoenzymes. For 
instance, the genes air A  (alanine racemase) and ddl (D-alanyl-D-alanine ligase) are 
both involved in peptidoglycan synthesis, and are both deemed FP (essential in silico, 
but non-essential in vitro). This suggests that the model is lacking some information, 
either the possible existence of isoenzymes to air and ddl, or that there is more than 
one pathway to D-alanyl-D-alanine synthesis in M. smegmatis.
Two of the false negative predictions surround reactions which are involved in energy 
production i.e. the FOFl-ATPase and NADH dehydrogenase. Even though the 
associated genes are essential in vitro, due to the existence of alternative 
routes/reactions within the model for converting ATP ADP, and NADH-^ NAD, 
the flux is diverted elsewhere, thus rendering the gene(s) non-essential in silico. In 
short, the system is simply recycling cofactors.
Some of the discrepancies identified between the FBA predictions and the 
mutagenesis data can be attributed to an undefined level of inaccuracy in the model. 
As it stands, the GMSN is predominantly theoretical, relying on minimal 
experimental data for validation, relative to previously modelled organisms. Future 
biochemical data from M. smegmatis will include current gene numbers, which can be 
added to the model to further supplement it. As a result, new data will either confirm 
the genes which have been identified via in silico homology searches, or conversely 
the model will need to be adjusted accordingly (i.e. deletion/addition of 
genes/reactions), thus further validating, and in turn increasing the accuracy of the 
model.
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3.4.1.4.1. Prediction of gene essentiality for known TB drug targets, in M. 
smegmatis
The GSMN of M. smegmatis contains five genes encoding enzymes which are known 
drug targets in M. tuberculosis: inhA (isoniazid, ethionamide), fa si (pyrazinamide), 
embABC (ethambutol), ddlA (cycloserine), air (cycloserine). All of them are predicted 
to be essential in M. smegmatis, although only inhA, fa sl and embABC are known to 
be essential in this species (McMurry et al., 1999, Vilcheze et al., 2000).
The differences in gene essentiality between the two species, shows that there are 
metabolic differences between the two mycobacteria, and that not all orthologues of 
essential genes are essential in both organisms. Although it does reveal the utility of 
this approach to identify essential metabolic reactions as possible drug targets for M. 
tuberculosis using the M. smegmatis GSMN. However, they will have to be 
confirmed in vitro in M. tuberculosis.
3.4.1.4.2. The effect of energetic parameters on the in silico deletions
The results of the gene essentiality predictions showed that out of 46 genes, the in 
silico predictions were correct for 29 genes (Table 3.20), which is a prediction 
accuracy of 63%. Nevertheless, when the energetic parameters were changed to 
various combinations; P/O ratio, ATP dissipation (mAxp) and biomass formation 
(growth-associated maintenance) ( Y x a t p ) ,  were set between 1-3, 1-10 mmol/g DW/h 
and 15-60 ATP molecules, the results remained the same for all the genes. Therefore, 
the predictions appear to be robust with respect to the energetic parameters of the 
FBA model.
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3.4.15. Methanol dependent growth
In order to simulate aerobic growth on methanol in silico, the reaction for methanol 
uptake (the “methanol gate”) was opened. The theoretical methanol uptake rates are 
shown in Fig. 3.7. Simulations show that the uptake rate for methanol is three times 
greater than that of glycerol and succinate. This indicates, that out of the four carbon 
sources (glycerol, succinate, methanol, and carbon monoxide), the in silico cell 
requires more methanol (Ci) to produce/sustain growth/biomass, than glycerol (C3) 
and succinate (C 4 ).
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Figure 3.7. Comparison of predicted substrate uptake rates (qS) as a function of 
controlled growth rate, for four different dilution rates by the GSMN. (solid
triangles) methanol; (hollow triangles) carbon monoxide; (solid circle) succinate; (hollow circle) 
glycerol.
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3.4.I.6. Carbon monoxide dependent growth
In order to simulate aerobic growth on carbon monoxide in silico, the carbon 
monoxide gate was opened. The theoretical growth curves and carbon monoxide 
uptake rates were simulated (Fig. 3.7). This indicates, that out of the four carbon 
sources (glycerol, succinate, methanol, and carbon monoxide), the in silico cell 
requires more carbon monoxide (Ci) to produce/sustain growth/biomass, than glycerol 
(C3) and succinate (C4).
Methanol grown M. smegmatis grown cells have a doubling time of 7.7 hours, which 
is of longer duration than carbon monoxide grown M. smegmatis grown cells with 6.2 
hours (Park et al., 2003) (glycerol grown cells have a doubling time of approximately 
4 hours). The growth rate is the maximum rate at which the cell is dividing, and in 
turn producing the highest specific yield of biomass. Therefore the cells have to 
uptake methanol at a higher rate to sustain biomass production, as the growth rate is 
longer than that of carbon monoxide, glycerol, and succinate.
3.5. Chapter 3 conclusions
In this study, the first reconstruction and constraint-based simulation of genome-scale 
metabolic reaction network of the saprophytic Mycobacterium, M. smegmatis was 
presented. The GSMN of M. smegmatis consists of 1287 unique reactions and 830 
metabolites, and involves 1140 genes. The model includes central biosynthetic 
pathways as well as pathways for most of the mycobacterial-specific lipids and 
carbohydrates such as mycolic acid, arabinogalactan and PIMs. M. smegmatis was 
grown in continuous cultures with glycerol-limited and succinate-limited conditions, 
and steady-state growth parameters were measured and used to test and calibrate the
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model. Predicted substrate consumption rates were shown to differ substantially to 
experimentally-determined values, indicating that the model needs refining before it 
can be used to make growth-rate related predictions. However, the model successfully 
simulated many of the growth properties of M. smegmatis, such as its ability to grow 
in microaerophilic (0% uptake rate = 0.0001 nunol/g DW/h), but not anaerobic 
conditions; and also its ability to grown in the presence of methanol and carbon 
monoxide as a carbon source. When the M. smegmatis GSMN was compared to the 
M. tuberculosis GSMN, it was noted that there are numerous additional pathways 
present in M. smegmatis which are not present (or are incomplete), in M. tuberculosis. 
The nature of these additional pathways (they metabolise xenobiotics), highlights the 
difference in the native environments of the two mycobacteria, in that M. smegmatis 
is an environmental bacterium.
Predictions of gene essentiality in silico, were compared with single knock-out data 
for in viïro-grown M. smegmatis, and generated a prediction accuracy of 63%. The 
GSMN contains five known drugs targets; however, even though the model predicts 
all to be essential, only three are essential in vitro, highlighting the fact that the two 
have very different sets of essential genes. This demonstrates the metabolic 
differences between the two mycobacteria, and that not all essential genes are 
essential in both organisms. Therefore the M. smegmatis GSMN would be useful in 
predicting and identifying essential genes as possible drug targets from in vitro grown 
M. tuberculosis, but not without prior conformation in vitro. The M. smegmatis 
GSMN requires further refinement if it is to be able to accurately predict, on a global 
scale, the set of essential genes from in vitro grown M. smegmatis.
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The model also provides a way to examine the metabolic flexibility of the bacterium 
and highlights previously unexplored features of M. smegmatis metabolism that 
warrant further investigation, such as it’s ability to grown on a wide ride of substrates 
encoded for by the degradative enzymes present in its genome. These validations and 
predictions collectively demonstrate the potential utility of this model in 
understanding the metabolic state of experimentally problematic in vivo M. 
tuberculosis i.e. by comparison to M. smegmatis. This model and its successors will 
be an important resource for understanding the basic biology of the saprophytic 
mycobacterial cell in the evolution of pathogenic strain M. tuberculosis and in turn aid 
in elucidating metabolic differences between the two species, which will guide future 
research in the development of novel chemotherapeutics against TB.
In summary, the GSMN of M. smegmatis represents an in silico model constructed 
predominantly from genomic information for an organism for which there is less 
biochemical and experimental data available relative to previously modelled 
organisms such as M. tuberculosis and E. coli. Some of the discrepancies identified 
between the FBA predictions and the mutagenesis predictions can be attributed to an 
undefined level of inaccuracy in the model. Currently the scope of the model is 
limited, however, it successfully addresses the first three of Wiecherts’ modelling 
aims (section 7.1.3); 1) Structural understanding', 2) Exploratory simulation’, and to a 
lesser extent, 3) Interpretation and evaluation of measured data.
The model correctly predicted mutagenesis data with a specificity score of 63%; even 
though it failed to reproduce experimental data (substrate uptake rates). However, it 
serves as a good basis from which to develop hypothesis-driven experiments, the
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results of which must be replicated in vitro, before they can be used to further 
supplement the model. However, now that genome annotation is complete, future 
experimental data from M. smegmatis will include up-to-date gene numbers, which 
can be added to the model to further validate the genomic and biochemical 
information contained in the model, and will also update genome annotation. 
Therefore as its accuracy increases, its predictive power will increase also. The aim is 
to fully validate the model, thus creating a model with high predictive power. It is at 
this point that the model can be optimised, and should be able to reproduce aspects of 
M. smegmatis metabolism.
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Chapter 4: A computational resource for constraint-based 
simulation of reconstructed genome scale metabolic network 
of Mycobacterium tuberculosis
4.1. Introduction
As mentioned previously, TB is an acute bacterial infection caused by M. 
tuberculosis. The tubercule bacillus has evolved a variety of mechanisms by which it 
is able to evade the host immune system and survive/persist intracellularly. However, 
investigation into the determinants of persistence has proven to be challenging due to 
the difficulty in defining and replicating the physiological state of the bacilli during 
persistent infection. Current anti-TB drugs have been around since the late forties and 
fifties, but they only target active disease. An ideal drug would be one that targets and 
eliminates persistent bacilli from the body before they reactivate, thus 
preventing/minimising the spread of TB.
The availablilty of bacterial genome sequences allows the construction of genome 
scale metabolic reaction networks (GSMNs) for the microorganism in question. By 
reconstructing the metabolism of bacteria according to the reaction stoichiometry, 
reaction directionality and thermodynamic constraints, the metabolic capabilities of 
microorganisms can be studied in silico. Previous models have proven to be useful in 
hypothesis generation and correction of errors in genome annotation, and have also 
been successful in predicting phenotypic behavior. Constraint based modelling has 
been applied to the genome scale metabolic network of M. tuberculosis. It is hoped 
that the GSMN of M. tuberculosis will be used to generate new hypotheses and in turn 
guide research into novel anti-TB drugs.
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The following Results section is part of a much larger study: Beste et al, 2007, the 
complete published version of which is presented in the appendix.
4.2. Results
A genome-scale metabolic model of Mycobacterium tuberculosis was constructed 
based on the annotated genome sequence (Cole et ah, 1998), consisting of 849 unique 
reactions and 739 metabolites, and involving 726 genes.
The construction of the model required intensive annotation, supplementing genomic 
data with experimental information from the literature. For example, as a rule ATP- 
dependent PEPCK are found in bacteria, whereas M. tuberculosis PEPCK (pckA) is 
GTP-dependent (Mukhopadhyay et ah, 2001). The raw data contained in the network 
text file was checked, to ensure that each reaction had the correct gene number, and 
that the corresponding enzyme had been assigned the correct name and EC number.
The procedure also involved filling in the gaps in reconstruction by identifying those 
internal metabolites which could only be produced (sinks) or only be consumed 
(sources). There needs to be a continuous pathway from media substrates to biomass 
components, as fluxes would be interrupted if there is discontinuity in the network. 
Any identified sinks/sources were integrated into the rest of the network, either by an 
internal reaction, or by a transport reaction The Kegg and Biocyc databases were 
interrogated in order to identify reactions that would join up those sinks and sources 
to the rest of the network (Table 4.1).
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Table 4.1. List of reactions added (by myself) to the model to join the 
sinks/sources to the rest of the model.
Reaction
#
Reaction Comment
R 373
R 374
1 NACD + 1 ATP = 1 NACN + 
1 ADR
1 NAMD + 1 ATP = 1 NAMN + 
1 ADR
NACD a n d  NAMD w ere  sink  m e tab o lite s . 
A d d ed  tw o re a c tio n s  from K egg; O n e  with an  
Rv n u m b e r a n d  o n e  w ithout.
R 824
1 S U C xt + 1 ATP = 1 s u e  + 1 
ADR + 1 PI
S u c ro s e  w a s  a  so u rc e  m etab o lite . A dded  
s u c ro s e  tra n sp o rt reaction .
R28
R29
1 M L T + 1  Pl = 1 b D G 1P  + 1 
bDGLC
1 b D G 1P  = 1 bD G 6P
T ried  to g e t a ro u n d  th e  lack  of g e n e s  for R 30, 
by  b y p a ss in g  th e  reac tion  bu t d idn 't w ork. T h e  
addition  of R 28 a n d  R 29 did in c re a s e  th e  
grow th ra te  slightly, an d  in c re a se d  th e  n u m b e r  
of T N s.
R 139
R 140
1 P5G  + 1 NAD = 1 
HYDROXYGLU + 1 NADH 
1 HYDROXYGLU + 1 AKG = 1 
HYDROXYAKG + 1 GLU
H yd ro x y -a-k e to g lu ta ra te  is a  sink  m e tab o lite  
(R 141). A dded  R 139  an d  R 140.
R 909 1 H EXA C OSA NO A TExt = 1HEXACOSANOATE
R 910 1 TETR A C O SA N O A TExt = 1T ETR A C O SA N O A TE
R 912 1 EIC O SA N O A TExt = 1EIC O SA N O A TE T h e s e  fatty  a c id s  w e re  sinks . A dded  a s s o c ia te d
R 913
1 PEN TA D EC A N O A TExt = 1 tra n sp o rt rea c tio n s .
PEN TA D EG A N OA TE
R 914 1 H EPTA D EG A N OA TExt = 1HEPTA D EG A N OA TE
R 915 1 NONADEGANOATExt = 1NONADEGANOATE
The newly added reactions fell into two categories: 1) reactions for which the 
accompanying genetics are unknown; 2 ) reactions for which associated genetics are 
known in the closely related species M. tuberculosis CDC1551. For example the 
pathway for methionine synthesis was already present in the model, but it had one gap 
(4.4.1.8 ), however, the missing enzyme was found to be encoded by the CDC1551 
genome.
Another important process in the construction of the model was the detection and 
deletion of duplicated reactions. Rather than being modelled by a duplication of 
reactions, isoenzymes were accounted for by Boolean statements describing gene-
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protein associations. Thus, all the reactions from the Streptomyces model that 
presented duplications were removed. When futile cycles were identified, they had to 
be removed, as their presence causes mathematically unsolvable problems (Chao and 
Liao, 1994, Schilling et al., 1999). Futile cycles involve two enzymes which 
simultaneous convert substrates in opposite direction, whilst utilising currency 
exchange fluxes and degrading charged cofactors such as ATP (Schilling et al., 1999). 
They are called futile for the lack of any identifiable biological purposes; however, 
they may have roles in thermogenesis and metabolic regulation (Hue, 1982, 
Newsholme and Crabtree, 1976).
Another step in the construction of the model was to identify any reactions which 
resulted in carbon fixation by the system; these reactions were identified by carrying 
unusually high fluxes, which in turn resulted in an inaccurately high growth rate.
Finally, some pathways were absent from the network and had to be created, such as 
the pathway for thiamine synthesis, which is known to be present in Mycobacterium 
metabolism (Table 4.2). Similarly, reactions for the synthesis of the macromolecular 
components of the biomass (RNA, DNA and protein) had to be created (mmol/g 
macromolecule) (Table 4.2).
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Table 4.2. Pathways and reactions added (by myself) to the model.
Reaction # Reaction Pathway
R 465
R 466
R 467
R 468
R 469
R 470
R471
R 472
R 473
R 474
1 TYR = 1 T S-C O S H -T Y R  
1 T S-P R O T E IN  = 1 T S -C O S H -T Y R  
1 AIR = AHMMP
1 AHMMP + 1 ATP = 1 A M PM P + 1 ADP 
1 AM PM P + 1 ATP = 1 M A H M PPP + 1 A DP 
1 DX5P + 1 T S -C O S H -T Y R  = 1 HEM T + 1 T S - 
PRO TEIN
1 HEM T + 1 ATP = 1 M PET + 1 ADP 
1 M A H M PPP + 1 M PET = 1 TH IP + 1 PPI 
1 TH IP = 1 THI + 1 PI 
1 THI = 1 AHMMP + 1 HEMT
T hiam ine  sy n th e s is  
T h iam in e  sy n th e s is  
T h iam in e  sy n th e s is  
T h iam in e  sy n th e s is  
T h iam ine  sy n th e s is
T h iam ine  sy n th e s is
T h iam ine  sy n th e s is  
T h iam ine  sy n th e s is  
T h iam ine  sy n th e s is  
T h iam in e  sy n th e s is
Macromolecule Macromolecular synthesis reaction Comment
RNA
DNA
P R O T
0 .641  UTP + 0 .7 0 8  C T P  + 1 .9 8  ATP + 1 .1 3  G T P  = 
1 RNA + 1 .2 5  A DP + 1 .2 5  PI + 3 .21  PPI 
0 .5 5 7  DTTP + 1 .061  D G TP + 1 .061  DO TP + 4 .4 4  
ATP + 0 .5 5 7  DATP = 1 DNA + 4 .4 4  ADP + 4 .4 4  
PI + 3 .2 4  PPI
0.389 ILE + 0.832 VAL + 0.173 MET + 1.324 ALA 
+ 0.208 HIS + 0.192 LYS + 0.899 LEU + 0.696 
ARG + 0.537 A S P  + 0.541 S E R  + 0.429 GLU + 
0.283 GLN + 0.556 TH R + 0.132 T R P  + 0.187 
TYR + 0.094 C Y S + 0.213 ASN + 40.74 A TP + 
0.958 GLY + 0.56 P R O  + 0.26 PH E  = 1 PR O TEIN
m m ol/g RNA
m m ol/g DNA
m m ol/g protein
4.3. Conclusions
The GSMN of M. tuberculosis was able to predict the phenotype of in silico deletion 
mutants with high accuracy (78%) when compared against published TraSH data. In 
turn, the model successfully confirmed the essentiality of known metabolic drug 
targets, such as inhA (isoniazid and ethionamide) (Baneijee et al., 1994), fa s l  
(pyrazinamide) (Cynamon et al., 1992), embAB (ethambutol) (Alcaide et al., 1997), 
ddlA and air (cycloserine) (David et al., 1969).
The first version of the GSMN of M. tuberculosis provides a basis from which in 
silico experiments can be designed. This undoubtedly represents a major 
breakthrough in the development of new drugs. Nevertheless, it has to be kept in mind 
that those predictions should be corroborated in vitro. The current model has 
increased our understanding of the metabolism of the tubercle bacillus, in that cutting
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edge in silico methods (such as MFA and FBA); can be used for the elucidation and 
analysis of the metabolic capabilities of this pathogen.
Furthermore, exploration of the behaviour of the system has given a basis for the 
rejection of false hypotheses (e.g. ink was shown to be nonessential in the TraSH 
experiment but was correctly predicted to be essential for growth by the GSMN-TB 
model), and help focus the attention on the behaviour on the metabolic system as a 
whole.
In summary, the reproduction of the TraSH Data, and the characterization of nutrient 
uptake and biomass formation in silico, has enabled the evaluation of the predictive 
power of the GSMN and provided a better understanding of the behaviour of the 
system as a whole. However, further in vitro and in silico investigation is required to 
create a precise model. As the model becomes more accurate, more meaningful results 
can be obtained, and in turn the predictive power will increase. The aim is to generate 
a precise model, which could be fully validated. Therefore, once a validated model 
has been generated, the outcome of future experiments can be predicted.
Once the GSMN of M. tuberculosis had been generated, it was possible to use this as 
a basis for the construction of the GSMN of M. smegmatis. This would enable the 
comparison of the metabolic capabilities of the two mycobacteria, and the elucidation 
of any metabolic differences between them (Chapter 3).
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4.4. Future work: The GSMN of M. tuberculosis
• Model refinement. Further refinement of the model as new relevant
experimental data becomes available. Subsequent versions of the model
should increase the accuracy and precision of the results gained from the in 
silico analysis.
• Extreme Pathway (EP) analysis. This type of analysis is used to describe all
the potential steady-state flux routes through the network. EP analysis can be
used to demonstrate the capabilities and the flexibility of the network under 
defined environmental conditions. This approach has been carried out on 
genome scale models of H. pylori (Schilling et al., 2002), and H. influenzae 
(Schilling and Palsson, 2000). From the results (reaction participation matrix), 
it was possible to visualise the essential reaction sets, and in turn identify areas 
of weakness within the organisms metabolism.
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Chapter 5: Discussion, conclusions & future direction
5.1. Discussion and conclusions
The tubercle bacillus is one of the most successful and complex pathogens, and the 
mechanisms by which it persists within the host are multifactorial. It is known that 
although M. smegmatis fails to persist within macrophages it does share some features 
of dormancy with M. tuberculosis, such as its abihty to adapt to oxygen depletion in a 
mechanism analogous to M. tuberculosis. Due to these similarities, the saprophytic 
Mycobacterium can be used to investigate the mechanisms of persistence and 
dormancy in vitro, and how they differ to those mechanisms identified in the tubercle 
bacillus.
Evidence has also shown that M. smegmatis has the ability to cause both non- 
tuberculous and granulomatous disease. In light of recent research, M. smegmatis was 
shown to be a suitable candidate in pre-screening anti-TB compounds against MDR- 
TB (Chaturvedi et al., 2007). In summary, M. smegmatis could play a key role in the 
quest for new anti-TB drugs and in particular those able to combat MDR-TB.
At the beginning of this project it was not known if M. smegmatis shared aspects of 
metabolism with the tubercle bacillus {M. bovis BCG). The macromolecular biomass 
composition of M. bovis BCG and M. smegmatis grown under glycerol-limitation in 
continuous culture, responded differently to changes in dilution rate (Chapter 2). 
Results from chemostat cultures also show that the macromolecular biomass 
composition of each species is different, indicating that each mycobacteria has 
different metabolism (indicated by the accumulation of different storage compounds). 
Yet, although the two species have different doubling times (growth rates), under
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carbon-limitation the biomass of M. smegmatis and M. bovis BCG responded in the 
same way to an increase in dilution rate, which is reflected in a trend of exponential 
decay towards washout (Chapter 2). This confirms the observation that both species 
of mycobacteria do not follow the typical profile of growth (the Monod kinetics). 
Therefore, although the two have very different biomass compositions, their 
physiology responds in a similar way to an increase in dilution rate.
It has been shown that continuous culture can be used as a system to cultivate 
mycobacteria at different dilution/growth rates. Previous chemostat models have used 
M. bovis BCG and M. tuberculosis to mimic different phases of TB infection within 
the chemostat, but due its slow growth rate, experiments were lengthy (Beste et al, 
2005). The aim of this project was to determine if M. smegmatis could be considered 
as a faster growing, non-pathogenic model of mycobacterial metabolism, and in 
particular a metabohc model of the tubercle bacillus. The results of which could have 
lead to one of the following two outcomes:
• If M. smegmatis has a similar biomass composition to M  bovis BCG, and each 
macromolecular compartment responds similarly to an increase in dilution 
rate, then M. smegmatis could be thought of as a metabolic model of the 
tubercle bacillus, with the abihty to drive future experiments into possible 
drug targets.
• Conversely, if M. smegmatis has a different biomass composition to M. bovis, 
and each macromolecular compartment responds differently to an increase in 
dilution rate, then M. smegmatis will not be suitable as a metabolic model of 
the tubercle bacillus. Instead, it could be used to investigate aspects of general 
mycobacterial metabolism, in particular fast growing mycobacterial
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metabolism, and elucidate differences in metabolism which have been 
lost/gained since the two species diverged.
M. smegmatis was grown under carbon-limitation at four dilution rates, and the 
resulting steady-state biomass composition was analysed. The macromolecular 
composition determined for M. smegmatis, at each growth rate, under carbon- 
hmitation, was compared to that from M. bovis BCG.
It is known that the macromolecular biomass composition of different micro­
organisms varies within a very wide range. This is particularly notable in the case of 
the mycobacteria, as they contain a much higher lipid content than other bacteria. 
Consequently, it was deemed unreliable to use for a M. smegmatis model the 
macromolecular composition from a different and possibly unrelated bacterium. 
Although the macromolecular data for M. smegmatis is scant and incomplete, a basic 
macromolecular composition for M. smegmatis was generated from the combination 
of the experimental data presented in this work and published data. The resulting 
macromolecular biomass formula was used in the model, with the aim of increasing 
the accuracy of the in silico simulations, and in turn replicating M. smegmatis 
experimental data such as uptake rates, in silico vs. in vitro g&ne deletions, etc. In this 
way, it could be possible to increase the accuracy of the simulations, and in turn 
validate the model.
The macromolecular composition for M. smegmatis grown at four dilution rates under 
carbon-limitation (glycerol and succinate) was determined. It was shown that the 
macromolecular biomass composition differs slightly, depending on the carbon source
158
utilised. However, the biomass composition for succinate-limited and glycerol-limited 
cells was shown to respond in an equivalent way to an increase in dilution rate. As a 
result, a biomass composition was created for FBA simulations on each carbon 
source, which is an average of each of the five different macromolecular biomass 
compartments across the four dilution rates.
When comparing the biomass composition of M. smegmatis to that of M. bovis BCG 
(Mtb), differences in macromolecular composition between the two mycobacteria was 
revealed. It was also shown that the biomass composition for each of the two 
mycobacterial species responds differently to an increase in growth rate. Some of the 
macromolecular compartments respond in the same way, whereas some do not.
It has been demonstrated that M. smegmatis has a different macromolecular biomass 
composition to that of M. bovis BCG. These differences most likely reflect the native 
environments of the two mycobacteria, and the metabolic response required by each 
species for survival in their native environment. In other words, it reflects how the 
metabolism differs under nutrient limitation in the soil vs. the macrophage. These 
differences are most likely to be evolutionary, and would have arisen since they 
diverged.
Although the composition of each species reacts differently to changes in growth rate, 
they have a “similar” profile of essentials genes. Therefore, because the two have 
different macromolecular compositions, there may be no single model of general 
mycobacterial metabolism. Consequently, as it stands, they may each represent two 
separate models, one for saprophytic mycobacteria, and another for tubercle bacilh.
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Models from many mycobacterial species such as M. tuberculosis GSMN and M. 
smegmatis GMSN, may help to elucidate key metabolic differences between 
tuberculous and non-tuberculous mycobacteria. The GSMN of M. smegmatis is a first 
version, and may be subject to further annotation as the databases are updated. The 
GSMN of M. smegmatis consists of 1287 unique reactions, 830 metabolites and 
involves 1140 genes.
When comparing the GSMN of the two species side by side, it can be seen that M. 
smegmatis has more pathways involved in the metabolism of xenobiotics, reflecting 
the native environment of M. smegmatis.
It is known that M. smegmatis is able to grow on methanol and carbon monoxide, and 
the model is able to replicate growth on these compounds. However, due to the lack 
of experimental data regarding uptake rates of these compounds during continuous 
culture, the accuracy of the predicted uptake rates is not known. However, the 
predictions did show that the carbon monoxide and methanol uptake rates are greater 
than succinate and glycerol uptake rates. This result may reflect the needs of the cell; 
more methanol (Ci) and carbon monoxide (Ci) is needed to produce/sustain 
growth/biomass, than glycerol (C3) and succinate (C4).
The prediction accuracy for a list of 46 genes was shown to be 63% (Chapter 3). 
However, even though the model predicted the five known front line TB drug targets 
to be essential in M. smegmatis, it is known that only three of those are essential. This 
result highlights the differences in gene essentiality, and in turn metabolism, between
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the two species. Therefore, any potential drug targets identified using the M. 
smegmatis GSMN, would need to be confirmed in vitro in M. tuberculosis and in M. 
smegmatis.
When observing the flux distributions from in silico simulations on glycerol and 
succinate, there was a flux through the glyoxylate shunt at the lowest growth rate 
(O.Olh’^ ), but there was no flux through the glyoxylate shunt at the higher growth 
rates. This is in agreement with previous experimental evidence showing that 
isocitrate lyase is more active in M. bovis BCG during low growth rates (Beste et al., 
2007),
The main obstacle involved with TB research is the inability to define and replicate 
the physiological/metabolic state of the bacilli during persistence. This has made it 
extremely difficult to study and identify the metabolic/genetic basis of latency and 
infection. The GSMN of M. tuberculosis predicts global mutagenesis data with an 
accuracy of 11%. This model provides a useful platform from which to initiate further 
studies into specific metabohc aspects of different phases of TB disease such as 
pathway utilisation during active infection vs. persistence.
The primary role of GSMNs is flux analysis, however, they also provide the scientific 
community with a central resource for organising all the metabolic data and the 
corresponding biochemical and genomic information from the organism in question. 
The addition of new information increases the accuracy and validity of the gained in 
silico results. Thus, the construction of the GSMNs from M. tuberculosis and M. 
smegmatis, has allowed a comparison to be made between the similarities/differences
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in metabolic reactions, pathways, and associated genomics between saprophytic and 
pathogenic species of mycobacteria. It has been shown that although M. smegmatis 
has a very different biomass composition to the tubercle bacillus (M. bovis BCG), the 
GSMNs of M. smegmatis and the tubercle bacillus (M. tuberculosis) were able to 
accurately predict the essentiahty of drug targets. In summary, M. smegmatis could be 
adopted as fast growing “metabolic” model of the pathogen, for pre-screening 
potential essential genes in M. tuberculosis, provided that the results were confirmed 
in vitro.
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5.2. Future direction
• As new genomic information becomes available (from ftiture publications), 
the model can be updated (Presence of isoenzymes, new pathways/reactions). 
This will lead to subsequent improved versions of the GSMN. The GSMN 
should increase in accuracy as the amount of experimental data increases, in 
turn producing more accurate/reliable predictions.
• Determine the exact macromolecular biomass composition of M. tuberculosis 
and M. smegmatis using mass spectrometry. This will impact in the accuracy 
of the prediction generated by the model.
• Perform global mutagenesis (TraSH) on M. smegmatis, in order to characterise 
the metabolic genes in the genome. Global mutagenesis data {in vitro) from M. 
smegmatis, could then be compared to the in silico deletions, to determine the 
accuracy of the entire model. Subsequent global mutagenesis data could be 
compared to that from M. tuberculosis. Any differences in gene essentiality 
between the two species would show how the metabolic and genetic 
requirements of each Mycobacterium has changed since the divergence and 
evolution of the two species.
• Refinement of the M. smegmatis GSMN via hypothesis-driven experiments, 
the results of which could be used to further annotate/validate the model.
• Perform pathway analysis (such as elementary modes analysis) on the GSMN 
of M. tuberculosis to observe the flexibility of M. tuberculosis grown in silico 
on different substrates. Elementary modes can be defined as the ''smallest sub 
networks enabling the metabolic system to function at steady-state'’ (Schuster, 
1999). Therefore by using elementary mode analysis, one can observe the 
effects of knocking out different genes in silico. Previous pathway analysis on
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the genome scale models of Haemophilus influenzae (Schilling and Palsson 
2003) and S. coelicolor (Borodina et al, 2005) allowed them to identify “core” 
reactions essential for growth on different carbon sources. Thus, as the 
tubercle bacillus is thought to consume host lipids during infection, pathway 
analysis may enable the identification of essential reactions involved in fatty 
acid metabolism, which could be potential drug targets.
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APPENDIX 
Macromolecular A ssays
(B io m ass w a s  w e ig h ed  ou t 30m g/m l, an d  th e  s to c k  u se d  for s u b s e q u e n t b io m a ss  a s s a y s )  
Determination of the carbohydrate content by the phenol-sulphuric acid reagent 
(Dubois et al., 1956)
• P re p a re  a  s e t  of G iu co se  s ta n d a rd  so lu tio n s for th e  s ta n d a rd  curve , e a c h  in a  to tal 
vo lum e 2mI from  5-150  pg.
• P re p a re  te s t  s a m p le s  in 2m l of R O  w a te r  con ta in ing  app ro x im ate ly  75  pg/m l 
c a rb o h y d ra te  (approx  660  pg  b io m a ss) .
• P ip e tte  s a m p le s  an d  s ta n d a rd  so lu tio n s into g la s s  te s t  tu b e s .
• T o  e a c h  ad d  0.5m i 5%  ph en o l an d  vo rtex  carefully.
• Add 5ml c o n c e n tra te d  su lphu ric  ac id  rapidly to  e a c h  te s t  tu b e , vo rtex  a n d  cover.
• In cu b a te  for 10 m in u tes  a t room  te m p e ra tu re  (RT).
• In cu b a te  for a  fu rther 1 hr a t 25-30°C .
• T ra n sfe r  1ml into a  cu v e tte  an d  m e a s u re  a b s o rb a n c e  a t 488nm .
Determination of the protein content by the phospho-molybdic-phosphotungstic 
reagent (Lowry assay) (Lowry et al., 1951)
P re p a re  a  s e t  of BSA pro tein  s ta n d a rd  so lu tio n s for th e  s ta n d a rd  cu rve , e a c h  in a  to tal 
vo lum e of 0 .5m l from 25 -2 0 0  pg.
P re p a re  te s t  s a m p le s  in 0 .5m l of R O  w a te r  con tain ing  app rox im ate ly  100  pg  p ro tein  
(Approx 40 0  pg  b io m a ss) .
P ipe tte  s a m p le s  an d  s ta n d a rd  so lu tio n s into g la s s  te s t  tu b e s .
To e a c h  ad d  0.5m l of 1 M sod ium  hydroxide (N aO H ).
C o v er with a  m arb le  an d  boil for 10 m in u tes .
Cool in a  b a th  of cold w ate r.
Add 2.5m l Lowry re a g en t.
V ortex an d  in c u b a te  a t RT for 10 m inu tes.
A dd 0.5m l Folin C io ca lteau  re a g e n t rapidly a n d  vortex  
In cu b a te  for 30  m inu tes  a t room  te m p e ra tu re  (RT).
T ra n sfe r  1ml into a  cu v e tte  an d  m e a s u re  a b s o rb a n c e  a t 750nm .
Determination of the lipid content by the sulfo-phospho-vanillin reagent (Izard and 
Limberger, 2003)
• P re p a re  p h o sp h o ric  acid-vaniiiin re a g e n t (0 .12 0 g  vanillin in 20  mi w a te r  up  to  100m l 
with 85%  p h o sp h o ric  acid) 5m i requ ired  for e a c h  sa m p le  an d  s ta n d a rd  cu rv e  point.
•  P re p a re  triolein (giyeroi trio leate) s ta n d a rd  curve . D isso lve th e  triolein in 100%  
ethano l.
•  Apply re s u s p e n d e d  f re e z e  dried  b io m a ss  s a m p le s  (600pg) a  te s t  tu b e  (in trip licate) 
an d  m a k e  up  to  10Opi with ethano l.
•  T o  e a c h  te s t  tu b e  a d d  2m i of c o n c e n tra te d  (18M) su lphu ric  ac id  (g la ss  p ip e tte s).
•  G ap  te s t  tu b e s  with m a rb le s  an d  in c u b a te  in a  boiling w a te r  b a th  for 10 m in u tes .
•  Cool tu b e s  in a  w a te r  b a th  a t room  te m p e ra tu re  for 5 m inu tes.
•  Add 5ml p h o sp h o ric  acid-vaniiiin re a g e n t to  e a c h  tu b e  (g la ss  p ip e tte s). R e c a p  with 
m arb les .
•  Incuba te  in a  w a te r  b a th  a t 37°C  for 15 m in u tes .
•  Cool tu b e s  in a  w a te r  b a th  a t room  te m p e ra tu re  for 10 m inu tes.
•  T ra n sfe r  Im i into a  cu v e tte  an d  m e a s u re  a b s o rb a n c e  a t 530nm .
Determination of the fructosyl carbohydrate content by the indoleacetic-acid-HCI (lAA) 
reagent (Mousdale, 1997)
Add 0.1 mi of e a c h  s a m p le  in trip licate to  15ml g la s s  te s t  tu b e s  
P re p a re  fru c to se  s ta n d a rd s  (0, 5 ,1 0 ,  20 , 40 , 8 0 , 160pg) in 0.1m l.
Add 0.1m l of th e  lAA re a g e n t to  e a c h  tu b e .
Add 4m l c o n c e n tra te d  hydrochloric acid  (HOi) to  e a c h  tu b e .
P lac e  all tu b e s  im m edia te ly  in a  w a te r  b a th  a t 37°G  a n d  in c u b a te  for 60m in.
182
•  R e m o v e  tu b e s  from  th e  w a te r  ba th , coo l to room  tem p .
• T ra n sfe r  1 ml to  a  cu v e tte  an d  m e a s u re  a b s o rb a n c e  a t 530nm .
Determination of the DNA content by the Diphenylamine reagent (Burton, 1956)
•  M ake up a q u e o u s  a c e ta ld e h y d e  (1.6% )
• M ake up d ipheny lam ine  re a g e n t: lOOmi giaciai a c e tic  acid , 1 .5g  d ip h en y iam in e , I.S m i 
su lphu ric  acid .
•  J u s t  b e fo re  you ’re rea d y  to  do th e  a s s a y ,  ad d  lOOul of cold a q u e o u s  a c e ta ld e h y d e  
so lution  p e r  20m i re a g en t.
• P re p a re  th e  s ta n d a rd  DNA by incubating  20 m g  calf th y m u s DNA in 10 ml 5%  TCA 
in c u b a te  a t 7 0 o C  for 2 h o u rs .
•  Add 1 200ug  of b io m a ss  to  a  te s t  tu b e  (in triplicate) an d  th e n  m a k e  up  to  1ml with 5%  
TCA. In cu b a te  a t 70°C  for 2 hours.
•  In cu b a te  a t room  te m p  for 16-24  h o u rs .
• T ra n sfe r  1ml to a  cu v e tte  a n d  m e a s u re  a b s o rb a n c e  a t 600nm .
Determination of the RNA content by the Orcinol assay (Munro, 1966)
• P re p a re  O rcinol rea g e n t: 1 vo lum e 1%  orcinol so lu tion  to  4  v o lu m e s of a  so lu tion  of
0 .0 2 g  F eC l3.6H 20 in 100m l c o n c e n tra te d  hydrochloric acid  (HOI).
• P re p a re  s ta n d a rd s  by disso lv ing  RNA in 10%  TCA. O r u s e  g u a n o s in e  (0, 5, 10, 20, 
40 , 80, 160pg).
• E xtract RNA by  incubating  b io m a ss  in 10%  TCA  (final co n c en tra tio n : 1800ug/m i) a t 
70°C  for 15-30 m inu tes.
•  C en trifuge th e  tu b e s , th e n  rem o v e  th e  su p e rn a ta n t an d  divide by 3 tu b e s  (e a c h  tu b e  
h a s  ap p ro x  600ug  b io m a ss) .
•  M ake e a c h  te s t  tu b e  up  to  2m l with 6%  TCA. T h en  ad d  2m i of orcinol re a g e n t, cap , 
an d  th e n  boil for 15 m in u tes .
• T ra n sfe r  1ml to a  cu v e tte  an d  m e a s u re  a b s o rb a n c e  a t 530nm .
Biomass estimation. Determination by dry cell weight (Lynch and Bushell, 1995)
•  P re -d ry  th e  filter (W hatm an  0 .5pm ), by  h ea tin g  in th e  m icrow ave a t m ax  p o w er for 6 
m inu tes.
D es ic c a te  th e  filter for 2 4 -4 8  ho u rs .
W eigh  th e  filter, an d  reco rd  th e  w eight.
W et th e  filter in 0.01 %  T w ee n  80.
P la c e  in a  filter ho lder a n d  rin se  with 2x1 Omi of MQ w ate r.
D iscard  th e  w ater.
S h a k e  th e  b io m a ss  sa m p le  an d  filter a  10 ml sa m p le .
R in se  with 3x1 Omi of R O  w ate r.
P la c e  th e  filter in a  Petri d ish  an d  m icrow ave a t m ax  p o w er ( 3 x 4  m inu tes) (Line th e  
Petri d ish  with p a p e r  to  p rev e n t th e  filter sticking to  th e  d ish).
Cool u n d e r d es icca tio n  for 48  h ou rs.
R e-w eigh  an d  record .
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Abstract
Background: An impediment to the rational development of novel drugs against tuberculosis (TB) 
is a general paucity of knowledge concerning the metabolism of Mycobacterium tuberculosis, 
particularly during infection. Constraint-based modeling provides a novel approach to investigating 
microbial metabolism but has not yet been applied to genome-scale modeling of M. tuberculosis.
Results: GSMN-TB, a genome-scale metabolic model of M. tuberculosis, was constructed, 
consisting of 849 unique reactions and 739 metabolites, and involving 726 genes. The model was 
calibrated by growing Mycobacterium bovis bacille Cal mette Guerin in continuous culture and 
steady-state growth parameters were measured. Flux balance analysis was used to calculate 
substrate consumption rates, which were shown to correspond closely to experimentally 
determined values. Predictions of gene essentiality were also made by flux balance analysis 
simulation and were compared with global mutagenesis data for M. tuberculosis grown in vitro. A  
prediction accuracy of 78% was achieved. Known drug targets were predicted to be essential by 
the model. The model demonstrated a potential role for the enzyme isocitrate lyase during the 
slow growth of mycobacteria, and this hypothesis was experimentally verified. An interactive web- 
based version of the model is available.
Conclusion: The GSMN-TB model successfully simulated many of the growth properties of M. 
tuberculosis. The model provides a means to examine the metabolic flexibility of bacteria and predict 
the phenotype of mutants, and it highlights previously unexplored features of M. tuberculosis 
metabolism.
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Background
Tuberculosis (TB), ca u sedh yM ycobacteriu m  tuberculosis, is 
one of the most important diseases in the world today, being 
responsible for more than 8 million cases of disease each year 
and approximately 3 million deaths [1,2]. Control of human 
TB relies on vaccination, case finding, and chemotherapy. 
Current anti-TB drugs are relatively ineffective against 'per­
sistent bacteria', and consequently prolonged treatment with 
combinations of drugs for 6 to 12 months is required to cure 
acute disease or eliminate persistent infections. The eco­
nomic and logistic burden of administering TB treatment is 
enormous, particularly in industrially under-developed coun­
tries, where TB is most prevalent. A further complication in 
the treatment of TB is the emergence of multidrug-resistant 
strains of TB (both M. tuberculosis and M ycobacteriurri 
bovis) in many parts of the world [3,4]. Very few new classes 
of antibiotics have been approved for clinical use during the 
past decade. The exceptions (for instance, the oxazolidinones 
and daptomycin) are not applicable to TB infections. New  
anti-TB drugs are urgently required that shorten the duration 
of treatment, that have activity against drug-resistant strains, 
and that specifically target persistent cells.
An impediment to the rational development of novel drugs 
against TB is a general paucity of knowledge concerning the 
metabolism of M . tuberculosis, particularly during infection. 
One reason for this lack of knowledge is difficulty in applying 
biochemical techniques to the bacterium in v ivo . In spite of 
this, several features of in v ivo  bacterial metabolism have 
been established. First, the essentiality of the glyoxylate shunt 
during intracellular growth indicates that M . tuberculosis 
survives by scavenging host lipids [5-7]. Second, there is 
growing evidence of a shift to anaerobic respiration during 
persistent infection [8-10]. These findings have been useful in 
directing rational drug development [11], but a more com­
plete understanding ofM . tuberculosis metabolism remains a 
major goal of TB drug research.
Availability of full genome sequences allows reconstruction of 
genome-scale metabolic reaction networks in micro-organ­
isms. Metabolic capabilities of reconstructed networks con­
sistent with stoichiometry of enzymatic conversions, their 
physiologic direction, and maximal allowable throughput can 
be studied by constraint-based computer simulation meth­
ods. These simulations provide a very useful framework in 
which to study metabolism in a systemic manner; they are 
also a novel approach to rational design of biochemical proc­
esses and drug discovery. Whole-genome metabolic network 
models of sequenced micro-organisms such as H aem ophilus  
influenzae  [12], Escherichia coli [13], H elicobacter p y lo r i  
[14], and Saccharom yces cerevisiae  [15] have proven to he 
useful in hypothesis generation and correction of errors in 
genome annotation, and have also been successful in predict­
ing phenotypic behavior. These models, interrogated with 
various constraint-based computer simulation methods such 
as flux balance analysis (FBA) [16], elementaiy flux modes
[17], or extreme pathways [18], provided information on the 
robustness of the metabolic networks and identified vulnera­
ble pathways that may be targeted with novel drugs [19].
FBA has already been conducted in a network of reactions 
involved in mycolic acid synthesis [20] to identify TB drug 
targets. However, the network was limited to the fatty acid 
synthesis pathways and included just 28 enzymes. In this 
study we present the first reconstruction and constraint- 
based simulation of a genome-scale metabolic reaction net­
work in M . tuberculosis. The model is calibrated by compari­
son with our experimental data on M . bovis  bacille Calmette 
Guerin (BCG) growth in continuous culture. The model cor­
rectly predicted the growth phenotype of 78% of mutant 
strains in a published global mutagenesis dataset. Software 
allowing constraint-based simulations of M . tuberculosis 
metabolism via a web-based interface was developed in order 
to make our model available to the research community. This 
is the first reconstruction of a genome-scale metabolic reac­
tion network published as a web resource, providing both 
data and interactive access to constraint-based simulation 
methods. We also demonstrate here that this model can be 
used to generate new hypotheses and thereby guide future 
research in the development of novel chemotherapeutics 
against TB.
Results and discussion
The genom e-scale m etabolic network of M. tuberculosis
The genome-scale metabolic network of M. tuberculosis  
(GSMN-TB) was constructed as described in the Materials 
and methods. The GSMN of S trep tom yces coelicolor [21] was 
used as a starting point in the iterative model building proc­
ess. S. coelicolor is an actinomycete that shares significant 
portions of genome synteny with M . tubercu losis  [22]. The 
Kyoto Encyclopedia of Genes and Genomes (KEGG) gene 
orthology clusters were used to map the genes between two 
species and transfer corresponding metabolic reactions to the 
TB model. Of 849 unique reactions present in the final model, 
487 (57%) were directly transferred from the S. coelicolor  
model following KEGG gene orthology mapping. This prelim- 
inaiy model has been further supplemented by data from 
KEGG and BioCyc databases.
A significant proportion of the model could not be con­
structed using semi-automatic methods and was therefore 
generated by analysis of original research articles. Table 1 lists 
these unique M . tuberculosis metabolic pathways, including 
those relevant to the synthesis of the cell envelope of M . 
tuberculosis, which contains a diverse array of complex lipids 
and carbohydrates that are important for growth and patho­
genesis, and are important drug targets. Because fatty acid 
metaholism is thought to be a crucial factor in TB pathogene­
sis [23], standard biochemical pathways for p-oxidation of 
fatty acids pathways were added, including additional reac­
tions for catabolism of odd and even numbered fatty acids
Genome B io lo g ] f^ ^ 7 , 8:R89
http://genotnebiology.eom/2007/8/5/R89 Genome Biology 2007, Volume 8, Issue 5, Article R89 Beste et al. R89.3
T a b le  I
M e tab o lic  p a th w ay s t h a t  h av e  b e e n  m o d e lle d  by  d i r e c t  a n n o ta ­
t io n  o f  orig ina l l i te r a tu r e  d a ta
Pathway References
Biosynthetic pathways
Arabinogalactan [60,61]
Mycolic acids [62]
T rehalose m onom ycolate, trehalose dimycolate [63]
D im ycocerosate esters (DIMs) [64-66]
Phenolic glycolipid (PGL) [67]
Sulfolipid SL-I [68-70]
Phosphatidylinositol mannosides (PIMS) [71]
Lipomannan (LM)
Lipoarabinomannan (LAM)
Mannosyl P-l-phosphodolichol (MPD) [72]
Siderophore mycobactin [73]
C o-factor F420 [74]
Mycothiol [75]
Catabolic pathways
Additional beta  oxidation pathways
O dd and even num bered fatty acid catabolism
Respiratory pathways
NADH dehydrogenases, cytochrom es [76,77]
N itrate  as an alternative electron accep tor [78]
and unsaturated fatty acids. Respiratory pathways and syn­
thesis of biomolecules specific to mycobacteria were also 
modeled by manual annotation. Transport reactions included 
those responsible for the the import of minerals, carbon, 
nitrogen and high molecular weight compounds such as 
biotin. Transport reactions for long chain fatty acids such as 
palmitate and oleic acid were also included because there is 
evidence that M . tuberculosis consumes host-derived lipids 
in v ivo  [23]. Iron metabolism is also an important component 
of the pathogenesis of many microbes, including M . tubercu­
losis [24]. We simulated a requirement for iron by allowing 
ferric ion transport (both citrate and mycobactin mediated) 
and incorporating iron into the heme group of cytochromes 
such that it cycles between the ferric and ferrous valence 
states according to the oxidation state of the electron carrier.
M . tuberculosis is a facultative intracellular parasite that is 
capable of growth within host cells, in the extracellular 
milieu, and in v itro . Biomass composition data are available 
only for in v itro  grown M . bovis  BCG, and so this was used to 
model the M . tuberculosis cell for the in silico  model. How­
ever, it is well established that many of the outer cell wall 
components of M. tuberculosis (such as phenolic glycolipid), 
although produced in v itro , are not essential for in v itro  
growth but are required for pathogenesis. In order to make 
the model applicable to M . tuberculosis grown both in v itro  
and in v ivo , we therefore defined two biomass components 
based on published experimentally derived values for macro­
molecular composition of M . tuberculosis. (See Additional 
data files 1 to 3: Additional data file 1 illustrates the estimated 
macromolecular composition for M . tubercu losis. Additional 
data file 2 shows the calculations used to estimate that com­
position, and Additional data file 3 shows the conversion 
between stoichiometric formulae and mmol/1 per gram of 
biomass.) The first (BIOMASSi) reflects the actual macromo­
lecular composition of M . tuberculosis. The second (BIO- 
MASSe) is a minimal macromolecular composition of M . 
tuberculosis and includes only those components (DNA, 
RNA, protein, essential co-factors, and cell wall skeleton) that 
are thought to be essential for in v itro  growth. It is this second 
biomass that was used to make predictions regarding gene 
essentiality in  v itro . To simulate the requirement of co-fac­
tors for nonessential reactions, we introduce the concept of a 
'replenishing flux', in which the co-factors are included in 
reactions but with a low (0.001), unbalanced stoichiometric 
coefficient toward consumption, forcing co-factor synthesis 
only when the co-factor utilizing reaction is active.
The final model contains 849 reactions and 739 metabolites, 
and involves 726 genes (Table 2). These numbers refer to 
unique stoichiometric formulae, because paralogous genes, 
involved in the same reaction, were accounted for by Boolean 
statements describing gene-protein associations, rather than 
being modeled by duplication of reactions (see Materials and 
methods). The reaction formulae, FBA parameters, and gene- 
protein associations are summarized in Additional data files 
4 (reaction formulae, limits. Enzyme Commission (EC) num­
bers, genes, and pathway classifications), 5 (references for 
those reactions), and 6 (metabolite names).
Quantitative calibration and validation of the GSMN- 
TB model
Quantitative calibration o f  the model
The quantitative results of FBA of the GSMN-TB model 
depend on the three global energetic parameters, which are 
not explicitly accounted for by currency metabolite produc­
tion/consumption included in the stoichiometry of individual 
enzymatic reactions. Specifically, these parameters are as fol-
T a b le  2
S ta tis tic s  o f  th e  G SM N -T B  m o d e l
Reaction Class N um ber
Enzymatic conversions 723
T ransport reactions 126
Total num ber of reactions 849
O rphan reactions 210
G enes 726
Internal m etabolites 638
External m etabolites 101
Total num ber of m etabolites 739
GSMN-TB, genom e-scale m etabolic netw ork  of M. tuberculosis.
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lows; the ratio of the number of ATP molecules formed to the 
number of 0  atoms reduced (P/0  ratio); the cost of polymer­
ization of the building blocks into biologic polymers (DNA 
replication, transcription, translation, and so on); and ATP 
costs for growth-associated maintenance (see Materials and 
methods, below). These parameters must either be measured 
or calibrated by comparison of the model predictions with 
experimental data. For well established model systems such 
as Escherichia coli there is a plethora of metabolic flux data 
available from steady-state chemostat cultivations, which 
allows reliable estimation of energetic parameters. The slow 
growth rate of pathogenic mycobacteria, combined with 
problems associated with clumping of this group of bacteria 
and safety considerations, has created obstacles for research­
ers attempting chemostat cultures of these strains. As a 
result, quantitative metabolic flux data for M. tuberculosis 
group organisms are limited to the findings of chemostat 
experiments included in our previous report [25] and the 
Additional data files presented here.
Experimental data obtained for growth of M. bovis BCG in 
glycerol-limited continuous culture at three growth rates 
were compared with the quantitative predictions of the 
GSMN. BCG and M. tuberculosis have a high degree of hom­
ology, sharing 99.9% of DNA, and possess identical metabolic 
pathways for utilization of glycerol [26]. FBA minimization of 
glycerol consumption at fixed growth rates was simulated by 
setting the P/0  ratio to 1 and the ATP dissipation flux due to 
polymerization of biomolecules to 1.0 m mol/g dry weight 
(DW) per hour, and consumption of 47 mmol/g DW ATP for 
maintenance was added to the biomass formation reaction. 
These values were set using data obtained from related bacte­
ria [21,27], because no data were available from mycobacte­
ria. However, it is demonstrated below that gene essentiality 
predictions and other important qualitative insights into TB 
biology generated by this model are not affected if the ener­
getic parameters are varied within the range of values 
reported for different microbial species. The resulting plot 
(Figure 1) demonstrates that the predicted biomass produc­
tion yield (reciprocal of the slope of the line) was within the 
95% confidence interval of the experimental value. However, 
predicted glycerol consumption rates were higher than the 
experimentally determined values. This discrepancy could 
not be resolved by testing different values of the three ener­
getic parameters in the ranges reported for different micro­
bial species (data not shown).
A possible explanation of the discrepancy between the pre­
dicted and experimental data is that BCG cells consumed car­
bon from an additional source. Although glycerol is the main 
carbon source in Roisin's minimal medium. Tween 80 is also 
present in the culture medium to reduce cell clumping. Tween 
80 is an oleate ester of sorbitol, with an oleate content above 
75%, and minor amounts of other unsaturated and saturated 
fatty acids. The tubercle bacillus is known to be able to hydro­
lyze Tween 80 and can also utilize the fatty acids released as
0.8
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F ig u re  I
Comparison of predicted and measured glycerol uptake rates as a function 
of controlled growth rate. Triangles indicate experimentally measured 
glycerol uptake rates for three growth rates set by th ree different dilution 
rates in the chem ostat model. The dashed line represents the linear 
function fitted to  the experimental data. Diamonds and solid line represent 
predictions of the model if glycerol w ere the only carbon source. Circles 
and dotted line show predictions of the model when additional oleic acid 
(hydrolysis product of Tween 80) transpo rt in the  range of 0 to  0.04 
mmol/g dry weight (DW) per hour was allowed.
a sole carbon source [26]. The FBA simulation was repeated 
with minimization of glycerol uptake flux and oleic acid trans­
port flux constrained in the range of o to 0 .04 m mol/g DW 
per hour. The resulting plot (Figure 1) demonstrates that the 
predicted line is contained within 95% confidence (both slope 
and intercept) intervals of experimentally measured values at 
experimentally reasonable oleic acid consumption rates. Pre­
liminary nuclear magnetic resonance analysis (data not 
shown) on spent culture media are also consistent with the 
hypothesis that Tween 80 was being assimilated under the 
conditions of the experiment and contributing to the biomass 
yield.
Validation o f  th e  m o d el by com parison with global m u ta g en esis  da ta  
To evaluate the predictive power of the model we compared in 
silico predictions of gene essentiality with the findings of a 
previously reported global mutagenesis study of gene essenti­
ality in M. tuberculosis by transposon site hybridization 
(TraSH) [28]. The TraSH technique combines high-density 
transposon mutagenesis with microarray mapping of pools of 
mutants, which allows rapid determination of the full reper­
toire of genes required for growth under given environmental 
conditions.
It is well established that many of the macromolecular com­
ponents of M. tuberculosis, although essential for virulence, 
are not required for in vitro  growth. For in vitro  gene essen­
tiality predictions, we therefore used BIOMASSe as the objec­
tive function of the GSMN-TB; BIOMASSe is a minimal 
biomass composition that reflects current knowledge of the 
biomass components of M. tuberculosis that are essential for
Genome B io lo ^S .^0 7 , 8:R89
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growth in v itro . To model the composition of the minimal 
media Middlebrook 7H10 used in the TraSH experiment of 
Sassetti and coworkers [28] we simulated the transport or 
secretion of the following external metabolites in the model: 
glucose, glycerol, iron (citrate-mediated iron transport), 
ammonia, nitric dioxide, phosphate, sulfate, oxygen, carbon 
dioxide, molybdenum, and biotin.
Theoretical predictions were generated by removing single 
genes from the GSMN-TB (in silico  mutation) and calculating 
the resulting maximum growth rate for each in silico  mutant. 
We emphasize, however, that this predicted maximum 
growth rate should be viewed solely as a qualitative predic­
tion. Our aim was to identify genes that prevented or severely 
compromised the capacity to synthesize biomass, which 
would lead to zero or greatly reduced growth rates in the 
GSMN-TB. Most mutations had little or no effect on growth 
rate, but some in silico  mutations were lethal (in the sense 
that the resulting maximum growth rate was zero) or 
depressed growth rate to values between zero and the maxi­
mum predicted growth rate for the 'wild type'. To identify 
essential genes we set an arbitrary growth rate threshold (see 
Materials and methods, below) such that mutants with a max­
imum predicted growth rate below that threshold were con­
sidered to be essential for growth. (Below, we examine the 
effect of varying the growth rate threshold on prediction 
accuracy.)
The lists of essential and nonessential genes predicted by the 
model were compared with essentiality assignment according 
to the previously reported TraSH analysis [28]. Note that in 
the TraSH study gene essentiality predictions were based on 
the ratio of the microarray hybridization signal obtained from 
labeled insertion sites in a saturated transposon mutant 
library compared with a control of labeled genomic DNA. This 
ratio reflects the relative abundance of each transposon 
mutant in the TraSH library. Genes with microarray signal 
ratios of less than 0.2 were predicted to be essential. We des­
ignate this cut-off value as the TraSH threshold. GSMN-TB
and TraSH-based gene essentiality assignments were com­
pared and the numbers of true-positive (essential both in the 
model and experiment), false-positive (essential in the model, 
nonessential in experiment), true-negative (nonessential in 
the model and experiment), and false-negative (nonessential 
in the model, essential in experiment) predictions were com­
puted (Table 3).
In order to visualize the influence of the two thresholds 
(growth rate threshold and TraSH threshold) on the sensitiv­
ity and specificity of the GSMN-TB predictions, receiver oper­
ating characteristic (ROC) curves were plotted (Figure 2a). 
The ROC curves (Figure 2a) demonstrated that varying the 
growth rate threshold had little effect on either sensitivity or 
selectivity. This is a consequence of the fact that most in silico  
mutants had either a predicted growth rate that was the same 
as the wild type or a predicted growth rate of zero. In contrast, 
varying the TraSH threshold had a marked effect on the pre­
diction parameters (Figure 2a). The ROC curve correspond­
ing to the TraSH threshold of 0.1 was closest to the best 
possible prediction result (sensitivity and selectivity of 1). The 
curve obtained for the TraSH threshold of 0.2 (the value used 
in the reported study [28]) exhibited lower sensitivity and a 
slightly lower number of correct predictions. The results of 
the comparison of essentiality predictions for individual 
genes with the previously published in v itro  TraSH data [28], 
using a growth rate threshold of 0.001 and TraSH ratio 
thresholds of either 0.1 or 0.2, are shown in Table 3,
The GSMN-TB model predicts that approximately 34% of M. 
tuberculosis  genes in the model are essential for growth in 
minimal Middlebrook 7H10 media, which is very close to the 
estimated value of 35% essential genes in M . tubercu losis  
[29]. The number of true predictions was significantly higher 
than expected by chance (Fisher exact test; P  < 2.2 lO"^ )^. The 
overall fraction of correct predictions is 78%, with sensitivity 
and specificity of 71% and 80%, respectively, if  a TraSH ratio 
threshold of 0.1 is applied. Predictions are robust with respect 
to the quantitative parameters of the FBA model. When ener-
T a b le  3
C o m p a r iso n  o f  th e o re t ic a l  g e n e  e s se n tia lity  p re d ic tio n s  w ith  re su lts  o f  T ra S H  e x p e r im e n t  in vitro
TraSH threshold  o f 0.2 TraSH th reshold  of 0.1 TraSH th reshold  of 0.1, altered  
energetic param eters
T rue positive 154 115 114
False positive 71 110 no
T rue negative 385 432 432
False negative 95 48 49
Sensitivity 62% 71% 70%
Specificity 84% 80% 80%
C o rre c t predictions 76% 78% 77%
P < 2 .2  X 10-16 < 2 .2 x  10-16 < 2 .2  X 10-16
“Fisher exact test. TraSH, transposon site hybridization.
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Figure 2
Comparison of gene essentiality predictions with TraSH data for In vitro growth on Middlebrook 7H 10 medium, (a) Dependence of prediction results on 
the model and experimental thresholds for declaring gene essentiality. The plot shows receiver operating characteristic (ROC) curves for different 
transposon site hybridization (TraSH) ratio thresholds for determination of essential genes in experimental data. Each ROC curve shows ICO points 
corresponding to sensitivity and specificity of the model predictions obtained for growth rate thresholds varying in the range from 0.0 to 0 .1 (increment 
0.001). The growth rate threshold has little effect on prediction parameters. For values greater than 0.052 all genes were declared essential. Any threshold 
in the range from 0.001 to 0.041 resulted in exactly the same gene essentiality predictions. The ROC curve closest to the best theoretically possible 
prediction (sensitivity and specificity equal to I) was obtained for a TraSH ratio threshold of 0 .1, (b) Distributions of the hybridization ratio of the TraSH 
library to genomic DNA signal recorded in TraSH experiment for genes present in the model. Blue line shows distribution of the TraSH ratio among the 
genes that were predicted by the model to be essential for growth. Red line shows distribution of TraSH ratio among genes predicted to be nonessential 
for growth. Medians of the two distributions are significantly different by means of the Mann-Whitney test (P < 2 x 10 '^). Thus, the genes that are 
predicted to be essential have significantly lower median value of insertion probe to genomic probe ratio than genes predicted to  be nonessential. This is 
in accordance with experimental data, because the low ratio indicates that inactivation of the target gene by transposon insert results in depletion of the 
mutant strain after the growth on Middlebrook 7H 10 medium.
getic parameters were set to i  (P / 0  ratio), 5 .0  m m ol/g  DW  
per hour (ATP dissipation), and 60 m m ol/g  DW per hour ATP 
m olecules (growth-associated m aintenance), the result 
changed for only one gene (a true positive becom es a false 
negative). Therefore, the prediction accuracy was not affected  
by substantial change in energetic parameters.
To validate further the predictive power of the m odel, the d is­
tributions o f TraSH hybridization signal (TraSH probe/ 
genom ic probe) were plotted for both essential and nonessen­
tial genes as predicted by the m odel (growth rate threshold of
0.001; Figure 2b). M edians o f the two distributions are signif­
icantly different (M ann-W hitney test; P < 2.2 lO'i^). The 
genes predicted to be essential have significantly lower TraSH  
hybridization ratios than genes predicted to be nonessential. 
This is in accordance with the experim ental data. This dem ­
onstrates the predictive power o f the m odel using an 
approach that is independent o f the TraSH signal ratio 
threshold.
Validation o f  the m odel by comparison with literature data on 
phenotypes o f  single gene knockouts
Som e of the discrepancies identified betw een the FBA predic­
tions and the global m utagenesis data can be attributed to an 
undefined level of inaccuracy in TraSH assays because there 
are several exam ples in which the in silico predictions are val­
idated by individual gene knockout studies. The inhA gene, 
which is the known drug target for the key antituberculous 
drug isoniazid [30] and has been show n to be essential in the  
related Mycobacterium smegmatis [31], was nonessential in  
the TraSH experim ent (TraSH ratio 0 .38 ) but was correctly 
predicted to be essential for growth by the GSMN-TB model. 
M any false-negative genes (nonessential in the m odel but 
essential in global m utagenesis data) m ay be due to gene reg­
ulation o f isoenzym es. Both m enaquinol oxidase system s (the 
aa3-type and bd-type) are predicted to be nonessential 
because they are functionally redundant in the model. 
However, the apparent essentiality (false-negative predic­
tion) o f genes encoding the aa3-type cytochrom e c oxidase
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T a b le  4
C o m p a r iso n  o f  T ra S H  a n d  G SM N -T B  p re d ic tio n s  o f  g e n e  e sse n tia lity  w ith  e x p e r im e n ta lly  d e te rm in e d  p h e n o ty p e
G ene Prediction K nock-out m utant Reference
GSMN-TB TraSH Species Phenotype
AfiA E E C. glutamicum Slow grow th [60]
AroK E E /VI. tuberculosis Essential [79]
Ask E E /VI. smegmatis A uxotroph [80]
CysH E E /VI. smegmatis A uxotroph [81]
GInAI E E M. tuberculosis Essential [82]
GlnA3 NE NE /VI. tuberculosis N onessential [82]
GlnA4 NE NE /VI. tuberculosis N onessential [82]
hem Z E E /VI. tuberculosis Essential [83]
InhA E NE /VL smegmatis Ts lethal [31]
inol NE NE /VI. tuberculosis A uxotroph [84]
KasA NE E /VI. smegmatis Essential [85]
LeuD E E /VI. tuberculosis A uxotroph [86]
LysA E E N\. tuberculosis A uxotroph [87]
manA E E /VI. smegmatis H yperseptation and 
loss of viability
[88]
mshB NE NE /VI. tuberculosis G row s poorly [89]
mshC NE E /VI. tuberculosis Essential [90]
murD E E N\. tuberculosis N onessential [82]
murl E NE /VI. tuberculosis N onessential [82]
Ndh NE NE /VI. smegmatis Ts lethal [91] -
NrdFZ E E /VI. tuberculosis Essential [92]
OtsA E E M. tuberculosis Slow grow th [93]
OtsBl NE E /VI. tuberculosis Essential [93]
panCD E NE /VI. tuberculosis A uxotroph [94]
panCD E E /VI. tuberculosis A uxotroph [94]
PimA E NE /VI. smegmatis Essential [95]
PurC E E /VI. tuberculosis A uxotroph [96]
Purl E E /VI. tuberculosis A uxotroph [96]
RmlB NE E /VI. smegmatis Essential [97]
TreS NE NE /VI. tuberculosis Nonessential [93]
Shown is a com parison of transposon site hybridization (TraSH) and genom e-scale metabolic ne tw ork  of/VI. tuberculosis (GSMN-TB) predictions of 
gene essentiality with experimentally determ ined phenotype fo r genes th a t have been investigated by specific gene knockout. E, essential; NE, 
nonessential.
indicates that this system is likely to be the main electron 
transport system operating in the aerobic conditions in which 
the global mutagenesis experiment was performed.
As a further check of the accuracy o f the GSMN-TB, we com­
pared (Table 4) the phenotype of known individual gene 
knockout mutants (sometimes in related organisms, such as 
M . sm egm atis) with gene essentiality prediction by both 
TraSH result and GSMN-TB. (All genes whose inactivation 
reduced growth rate were designated GSMN-TB essential; 
this was recorded as a correct prediction if the gene knockout 
mutant exhibited temperature sensitivity, slow growth, or 
auxotrophy.) As can be seen in Table 4, out of 29 genes exam­
ined the GSMN generated a correct prediction for 20 genes.
whereas TraSH generated the correct prediction for 22 genes. 
GSMN-TB and TraSH yielded discordant predictions for 
eight genes: GSMN-TB gave the correct prediction for three of 
those genes and TraSH generated the correct prediction for 
five genes. Errors in GSMN-TB predictions were immediately 
informative in suggesting model revisions. For instance, 
m shB  and m shC  are both involved in mycothiol synthesis, 
which is nonessential in the GSMN-TB because mycothiol is 
currently not a biomass component and neither is it required 
for the synthesis of any biomass component. The essentiality 
of m shC  and poor growth of m shB  indicate that mycothiol 
should be included as either a biomass component or an 
essential co-factor for synthesis of a biomass component, or 
both.
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Prediction o f gene essentiality for known drug targets 
The GSMN-TB contains five genes that encode enzymes that 
are drug targets: inhA  (isoniazid and ethionamide), f a s l  
(pyrazinamide), em bA B  (ethambutol), ddlA  (cycloserine), 
and a ir  (cycloserine). All of these genes were correctly pre­
dicted as essential for growth on 7H10. This demonstrates the 
utility of the GSMN-TB in identifying potential drug targets in 
metabolic reactions
Use of the GSMN-TB to  explore the metabolic state of 
M. tuberculosis
An important application of the GSMN-TB is to model the 
metabolic state of M . tuberculosis, particularly in situations 
that are difficult to approach experimentally, such as during 
infection. M. tuberculosis  is a versatile chemoheterotroph 
that can utilize a wide range of sources of carbon and nitro­
gen. Similarly, the in silico  model is able to generate feasible 
solutions to optimize biomass or 'grow' on a range of carbon 
and nitrogen sources. Feasible flux distributions include 
expected biochemical pathways; for instance, most of the flux 
from glucose is directed through glycolysis and the tricarbox­
ylic acid (TCA) cycle, whereas the glyoxylate shunt is utilized 
for growth on acetate (or fatty acids). The GSMN-TB also 
indicated thatM. tubercu losis  has much more metabolic flex­
ibility than is generally accepted. For example, TraSH data 
[28] demonstrated that several enzymes of the TCA cycle, 
including malate dehydrogenase, were nonessential, and this 
was also predicted by the model. When malate 
dehydrogenase was inactivated in silico  using the GSMN-TB, 
the resulting carbon flux was predicted to be shunted through 
the anaplerotic reactions catalyzed by malic enzyme, pyruvate 
phosphate dikinase, and phosphoenolpyruvate 
carboxykinase.
In order to investigate the value of the model as a hypothesis 
generating tool, we analyzed the in silico  metabolic response 
of M . tuberculosis  to slow growth, because this is a key com­
ponent of persistence/dormancy in M . tuberculosis. We com­
pared the predicted flux ratios for two different growth rates 
that could be experimentally verified in a chemostat. A dou­
bling time of 23 hours (dilution rate 0.03) was compared with 
a doubling time of 69 hours (dilution rate 0.01). Flux ratios 
for central metabolism (0 .01/0.03) were calculated by flux 
variability analysis (FVA) as the ratios of midpoints of flux 
ranges obtained for slow and fast growth rates (Figure 3). 
Although it should be emphasized that these predictions are 
qualitative in nature, the maj ority of the flux values were close 
to unity, indicating that the relative fluxes are unchanged. 
However, some reactions have markedly different flux predic­
tions in the two growth rates, including reactions that are 
involved in the glyoxylate shunt. There was a large predicted 
increase in flux through the isocitrate lyase reaction. This pre­
diction suggested the hypothesis that isocitrate lyase was 
involved in maintaining growth at slow growth rates. To 
investigate this hypothesis we measured the activity of isoci­
trate lyase activity in BCG cells grown at both growth rates in
a chemostat. In accordance with predictions, specific isoci­
trate lyase activity was significantly higher (twofold change; t- 
test, P  = 0 .0002) in the slow growing cells (Table 5).
The online resource for analysis of M. tuberculosis 
metabolism
We have created web-based software that allows online access 
to data files and computational methods used for constraint- 
based simulations of the GSMN-TB model of TB metabolism. 
This is the first GSMN model published as an interactive 
resource allowing the scientific community to interrogate the 
model with biologic data. The web server presents the most 
recent version of the model and will be continuously updated 
as more metabolic genes are identified and characterized. The 
current version of the system implements the following com­
putational methods. The FBA method computes the maximal 
theoretical growth rate under given experimental conditions 
and one of the possible metabolic flux distributions sustain­
ing maximal growth rate. To allow further exploration of the 
metabolic state of the cell, we have also implemented FVA. 
The FVA method determines the minimal and maximal flux 
for each reaction in the system that is consistent with this 
maximal theoretical growth rate (see Materials and methods, 
below). In contrast to the flux distribution computed in a sin­
gle FBA simulation, the FVA flux ranges are unique. Our 
server also allows gene and reaction essentiality predictions.
All calculations described above can be performed for a vari­
ety of experimental conditions. The user is able to specify 
media conditions by changing the bounds of the GSMN trans­
port reactions (most of the transport reactions in the GSMN- 
TB are currently constrained to zero). Both model file and 
results are displayed in tabular format, with the gene annota­
tion linked to the TubercuList database [32].
We have also implemented methods to investigate the in v ivo  
growth of M . tuberculosis  using the web-based software. The 
use of FBA to model in v ivo  growth is more problematic 
because it is not clear what to use as an objective function for 
optimization. We have tackled this problem by including two 
objective functions that can be optimized: one utilizes a min­
imal biomass composition, which includes only those compo­
nents that are thought to be essential for in v itro  growth; and 
the other uses a 'complete' biomass composition, which 
includes synthesis of macromolecular components (virulence 
factors), such as dimycocerosate esters and sulfolipid, that 
are thought to be essential for infection. This allows the user 
to model both in v itro  and in v ivo  growth and, for instance, to 
predict genes that are only essential for growth in v ivo .
Constraint-based computer simulations methods available in 
our software are computationally fast enough to allow inter­
active online work. Results of FBA and single gene essential­
ity predictions appear instantaneously in the user's browser, 
and FVA results are computed in less than 10 min.
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Predicted response of the Mycobacerium tuberculosis to  slower growth rate induced by carbon limitation. Only selected central metabolic pathways are 
illustrated. The slower growth rate was simulated by adjusting glycerol uptake rates to  obtain a predicted growth rate of 0.03 (fast growth rate 
corresponding to  doubling time of 23 hours) and 0.01 (slow growth rate corresponding to  doubling time of 69 hours). Arrows indicate biochemical 
reactions o r pathways, and the number on the arrow  indicates the response of the genome-scale metabolic network of M. tuberculosis (GSMN-TB) to 
slower growth rate. The numbers w ere calculated by flux variability analysis (FVA) as the ratios of midpoints of flux ranges obtained for slow and fast 
growth rates. The values have been normalized to  account for the lower absolute carbon flux values at the slower growth rate, except for the glycerol 
uptake rate, which is not normalized to  emphasize the fact that the growth rate was reduced by limiting glycerol. The direction of the arrow s indicates the 
direct of flux, not reaction reversibility. CoA, coenzyme A; E4P, D-erythrose-4-phosphate; MK, menaquinone; MKH, menaquinol; 57P, D-sedoheptulose-7- 
phosphate.
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T a b le  5
In vitro  i s o c itr a te  lyase  a c tiv itie s  in c ru d e  e x tr a c ts  o f  c h e m o s ta t  
c u ltiv a te d  BC G  cells
Dilution rate  (per hour) Specific activity
0.01 42.67 ± 2.68
0.03 21.20 ± 0 .6 9
Results rep resen t th e  average values ± standard deviations from  th ree  
independent m easurem ents. The unit o f enzyme activity is nmol/min 
p e r mg protein.
The web interface to our interactive resource is now available 
[33]. Figures 4 and 5 show the workflow of the software and 
screenshots from the interface. More detailed presentation of 
the interface can be found in the manual (Additional data file 
7)-
Conclusion
We have built the first genome-scale metabolic network 
(GSMN) model of the tubercle bacillus, which is the agent 
responsible for approximately 5% of all deaths worldwide and 
9.6% of all adult deaths. The model incorporates nearly all 
known biochemical reactions of the micro-organism and 
describes the biosynthetic pathways that lead to the synthesis 
of all of the major macromolecular components, including 
known virulence factors. The model provides new insights 
into the biology of the pathogen and provides a framework for 
integrating metabolic, proteomic, and transcriptomic data. 
Thereby, it can serve as a platform on which to build extended 
models of the M . tuberculosis cell, including all levels of bio­
chemical network organization.
To he representative, systems level models must he con­
strained with experimental data. The model was therefore 
calibrated using our data from chemostat cultivations of M . 
bovis  BCG. FBA simulations predicted a consistently higher 
rate of glycerol consumption than was observed. The most 
likely explanation for this is that the cells are simultaneously 
utilizing both glycerol and oleic acid (derived from hydrolysis 
of Tween 80) as a carbon source. This pattern of mixed sub­
strate utilization is in contrast to the more extensively studied 
diauxic growth that is typical o f batch-grown micro-organ­
isms, in which the substrate supporting the greatest growth 
rate is utilized first and the second substrate is only consumed 
after exhaustion of the preferred substrate. However, mixed 
substrate utilization has been shown to operate in carbon- 
limited chemostat cultures of organisms such as E. coli that 
demonstrate diauxic growth in hatch culture [34]. It is likely 
that the pattern of low availability of mixed substrates is 
closer to situations that pertain in most natural environments 
than the high single substrate conditions that are most often 
studied in hatch culture [35].
The accuracy of the GSMN-TB model of M . tuberculosis was 
tested by comparison of model predictions of gene essential­
ity with global mutagenesis (TraSH) experimental data. The 
model was shown to have a high degree of accuracy, correctly 
predicting the phenotype for more than 75% of single gene 
mutants. Discrepancies between the model and TraSH muta­
genesis data were also informative. In some cases the model 
prediction matched the phenotype of individual gene knock­
out studies more closely than the TraSH mutagenesis data. 
This was true for the inhA  gene, whose product is a target for 
the key antituberculous isoniazid. This result verifies the use 
of the model as a tool for drug discoveiy. In addition to known 
drug targets, the model predicts 220 essential genes in M . 
tuberculosis, any one of which is a potential target for new  
antituberculous drugs. The remaining 24% discordant pre­
dictions (174 genes) clearly must be investigated further in a 
reiterative cycle of hypothesis generation, experiment, model 
improvement, and further experimentation. Identification of 
discrepancies between model predictions and experimental 
data are informative in that they indicate errors in the model, 
errors in gene annotation, or incomplete knowledge of M. 
tuberculosis metabolism, such as the presence of an unknown 
isoenzyme.
The model is also an excellent tool for mining existing data­
sets, for instance those resulting from TraSH mutagenesis 
studies examining gene essentiality in different environ­
ments. Interrogation and integration of datasets such as glo­
bal mutagenesis data can thereby he used to refine further the 
model in an iterative process. The genome-scale model has 
considerable advantages over traditional genome annotation 
and pathway databases, including its internal stoichiometric 
consistency, systems level integration, and its ability to pre­
dict gene essentiality for different media conditions automat­
ically. The model inputs data such as growth characteristics of 
particular genotypes to auto-generate hypotheses in the form 
of predicted flux maps of internal metabolism. In addition, 
the model provides a platform that could he used to integrate 
and manage 'omics data in a manner that is consistent with 
the underlying biochemistry and genetics of the organism  
[14,15,36,37]. Moreover, the lists of genes and reactions pre­
dicted by the model to be essential for growth, under given 
media conditions, may easily be combined with other drug 
target prioritization protocols, which account for the availa­
bility of structural information about the enzyme, availability 
of its inhibitors, and sequence similarity to host and other 
bacterial proteins [38].
The constraint-based simulation methodology, used in this 
work and implemented in the GSMN-TB server, is currently 
the most practical solution for studying metabolic flux distri­
bution in the genome-scale metabolic reaction networks. This 
method involves optimization of the objective function repre­
sented by one of the fluxes in the network, usually the flux to 
biomass that determines growth rate. Although it could be 
argued that optimization of growth rate is not appropriate to
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USER
The list of four
simulation
protocols.
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conditions, objective function 
and the gene to be 
inactivated.
RESULTS
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simulations: 1) Computation of 
maximal growth rate. 2) Flux 
Variability Analysis. 3) Reaction 
essentiality scan. 4) Gene 
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Figure 4
Overview of interactive resource workflow of GSMN-TB. The user chooses one of four analysis protocols (computation of maximal growth rate, flux 
variability analysis [FVA], reaction essentiality scan, or single gene essentiality prediction). Depending on the choice, an appropriate input form is 
presented. The server runs linear programming using the genome scale metabolic reaction network of Mycobacterium tuberculosis. Constraints defined by 
the user overwrite the default set of constraints specified in the model file. Numerical results are formatted as HTML and sent to the user's browser. 
GSMN-TB, genome-scale metabolic network of M. tubercuiosis.
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(a)
(b)
Flux VariabiliK Analysis
Use 6 is  tool to explore metabolic state a t tiie rvstem The program computes anramal and maximal flux through the reaction (range c f  ftixes) consistent ’.vidi 
maximal flieoretical grovN*fli rate These 's'ahies are unique and can be used to draw conclusions about internal flux distribution Calculations wifi take about 10 
minutes. The program wifi set die growth rate to maximal tlieoretical value and compute the minimal and maximal flux fltrough each reaction Results wifi be 
displayed, as calculation progresses.
The output o f the Fhrt Variabifit:.- Anah'sis run contains maximal flieoretical growth rate, status o f the optimisation (OPTIMAL if the model is feasible.! and flie 
table o f metabolic flux ranges. Each row contains reaction name, computed minimal flux, computed maximal flux, reaction formula and gene annotation linked to 
TubercuList
Expérimental conditions. The form below shows definition o f  ^ c o s e  minimal medium and m % experiment M edia conditions are defined by specifring 
nutrient transport reactions Transport reactions are described in the foflowing format Reaction_name lower_bound tç5per_bound comment The ® o character 
followed by whitespace comments out the line You can modifi.' experimental conditions by commenting m or out nutrient transport reactions and changing their 
maximal uptake rates You can also constrain anv reaction in the svstem by stating its name, lower bound and upper bound See model file and the list o f 
metabolite names Tlw in \  iryo and lu v h  o experiment differ by tlie definition o f objecth e function
O prim isarioD  c r ite r io n
In vitro growth ^
- 1 0 0 0 0 0  1 0 0 0 0 0  
-1 0 0 0 0 0  lOCOOO 
-1 0 0 0 0 0  lOC'OOO 
-1 0 0 0 0 0  100000
M edia conditions
S V -c c s e  u p t a k e  - c  z ta x z t taZ. v e l u e  o i
O x y ç e r  c : e n a p c r % .  U r . lu ic i te d .
^im cn iu rt c r e n s p c x r .  U n lir-u te d
F ro c c r .  d e p e n d e d ':  N i - r x c  d ic x ic J e  ^ r a n s p o r ^ .
F r - c t i r .  d e p e r .d e n -  N i z x i c  c r i o x i d e  t r a r . s p c r t . 7 r.lx icu .xed .
The model: The G SM X model file including reaction formulas and gene réaction associations can be found here Follow diis ^  for the Hst o f metabolite
^  Internet
M axim al theoretical grox\th rate: 0.04852171175
Flux ranges consistent with maxim al theoretical growth rate;
M inim al flux M axim al flux R eac tion  formula G enes
R1 0 0 00134009624- 1 GL -  1 .ATP = 1 .ADP -  1 GL3P Rx 3696c
R2 -100000 100000 1 GL -  1 N.ADP =  1 T3 -  1 NADPH Rv29S2cOR R s0564O R R\
R3 -100000 100000 1 GL -  1 N.AD = 1X3 -  1 N.ADH Rv0162c
R4 0 0.05025*32928 1 GL3P -  1 M K  =  1 DHAP -  1 MKH2 Rv3302cO RRv2249c
R5 0 0.001305291061 1 T 3 - 1  NAD = 1 DGLYCERATE -  1 NADH Rv285ScOR Rs045S
R6 0 0.001305291061 1 DGLYCERATE -  1 ATP =  1 3PG -  1 .ADP Rv2205c
R - 0 0.05025*32928 1 R B  -  1 ATP = 1 .ADP -  1 R5P Rv2436
RS 0 0 1 F IP  = 1 DH.AP -  1 T3 Rs0363c
R9 0 0 1 F R U = 1 G L C orphan
RIO 0 0 1 F R U = 1 M A N orphan
R ll -0 00565;5S5.v -0 005646932*41 1 M AN6P =  1 F6P Rv3255c
R i : -0 00 5 6 5 ;« S 5 5 ' -0 005646932*42 1 .VLANIP =  1 MAN6P Rv325TcOR Rv330S
R13 0 .005646932*4; 0.0056525853* 1 .\LAN1P -  1 GTP =  1 GDP.YLAN -  1 PI Rv3264c
R14 0.00350S21S042 0.003511*29*99 1 GDPM AN -  1 DPP = 1 GDP -  1 PPM Rv2051c
R15 0 0 1 GDPM AN =  1 GDPDHDO.MAN Rx-0112ORRvl511
Wing for http://sysbio.sbs.5UTey.ac .ufi/cg-bm/tbfkjxvarl... «r @  internet MOO% '
Figure 5
Screenshots illustrating FVA of/VI. tuberculosis using GSMN-TB. (a) Simulation set up. User specifies media conditions by setting minimal and maximal 
capacities of transport reactions in the 'Media conditions' field. The field contains specification of minimal glucose media and lists transport reactions that 
can be included by removing comment character. The page contains the link to the full model file, and the user may identify other reactions to  be 
constrained. This adds additional flexibility to the simulation set up. The user may also choose one of the two objective functions used in our model to 
simulate in vitro or in vivo growth requirements, (b) Result of flux variability analysis (FVA) simulation. Maximal theoretical growth rate is displayed at the 
top of the page. Each row in the table contains reaction name maximal and minimal flux consistent with the maximal theoretical growth rate, reaction 
formula, and gene annotation. Gene names are linked to genome annotation pages of the TubercuList database. The rows of the table are loaded as 
computation progresses. The time of the simulation is about 10 min. GSMN-TB, genome-scale metabolic network of/VI. tuberculosis.
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the very slow growing M . tuberculosis, our results indicate 
that - under the carbon-limited conditions we tested - the 
organism uses carbon source efficiently with yields close to 
the maximal theoretical values predicted by the model. How­
ever, the conclusions presented in our work are qualitative 
and do not depend on whether the objective function flux 
actually reaches its maximal/minimal possible value. We 
demonstrated that gene essentiality predictions were not sen­
sitive to large changes in the growth rate thresholds used for 
viability predictions in mutants. Similarly, the findings of the 
FVA of M. tuberculosis growing at two different growth rates 
should he considered qualitative rather than quantitative 
predictions.
In addition to validating the model, we also demonstrated its 
potential to generate experimentally testable hypothesis by 
predicting the metabolic response of M. tuberculosis  to car­
bon-limited slow growth. Persistence is a central feature of 
the biology of M . tuberculosis, being responsible both for 
latency and the necessity for long treatment regimens [39]. 
Little is known about the physiologic state of M. tuberculosis 
during persistence, hut slow or zero growth is generally 
thought to be a key property. In v itro  models of persistence 
invariably involve slowing the growth rate through, for 
instance, mq^gen limitation [40] or nutrient starvation [41]. 
We therefore investigated the in silico  response of the tuber­
cle bacillus to slow growth in our model by FVA. The most sig­
nificant alteration was a predicted increased flux through the 
glyoxylate shunt, particularly the isocitrate lyase reaction, at 
slow growth rate. This hypothesis was supported experimen­
tally by the demonstration that isocitrate lyase activity was 
higher in slow (doubling time 69 hours) growing BCG cells 
than in faster (doubling time 23 hours) growing cells. This 
finding is consistent with the model flux prediction and 
thereby supports the hypothesis that isocitrate lyase plays a 
specific role in slow growing mycobacteria. Several patho­
gens, including M . tuberculosis, require  isocitrate lyase for 
long-term persistence in the host [42-45]. Increased isoci­
trate lyase activity has previously been reported in the Wayne 
(oxygen-limited) in v itro  model of M . tuberculosis persist­
ence [46]. In addition, Munoz-Elias and McKinney [6] dem­
onstrated that inactivation of the iso citrate lyase genes of M . 
tuberculosis led to attenuation for survival and multiplication 
in mice and macrophages, but this finding has generally been 
interpreted as indicating a role for fat catabolism in survival 
of this pathogen in the host. Our results indicate that isoci­
trate lyase may play a more general role in the slow growth of 
M . tuberculosis, irrespective of the means of growth limita­
tion. This finding could have implications for drug develop­
ment, because isocitrate lyase has been intensively 
investigated as a potential antituhuberculous drug target
[7 ,11,4 7 ].
The application of constraint-based modeling to the in v ivo  
situation is of course more challenging than simulation of in  
v itro  growth. Because the pathogen probably does not
maximize growth rate during infection, an objective function 
based exclusively of maximization of growth rate is unlikely to 
be entirely successful at simulating the pathogen's in v ivo  
metabolic state. In order to investigate metabolic require­
ments for in v ivo  growth, the weh-hased version of the M . 
tuberculosis GSMN is able to optimize for two different objec­
tive functions: the first specifying a minimal biomass with 
components essential for in v itro  growth, and the second 
specifying a complete biomass composition that includes syn­
thesis of virulence factors such as sulfolipid and dimycocero­
sate esters. Even if the growth rate of the pathogen does not 
reach its maximal value, simulation using the complete bio­
mass composition in the GSMN-TB will still produce valuable 
qualitative predictions concerning essentiality of genes and 
reactions required for in v ivo  growth. These qualitative 
results will be useful in predicting drug targets, even in the 
situation in which the actual growth rate of the pathogen is 
lower than that predicted by the model.
Our web-based software makes, for the first time, genome- 
scale metabolic simulations available to the nonspecialist. It 
is therefore a valuable resource for biologists investigating 
the physiology and pathogenicity of M . tuberculosis. This 
resource will be developed by continuous curation of the met­
abolic model, leading to improved gene annotation, 
incorporation of high throughput datasets, and direct experi­
mental testing of hypotheses generated by the model.
Materials and methods
Bacterial strains and growth conditions
M . bovis  BCG strain (ATCC 35748) was cultured in a 2-I bio­
reactor (Adaptive Biosystem Voyager, Adaptive Biosystems 
Ltd, Luton, UK) under aerobic conditions and at pH 6.6, as 
previously described [25]. Chemostat cultures were grown in 
Roisin's minimal medium at a constant dilution rate of 0 .02  
per hour (equivalent to a doubling time of 34.7 hours). 
Steady-state conditions were assumed when the carbon diox­
ide evolution, optical density at 600 nm, and DW remained 
constant for three consecutive volume changes. Once the 
steady state was reached, cells were harvested for analysis. 
Biomass was determined according to the method described 
by Lynch and Bushell [48]. The amounts of glycerol in the 
supernatant and in fresh medium were assayed by use of a 
commercial assay kit that employs a glycerokinase-coupled 
enzyme assay system (Boehringer Mannheim, Mannheim, 
Germany).
Assay of isocitrate lyase activity
Crude enzyme extracts were prepared as described by Honer 
zu Bentrup and coworkers [49] with minor modifications. 
Cells were harvested, washed three times with ice cold phos­
phate-buffered saline and resuspended in MOPS buffer (50 
mmol/1 MOPS (morphilinepropane sulfonate) [pH 6.8], 5 
mmol/1 MgClg, 5 mmol/1 L-cysteine, 1 m mol/1 EDTA) 
supplemented with protease inhibitors (Complete™; Roche,
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Welwyn Garden City, UK). The cells were disrupted using a 
Ribolyser (Hybaid, Hyhaid Ltd., Ashford, Kent, UK); speed 
setting 6.5 for 30 s) with careful cooling between each cycle. 
A lactose dehydrogenase coupled continuous method was 
used to assay isocitrate lyase activity [50].
Construction of the GSMN-TB
The genome-scale model of the related actinomycete S trep to ­
m yces coelicolor [21] was used as the starting point for the 
construction of the genome-scale metabolic network (GSMN) 
of M ycobacterium  tuberculosis. The gene orthology clusters 
computed by the KEGG database [51] were used to assign the 
respective M. tuberculosis  H37RV gene numbers to the genes 
present in the S. coelicolor model. The KEGG and MtbRvCyc 
(part o f BioCyc) databases were used to incorporate addi­
tional M . tuberculosis specific reactions that do not have S. 
coelicolor counterparts. In situations in which a reaction was 
essential to produce a viable in silico  model but the gene was 
not annotated in the genome, the reaction formulae was 
included in the model without genomic evidence. A  
significant proportion of the model was manually generated 
from journal publications describing dedicated experimental 
work (Table 1). For instance, the route for glycerol utilization 
is generally assumed to proceed via glycerol kinase followed 
by dehydrogenation [26]. However, many bacteria utilize an 
alternative pathway whereby glycerol is first oxidized by glyc­
erol dehydrogenase before being phosphorylated [52]. Glyc­
erol dehydrogenase activity has been detected in M . 
tuberculosis [53,54], hut no gene encoding this activity has 
been annotated in the genome. Several genes encoding puta­
tive alcohol dehydrogenases are present, which could oxidize 
glycerol to glyceraldehyde (EC 1.1.1.72) to be further oxidized 
and then phosphorylated before entering glycolysis. This 
pathway is also included in the model.
Flux balance analysis
Computer simulation protocols that are used in this work and 
made available in our interactive web resource are based on 
FBA. The principles of FBA are described in detail elsewhere 
[16,55]; here we briefly present the basic assumptions for the 
sake of introducing notation. The stoichiometric model of 
GSMN-TB was represented by the following equation:
b = S X V (1)
Where b = (dc^/dt,..., dc^/dt) is the vector of concentration 
changes of m metabolites (q  being the concentration of the Fh 
metabolite); v is the vector of metabolic fluxes carried out by 
n reactions in the network; and S is the m x  n  matrix of the 
stoichiometric coefficients. Fluxes are further subjected to the 
capacity constraints: Uj< Vj< Pj (where Oj and Pj are the lower 
and upper hounds of the flux carried by the j^ h reaction). The 
hounds of irreversible reactions were set to Oj = o and Pj = +00; 
the hounds of reversible reactions were set to aj = -00 and Pj = 
+00, allowing these reactions to carry either positive or nega­
tive flux. Following FBA methodology, we have studied
metabolism under steady-state conditions in which there is 
no accumulation of intracellular (internal) metabolites, and 
concentrations of these metabolites do not change:
b i = o  = ] £ S i j V j A C j e I
j= i
(2 )
Where I denotes the set of internal metabolites. Extracellular 
(external) metabolites transported from or secreted to the 
environment were not required to obey the balance equation 
(Equation 2) and were considered to have unlimited sources 
and sinks. Transport reactions for nutrient sources, which 
were rate limiting in chemostat experiments, were con­
strained to the experimentally determined flux values. In 
addition, a pseudo-reaction has been added to the system to 
model growth (biomass synthesis). The growth reaction has 
only one product, representing biomass, where the substrates 
correspond to biomass components and real-valued stoichio­
metric coefficients represent biomass composition. The flux 
through this reaction is equal to the growth rate of the hulk 
cell culture.
Linear programming was used to determine maximal theo­
retical flux toward a selected (internal or external) metabolite 
Z in the network, consistent with constraints imposed by 
stoichiometric matrix, balance conditions, and capacity 
bounds. The following linear programming problem was 
solved.
Maximize Z such that:
Z -  bj, —
j= i 
b = S x v
Vi G I, bj = o, i z
t t j  <  V j  <  P i
(3)
If the coefficients of optimization function Z have been set to 
the row of the stoichiometric matrix corresponding to bio­
mass metabolite, the result of linear programming optimiza­
tion represented the maximal theoretical growth rate.
The optimal value of the objective function calculated by FBA 
is unique, but associated metabolic flux distribution is not. 
There may be many flux distributions resulting in the same, 
optimal value of objective function. Therefore, flux distribu­
tions computed by single FBA simulation cannot be used to 
study internal metabolic state of the cell. The FVA method 
finds the full numerical range of each flux in all alternate flux 
distributions resulting in the same optimal value of objective 
function. During FVA simulation the objective function is 
constrained to its optimal value. Subsequently, the flux 
through each reaction in the model is subjected to minimiza­
tion and maximization, resulting in minimal and maximal
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value defining the flux range. These values are unique and can 
be used to investigate metabolic state of the cell.
Definition of growth requirem ents in vitro and in vivo
Biomass composition was estimated from reported data from 
a variety of sources (Additional data file i). To account for the 
different growth requirements of M. tuberculosis growth in  
v itro  and in v ivo , we defined two biomass synthesis formulae 
with different sets of components required for growth. 
BIOMASSi reflects the actual macromolecular composition 
of M . tuberculosis. BIOMASSe is a minimal macromolecular 
composition ofM . tuberculosis and includes only those com­
ponents thought to be essential for growth in v itro .
Modeling of co-factor requirem ent of enzym atic 
reactions
Numerous enzymes require nonpeptide co-factors that are 
regenerated either within the reaction or in a coupled reac­
tion. Co-factor utilization can provide useful clues to meta­
bolic activity, and co-factor synthesis pathways may provide 
potential drug targets. Stoichiometric models of metabolism  
published thus far either do not include co-factors in reaction 
formulae or balance co-factor consumption reactions with 
reactions that regenerate the cofactor (as for NAD/NADH in 
our model). However, in FBA analysis this strategy has the 
effect of eliminating the need for co-factor synthesis. 
Although enzyme co-factors are not consumed by reactions, 
they have finite chemical stability and must be replenished by 
de novo  synthesis. To force a flux toward synthesis, FBA mod­
els often include the co-factor in biomass composition but 
this has the effect of making synthesis of the co-factor consti­
tutive in all conditions, which may be appropriate for essen­
tial co-factors such as NAD but is less so for co-factors such as 
molybdenum, which m aybe required only under certain con­
ditions. To simulate the nonconstitutive requirement for 
these co-factors, we introduce the concept of a replenishing 
flux in which the nonconstitutive cofactors are included in 
reactions hut with an arbitrary veiy low (o .oo i) stoichiomet­
ric coefficient toward consumption. Reversible reactions are 
written twice with co-factor consumption in both directions. 
This has the effect of forcing co-factor synthesis only in con­
ditions where the co-factor utilizing reaction is active. The 
small replenishing flux toward co-factor synthesis has little 
influence on the magnitude of flux carried by the reaction and 
on the energy and mass balance of the metabolism, but it 
makes co-factor synthesis essential for the reaction to 
proceed.
Model calibration by comparison with chem ostat data
Calibration of the model involved determination of three 
energetic parameters. The first of these is the ratio of the 
number of ATP molecules formed to the number of O atoms 
reduced by electron transport (? /O ratio). The P/ 0  ratio is set 
by the stoichiometric coefficients of the reactions involved in 
electron transport and ATP synthesis. The second is the 
growth-dissociated cost of polymerization of the building
blocks into biologic polymers (DNA replication, transcrip­
tion, translation, and so on; m^Tp)- To account for growth-dis­
sociated cost, ATP dissipating reaction was included in the 
system and its flux was constrained to The final param­
eter is the cost of growth-associated maintenance (Yx^xp), 
modeled by including ATP hydrolysis as a part of the biomass 
synthesis formula.
To compare quantitative model predictions with our chemo­
stat data, we constrained the growth rate to a chemostat dilu­
tion rate and computed the minimal glycerol uptake rate. The 
stoichiometry of the electron transport chain was considered 
to be similar to that of C orynebacterium  g lu tam icu m  [56]. 
The ATP yield coefficient Y^atp and the maintenance flux 
m^Tpwere systematically changed to achieve good agreement 
with chemostat data, following previously reported 
approaches [21].
Gene essentiality prediction and comparison with 
TRASH data
For each gene we pre-computed the list of all reactions in the 
model that require the product of this gene, according to 
Boolean rules describing gene-protein relationships. Subse­
quently, the effect of gene inactivation on growth was pre­
dicted by constraining the fluxes through all reactions 
requiring this gene to 0 and running linear programming to 
determine the resulting maximal theoretical growth rate. If 
the resulting growth rate was less than 0.001, then the gene 
was considered to he essential for growth.
Computational predictions were compared with the findings 
of TraSH mutagenesis experiments [28,57]. Transport reac­
tions were constrained to reproduce the experimental condi­
tions utlilized in the TraSH mutagenesis experiment (7H10 
agar composition) and essential genes were computed. The 
list of genes that were predicted to he essential in v itro  was 
compared with the list of in v itro  essential genes identified by 
TraSH mutagenesis [28]. To test whether model predictions 
are closer to the TraSH mutagenesis data than expected by 
chance, we applied a Fisher exact test. The null hypothesis of 
this test, as applied to our data, states that gene essentiality 
assignments performed by the GSMN-TB model and TRASH 
experiments are independent.
Implementation of calculations presented in this work 
and web-based software
Linear programming calculations and evaluation of Boolean 
expressions representing gene-protein associations were 
implemented in C programming language using GNU Linear 
Programming Kit library [58]. The weh interface was imple­
mented as a collection of Perl-CGI scripts running computa­
tional module under Linux operating system. Data handling 
during model building was performed in MS Excel, Perl, 
Python, and MySQL. Comparison of gene essentiality predic­
tions with TRASH data was implemented in R [59].
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Additional data files
The following additional data are available with the online 
version of this paper. Additional data file i  illustrates the esti­
mated macromolecular composition for M . tuberculosis. 
Additional data file 2 shows the calculations used to estimate 
that composition. Additional data file 3 shows the conversion 
between stoichiometric formulae and mmol/1 per gram of 
biomass. Additional data file 4 shows reaction formulae, lim­
its, Enzyme Commission (EC) numbers, genes, and pathway 
classifications. Additional data file 5 provides references for 
those reactions. Additional data file 6 provides metabolite 
names. Additional data file 7 contains instructions on how to 
use the GSMN-TB server, illustrated by screenshots.
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For m e tab o lic  ab b rev ia tio n s, s e e  list of m e tab o lite s  in th e  G SM N ex cel file (CD).
Abbreviation Meaning
G row th ra te
AIDS A cquired  Im m unoD efic iency  S y n d ro m e
ATCC A m erican  T ype  C u ltu re  C ollection
BBSRC Biological S c ie n c e s  R e s e a rc h  C ouncil
BCG bacille Cal m e tte  G uerin
BLAST B asic  Local A lignm ent S e a rc h  Tool
CPU C olony form ing units
DW Dry w eight
EC number E nzym e C om m ission  n u m b e r
EMB E tham buto l
PASTA “FAST-ALL” DNA a n d  P ro te in  s e q u e n c e  a lig n m en t so ftw are  p a c k a g e
PBA Flux b a la n c e  an a ly s is
PN F a lse  N ega tive
PP F a lse  P ositive
PVA Flux variability an a ly s is
g G ram
GNU “G n u ’s  not Unix” (a  c o m p u te r  o p era tin g  sy s tem )
GSMN G e n o m e  sc a le  m etabo lic  netw ork
h H our
HIV H um an  Im m unodefic iency  Virus
HMM H idden M arkov M odel
INH Isoniazid
Kegg Kyoto E ncyc loped ia  of G e n e s  an d  G e n o m e s
LP L inear p rogram m ing
iriATP M a in te n an ce  en e rg y
MDR-TB M ultidrug-resistan t TB
MPA M etabolic flux an a ly sis
mRNA M e sse n g e r  RNA
MySQL S Q L  d a ta b a s e  m a n a g e m e n t sy s te m
NTM N on -tu b ercu lo u s m y c o b ac te ria
ORP O p en  read ing  fram e
P/0 ratio p h o sp h a te -to -o x y g en  ratio
PPP P e n to s e  p h o sp h a te  p a th w ay
PZA P y raz in am id e
qCOz C arb o n  dioxide p roduction  ra te
q02 O xygen u p ta k e  ra te
qS Specific  s u b s tra te  u p ta k e  ra te
R A p rogram m ing  la n g u a g e  for s ta tis tic s
RIP Rifam picin
ROC R e ce iv e r  op era tin g  ch a rac te ris tic
rRNA R ibosom al-R N A
SQL S tru c tu red  Q uery  L an g u a g e
STM S trep tom ycin
TB T u b ercu lo sis
TCA Tricarboxylic ac id  (K reb’s  cycle)
TN T ru e  N egative
TP T ru e  Positive
TraSH T ra n sp o so n  site  hybridization
tRNA T ransfer-R N A
WHO W orld H ealth  O rgan ization
XDR-TB E xtensively  D ru g -R esis tan t TB
Y xATP G row th a s so c ia te d  e n e rg y  co s t
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